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Chapter 1 
INTRODUCTION
Partly based upon: Tijdschrift voor Kindergeneeskunde 2001;69:193-200.  
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Introduction 
Preterm infants and postnatal growth 
At birth infants can be classified on the basis of their gestational age or 
on their weight. Infants born before 37 weeks of gestation are 
premature, those born with a weight less than 2500 g are low birth 
weight infants (LBW), those weighing less than 1500 g are very low 
birth weight infants (VLBW), and those less than 1000 g are extremely 
low birth weight infants (ELBW). If a neonate weights less than the 5th 
percentile for its gestational age, it is small for gestational age (SGA), 
if not, it is appropriate for gestational age (AGA). Intrauterine growth 
retardation (IUGR) is often used interchangeably with SGA, although 
its meaning is subtly different. To be IUGR implies that the infant’s full 
growth in utero was not achieved, for example, due to placental 
inadequacy. A SGA infant born to parents who are both less than the 
fifth centile for height may have achieved its full genetic potential in 
utero and is not IUGR. Similarly, LBW infants may be term IUGR, term 
SGA, appropriately grown preterm, SGA preterm, or IUGR preterm.  
Over the past two decades neonatal populations and nutritional 
standards have changed and the number of preterm infants with a 
birthweight <1000 g has increased. Furthermore, the advances in the 
ventilatory support, resuscitation, and pharmacological management, 
have increased the survival rate of preterm infants from 15 to 75%. 1-6 
However, the neonatologists involved with the care of these newborns, 
are now faced with a constellation of problems, which include 
prevention of morbidity. The importance of the gastrointestinal system 
in meeting these challenges is well recognized. According to the 
recommendations of the American Academy of Pediatrics, weight gain 
should occur at the same rate as intra-uterine weight gain (14-20 
g/(kg·d) 7,8, but several studies have shown that the growth rate of 
preterm infants does not reach intra-uterine growth rates, as is shown 
in Figure 1. 9-11 Postnatal linear growth retardation (body length <10th 
percentile of the Lubchenco’s curves at discharge) 12 was observed in 
22% of the AGA preterm infants at birth in an epidemiological study 
including approximately 800 preterm infants with a birthweight 
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<1500g. 13 The postnatal lag of growth is related to long term growth 
and neurodevelopmental delays at least through schoolage 14-18 and 
possibly, into adulthood. 19 Despite all this, information about protein 
and energy requirements of VBLW infants is sparse. The observed 
postnatal lag of growth defines critical needs for further studies about 
the nutritional requirements for growth of preterm infants, how they 
should be fed, and whether improved growth and developmental 
outcomes can be achieved with for instance earlier and more 
sophisticated postnatal nutrition.  
 
Figure 1. Average body weight versus postmenstrual age in weeks for 
infants with gestational ages 24 to 25 weeks (dotted line), 26 to 27 
weeks (short dashes), and 28 to 29 weeks (long dashes) from 
Ehrenkranz et al. 10 The reference intrauterine growth curves were 
plotted using the smoothed 10th and 50th percentile birth weight data 
reported by Alexander et al. 8 
Introduction 
 10 
 
Still, nutritional regimens differ greatly from one neonatal 
intensive care unit to another, particularly for neonates with critical 
illness or VLBW infants in the first weeks of life. In these neonates, 
total parenteral nutrition is often gradually advanced over the first 2 
weeks of life because of concerns of feeding intolerance and eventually 
necrotizing enterocolitis (NEC), despite the fact that parenteral 
nutrition for preterm infants theoretically should simulate intrauterine 
feeding. The presumed incapability to metabolize nutrients is often 
ascribed to the stress of birth, immature metabolic pathways, and 
pathophysiologic processes associated with different disease states, 
such as infection. Specifically, the introduction of amino acids in the 
first days of life in ill and premature infants is often limited due to 
concerns over these infants’ inability to metabolize specific amino 
acids, which could result in uremia, hyperaminoacidemia, and 
metabolic acidosis. 20 However, several studies have examined the 
issue of early initiation of parenteral nutrition, and they have shown 
that the preterm infant is capable of metabolizing parenterally 
administered amino acids from birth onwards. 21,22 There were no 
recognizable metabolic derangements, like hyperammonemia, 
metabolic acidosis or distorted plasma amino acids patterns. A rise in 
blood urea nitrogen, which is often observed after the start of total 
parenteral nutrition, is not an adverse effect or sign of toxicity. Rather, 
an increase in urea nitrogen is a normal accompaniment of an increase 
in the intake of amino acids. 23  
Evidence is accumulating that the amino acid requirements for 
neonates receiving total parenteral nutrition are significantly lower (25-
50%) than those for oral feeding. 24-26 On the other hand, the high 
rates of weight gain we are trying to establish in preterm infants are 
only possible with a well-developed gut that is able to absorb and 
digest a high intake per mass unit. A well-developed gut function 
reduces the need for prolonged parenteral nutrition, consequently 
reducing morbidity and will, therefore, have a significant health and 
economic impact.  
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A growing body of evidence suggests that the gut modulates 
amino acid flux and inter-organ relationships in various metabolic 
states. This may be particularly true during the absorptive period, 
when the intestine: 1) controls the amino acid absorption, 2) may 
modulate the different metabolic fates of absorbed amino acids, and 3) 
consequently influences the availability of amino acids for the 
peripheral tissues. For example, dietary amino acids are major fuels for 
the small intestinal mucosa (e.g. glutamine), 27-30 and are essential 
precursors for intestinal synthesis of glutathione, nitric oxide, 
polyamines, purine and pyrimidine nucleotides, and are obligatory for 
maintaining the intestinal mucosal mass and integrity. 31-33  
Given the key role of the intestine in the maintenance of neonatal 
health, there has been considerable interest in the intestinal amino acid 
requirements. In specific, our interest is on the developmental and 
physiological aspects of intestinal metabolism in relation to enteral 
feeding in preterm infants. Of the many factors that affect neonatal gut 
growth, probably the most physiologically stimulus is enteral nutrition. 
Oral nutrients act directly by supplying nutrients for growth and 
oxidative metabolism of mucosal epithelial cells, and indirectly by 
triggering the release of gut hormones, local growth factors, and 
activating neural pathways. Because of the intestinal absorptive and 
secretory functions, the energy requirements of the intestine are high. 
Moreover, the gut requires energy for the synthesis of digestive 
enzymes, and the renewal of enterocytes. In line with these high 
intestinal substrate requirements, enteral nutrient deprivation is known 
to adversely affect gut DNA and protein mass, cell proliferation, villus 
height, and protein synthesis. 34-36  
Regarding the different metabolic fates of intestinally absorbed 
amino acids; the catabolic and anabolic utilization of amino acids within 
the gut might significantly influence the requirements for specific 
amino acids. The impact of intestinal metabolism is particularly 
important for rate-limiting essential amino acids, i.e. lysine in the 
formula fed neonate (Figure 2), or for amino acids such as threonine 
that play a critical role in the secretory function of the gut. 37,38 Besides 
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non-essential amino acids, there is limited knowledge of the essential 
amino acids required for intestinal growth and function. Moreover, little 
is known about the interaction between intestinal essential amino acid 
requirements and the dietary protein intake. A recent study with 
piglets, however, showed that lysine oxidation in the portal-drained 
viscera (PDV; intestine, pancreas, spleen and stomach) is virtually 
absent in piglets during protein restriction, whereas the total lysine use 
of the PDV is largely unaffected by a low protein diet. 39  
The focus of this thesis is to evaluate the splanchnic metabolism, 
which includes the intestine and the liver, of two essential amino acids 
in particular, e.g. lysine and threonine. Because of limitations in 
studying nutrient metabolism in preterm neonates, several studies in 
neonatal animals have been performed to quantify protein metabolism 
in vivo. 
 
Figure 2. Amino acid composition of human milk and the fetus 
 
 
 
 
 
 
 
 
 
 
 
 
Lys, lysine; thr, threonine; leu, leucine; isoleu, isoleucine; val, valine; phe, 
phenylalanine; met, methionine. 
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1) ethical and practical restrictions that limit manipulation of feeding 
regimens and design of experiments, 2) a heterogeneous population 
with different illnesses that complicate metabolic demands, 3) 
validation of nutritional assessment techniques in this particular age 
group, 4) given the limited access to most organ systems, the 
approaches used must allow extrapolation from the sampled data to 
events in otherwise inaccessible areas, and 5) the maximal information 
possible must be obtained from a study owing the need for studying 
the smallest number of subjects necessary to evaluate adequately the 
proposed hypothesis.  
The use of an animal model permits experimental studies involving 
a healthy population, specifically designed feeding regimens, and more 
invasive and sensitive methods that would not be accepted in humans. 
Such a model can provide a comprehensive and profound picture of 
many fields in the neonatal nutrition research. 
 
Figure 3. Duodenal growth rate of neonatal pigs, expressed as a 
fraction of whole-body weight 
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permissibility for invasive studies. The neonatal pig fulfills these 
requirements. The neonatal piglet is considered to be an appropriate 
model for the human infant due to similarities in anatomy, physiology 
and metabolism. In specific, the amino acid metabolism is comparable 
between the piglet and the human infant, because both species show 
similar patterns of indispensable amino acid requirements. 40-42 The 
average gestational age and birth weight of the term infant are 
approximately twice those of the piglet. 43 In contrast, the piglet grows 
and develops more rapidly than the preterm infant (Table 1). 44  
 
Table 1. Comparison of the growth rates between the neonatal pig and 
the human infant 
 
Species 
 
Gestation 
d 
Birth Weight 
g 
Growth Rate 
g/(kg·d) 
Infant 280 3500 12.5 
Pig 120 1500 4.2 
 
Regarding the gastrointestinal tissues, the intestine grows rapidly 
in the first weeks of life, and undergoes a profound increase in weight 
compared to the total body weight (Figure 3). The gastrointestinal 
development and physiology of the neonatal pig is similar in preterm 
infants. 45-49 And finally, term piglets and preterm human infants also 
have many similarities in body composition of protein and fat; the 
greatest number of similarities occurs when the human infant is born 
between 23 and 31 weeks of gestation (Table 2).  
 
Table 2. Protein and fat composition of the neonatal pig and the human 
infant 
 
 Pig 
At term 
Infant 
23 wk 
Infant 
26 wk 
Infant 
31 wk 
Infant 
37 wk 
Infant 
40 wk 
Protein (%) 11.3 8.8 8.8 10.6 11.8 11.9 
Fat (%) 1.1 1.0 1.0 2.3 7.4 16.0 
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As a result of the reported similarities between the two species, 
the neonatal piglet has been used as a model for growth and 
development of the gut 50-53 and as a model for the TPN fed human 
infant. 50,54-56  
A complicating factor in studying intestinal metabolism is that the 
intestinal mucosa receives and utilizes nutrients from two sources, 
from the diet (brush border membrane) and the systemic circulation 
(basolateral membrane) (Figure 4). 57-59 Therefore, we have developed 
an arterial and portal catheterized piglet model to study visceral amino 
acid metabolism in growing, fed piglets. 60 We performed studies in 
their first weeks of life, because the impact of intestinal substrate 
metabolism on whole-body substrate metabolism should be maximal 
during this period due to the relatively high growth rate. In these 
studies on intestinal protein metabolism, we used stable isotope 
labeled tracers of several different amino acids and glucose.  
 
Figure 4. Schematic representation of the gut in the piglet model 
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Stable isotope techniques 
To study metabolic pathways and turnover in animals and humans, 
stable isotopes have been used for the last 65 years. Stable isotopes 
take advantage of being non-radioactive, and thus, can safely be used 
in preterm infants. Moreover, the primed constant intravenous infusion 
of amino acids labeled with stable isotopes has become the reference 
method for studying whole-body protein dynamics. 61-63 Importantly, 
the use of portal vein catheterization has demonstrated the important 
contribution of intestinal and hepatic tissues to whole-body protein 
metabolism. 64,65 To assess splanchnic amino acid metabolism in a non-
invasive manner in neonates, the constant gastric or intraduodenal 
infusion of a labeled amino acid can be used in combination with the 
intravenous infusion of different labeled tracer of the same amino acid.  
This dual route of infusion allows the calculation of “first-pass 
splanchnic extraction”; a reflection of the intestinal and hepatic 
utilization of a specific amino acid. With the assumption that there is no 
malabsorption of the tracer and substrates, the comparison between 
plasma enrichments of the enterally and intravenously infused tracers 
will allow the calculation of the first-pass splanchnic uptake. It has 
been demonstrated in several studies that there is hardly any 
malabsorption of tracers. First, less then 1% of [14C]phenylalanine was 
found in stools after oral [14C]phenylalanine administration. 66 Second, 
studies in adults have shown a high digestibility of approximately 98% 
of milk proteins, 67 and finally studies in infants showed that even 
intact proteins are rapidly and almost completely digested and 
absorbed in the distal region of the ileum. 68 Thus, dual tracer studies 
seem very useful in assessing splanchnic utilization and metabolic rates 
of different substrates.  
The antecedents of clinical applications of 13CO2 measurements lie 
in the use of [14C]labeled compounds for research and diagnosis in 
departments of nuclear medicine in the early seventies. In a number of 
instances, [13C]labeled substrates have been used to study metabolic 
and physiological conditions in which the recovery of 13CO2 in breath 
provided useful information. These studies have been designated 
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collectively as breath tests, i.e. for fat malabsorption, disaccharidase 
deficiency. 69-72 These tests share the common characteristics of 
requiring a substrate whose structure contains a labeled functional 
group that may be enzymatically cleaved under specific conditions. 73 
This may occur during the migration of the substrate down the 
gastrointestinal tract, during its absorption or subsequent to its 
transport to a specific organ, terminating in the release of labeled 
carbon dioxide from the lungs.  
 
Figure 5. Natural variation in the abundance of 13C expressed both as 
percent 13C and as relative enrichment or depletion relative to Pee Dee 
Belemnite limestone. 74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As shown in Figure 5, the natural abundance of 13C in nature is 
approximately 1.1%. 74 The natural enrichment of stable isotopes is 
normally accounted for by taking baseline samples prior to the start of 
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baseline sample from all the samples obtained during and/or after the 
isotope infusion. This is satisfactory for studies in which no change in 
metabolic status occurs during the study. By keeping the nutrient 
intake constant in the study subjects as is done in the studies 
presented in this thesis, it can be assumed that variation in 
background enrichment of expired CO2 is negligible.  
To assess splanchnic and whole-body protein kinetics with the use 
of different stable isotope labeled substrates, specific calculations are 
needed.  
 
Substrate metabolism calculations 
After the start of the stable isotope infusion, the labeled substrate will 
enter a metabolic pool by continuous infusion, and eventually an 
isotopic plateau will be achieved. Injecting a priming dose of tracer just 
before the start of the infusion can shorten the time it requires to reach 
an apparent isotopic equilibrium.     
The measurement of the quantity of excess 13CO2 over baseline 
values requires extremely precise techniques; therefore the isotopic 
enrichment of a labeled substrate is measured by mass spectrometry. 
Depending on the substrate an isotope ratio mass spectrometry 
(IRMS), a gas chromatograph mass spectrometry (GCMS) or a gas 
chromatograph isotope ratio mass spectrometry (GC-IRMS) can be 
used. For example, after an infusion of [13C]sodium bicarbonate, the 
ratio of the ion intensity of mass 45 to mass 44 (13CO2/ 
12CO2) is 
measured for the sample and compared with the identical ratio for the 
standard CO2 sample of known isotopic composition. The difference 
between the sample and the standard is given with the following 
calculation: 
   δ ‰ = [(Ru – Rs / Rs] x 1000  
where Ru is the sample and Rs is the standard ratio. The quantities are 
so small that they are multiplied by 1000; called per mil. To facilitate 
interlaboratory comparisons, the results are expressed relative to CO2 
delivered from the PDB limestone, a Belemnite limestone of well-
defined isotopic abundance (13C/12C = 0.011237). 75 
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The stable isotope technique for the in vivo assessment of protein 
kinetics is based on a model 76,77 which can be summarized as follows 
(Figure 6): amino acids from the diet (I) and from protein breakdown 
(B) enter a metabolic pool of amino acids. Amino acids are withdrawn 
from this pool for protein synthesis (S) or for amino acid oxidation (O). 
Assuming that this pool is constant in size, the input of amino acids is 
equal to the output and corresponds to Q, which is the rate of amino 
acid flux through the amino acid pool: 
Q = I + B = S + O  
Changes in the rates of these systems permit an adjustment in 
nitrogen balance, which might remain in equilibrium or detoriate in a 
negative balance depending upon the degree of change in protein 
intake.  
 
Figure 6. Model of protein kinetics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oxidation rates of substrates are calculated as the product of the 
flux rate and the percentage of the 13C-label transferred from the 
infusate to the breath. By measuring the rate of amino acid oxidation, 
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an estimate of the net retention of the amino acid (i.e. rate of protein 
synthesis) can be derived by subtracting the oxidation rate from the 
intake of the amino acid. Briefly summarized, with the use of 
[13C]labeled tracers it is possible to determine rates of substrate 
oxidation from expired breath 13CO2 measurement, whereas plasma 
[13C] enrichment at steady state allows for the calculation of the 
substrate appearance rate.  
For the calculations of substrate oxidation in preterm infants the 
CO2 production rate should be known. Several methods are known to 
quantify VCO2, but closed circuit indirect calorimetry is the most 
commonly performed method and serves as the gold standard for the 
estimation of VCO2. However, particular circumstances in preterm 
infants make the use of the results obtained from indirect calorimetry 
difficult. Another method to estimate the CO2 production and calculate 
substrate oxidation is the use of the previously mentioned [13C]sodium 
bicarbonate infusion. But, this tracer technique uses a relatively time 
consuming and complicated method to collect expired air.  
We aimed to develop an alternative method to collect expired air 
in preterm infants based on the previously described breath test by 
Perman et al. 69 This direct naso-pharyngeal sampling technique offers 
the advantage of being simple, easy to perform, and non-time 
consuming, and is therefore possibly appropriate for the use in preterm 
infants in combination with a [13C]bicarbonate infusion for the 
calculation of substrate oxidation. 
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Aims of the thesis 
The overall purpose of the work presented in this thesis is to quantify 
intestinal substrate metabolism in both the preterm neonate and the 
neonatal pig, and its relationship with the level of enteral intake. With 
the determination of the intestinal substrate metabolism and the 
response to an increase in enteral intake, a better understanding of the 
obligatory intestinal need of substrates in the first weeks of life of 
preterm infants is possible, ultimately leading to an improved feeding 
strategy to support growth. Overall, the ability to establish and 
maintain normal gastrointestinal function has a critical influence on the 
clinical care and nutritional support of neonates, especially those born 
preterm.  
Part one of this thesis describes the substrate metabolism of the 
portal-drained viscera in neonatal piglets under different feeding 
circumstances. 
The metabolism of dietary essential amino acids by the gut has a 
direct effect on their systemic availability and potentially limits whole-
body growth. The relative contribution of dietary and systemic 
utilization of threonine is an important question with regulatory 
implications, particularly in relation to nutritional effects. The first 
aim of this thesis is to determine the relative rates of arterial and 
dietary first-pass threonine metabolism during both a high protein and 
a low protein intake in neonatal piglets. 
The second aim is to quantify the net intestinal utilization of all 
amino acids, and glucose during a 12-h feeding period. Furthermore, 
we quantified the pattern of secretory (glyco-)protein recycling by the 
intestinal tissues during the following period of 12-h of fasting. 
The third aim is to answer the question whether the intestinal 
tissues of neonatal pigs have an obligatory requirement for amino acids 
as energy generating substrates, and what role they play under 
conditions of a low protein intake. 
Part two of this thesis describes the confirmation of the results 
obtained in neonatal piglets regarding intestinal substrate metabolism, 
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in comparison with splanchnic substrate metabolism in preterm human 
neonates.  
In clinical human studies, the metabolism of [13C]labeled 
substrates to CO2 and the measurement of the appearance of an 
excess of 13C in respiratory CO2 have progressed to an increasingly 
common method. However, the collection of respiratory CO2 currently 
used; trapping in NaOH, is not well suited for application in a clinical 
situation. In order to collect breath samples from preterm infants in a 
suitable manner, we employed the direct naso-pharyngeal sampling 
technique previously described by Perman et al. used in older 
children.69 The fourth aim of this thesis is to validate our direct 
sampling method for the collection of expiratory air in preterm infants.  
Lysine is the first limiting essential amino acid in the diet of 
newborns. Thus, if the pattern of amino acids in the diet is not ideal, 
the rate of protein synthesis and growth will be determined by lysine. 
Previously, we have found in piglets under normal high-protein-feeding 
conditions (22 g/(kg·d) protein) that about half of the dietary lysine 
intake was utilized by the portal-drained viscera (PDV: i.e. intestine, 
pancreas, spleen and stomach), and that this utilization fraction even 
increased during dietary protein restriction. 39 Apart from the first-pass 
lysine utilization, the magnitude of lysine catabolism is also important 
to the nutrition of preterm newborns. The fifth aim of this thesis is 
to measure lysine kinetics in preterm infants in order to gain insight 
into the importance of the splanchnic tissues, in particular the 
intestine, in relation to whole-body lysine kinetics.  
Threonine is an essential amino acid that is abundantly present in 
intestinally produced (glyco-)proteins. Aim number six is to answer 
the question whether the first-pass threonine metabolism by the 
intestine is substantial irrespective of the enteral intake, in preterm 
infants during their first weeks of life. 
Under both high and low protein feeding conditions, glucose is a 
major oxidative substrate for intestinal energy generation in neonatal 
piglets. The final aim of this thesis is to investigate the first-pass 
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uptake and oxidation of glucose by the intestinal tissues in newborn 
infants during a low and full enteral intake. 
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Background & Aims: The whole-body threonine requirement in TPN-fed 
piglets is substantially lower than the requirement in enterally fed 
piglets, indicating that enteral nutrition induces intestinal processes in 
demand of threonine. Regarding the significant contribution of threonine 
to intestinal (glyco-)proteins, we hypothesized that the threonine 
utilization by the portal-drained viscera (PDV; intestine, pancreas, spleen 
and stomach is independent of the dietary protein intake. Methods: 
Twenty-three growing piglets were fed an isocaloric diet with either a 
high-protein (HP) or a low-protein (LP) content. Intraduodenal and 
intravenous infusions of [U-13C]threonine were used to determine whole-
body and first-pass kinetics of threonine by the PDV. Results: In HP-fed 
pigs, both dietary and systemic threonine were utilized by the PDV in 
equimolar amounts [dietary utilization: 459 ± 53 vs. systemic utilization: 
497 ± 93 µmol/(kg·h)]. The total threonine utilization was significantly 
affected by protein restriction [HP: 765 ± 57 vs. LP: 355 ± 48 
µmol/(kg·h), P < 0.001]. However, the equivalent of the total dietary 
threonine intake was extracted by the PDV during LP-feeding. During 
high protein feeding conditions, both dietary and systemic threonine were 
oxidized by the PDV, and the first-pass threonine oxidation accounted for 
approximately one-third of the whole-body threonine oxidation [FP 
oxidation: 42 ± 14 vs. WB oxidation: 117 ± 18 µmol/(kg·h)]. The whole-
body threonine oxidation was significantly decreased by protein 
restriction, in contrast to the first-pass threonine oxidation which was not 
significantly affected. Similar to HP-feeding, both systemic and dietary 
threonine were oxidized in first-pass by the PDV. Conclusion: We 
conclude that, in vivo, the PDV have a high obligatory visceral 
requirement for dietary threonine, especially during a low protein intake. 
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he small intestinal mucosa is one of the most metabolically active   
tissues in the body. For example, the PDV in neonatal pigs accounts 
for 4 to 6% of the whole-body mass, but are responsible for about 
25% of the total whole-body CO2 production, and for 20-50% of the 
total protein turnover. 1-5  
Studies in animals have shown that more than 70% of the first-pass 
metabolism of some essential amino acids by the splanchnic tissues 
occur in the intestine. 6-8 For some non-essential amino acids, notably 
glutamate, the first-pass splanchnic extraction exceeds 90% of the 
dietary intake, both in humans and in pigs. 9,10 In humans, the 
splanchnic tissues retain between 20 to 50% of the dietary intake of 
specific essential amino acids. 11 Altogether, these studies indicate that 
the small intestine has a substantial amino acid metabolism. 
In this context, threonine is of critical nutritional importance, 
because it is the single most used essential amino acid by the PDV. The 
retention of threonine by the PDV ranges from 60-80% of the dietary 
intake under normal feeding circumstances. 12-14 A major metabolic fate 
of threonine might be incorporation into secretory (glyco-)proteins, 
because threonine is particular dominant in intestinal mucins, with 
threonine constituting 20% of amino acids in the core proteins of 
mucins.15 Interestingly and in a way confirming the above mentioned 
hypothesis is that whole-body threonine requirements are reduced by 
60% in piglets receiving total parenteral nutrition as compared to enteral 
nutrition. 16 Furthermore, dietary threonine does not seem to be 
incorporated in constitutive mucosal proteins to a large extend. 14 
The degree, to which the first-pass utilization of amino acids is 
dependent on the nutrient composition, and dietary protein intake in 
particular, is an important question. Although there have been few 
investigations concerning this question, the available data are 
contradictory. In a previous study with growing pigs, we showed that 
during protein restriction the intestinal growth is preserved, apparently 
at the expense of skeletal muscle growth. 17,18 In addition, we have 
found that a prolonged period of protein restriction lowers the fractional 
rate of mucosal protein synthesis by only 25%. 19 Furthermore, we 
T 
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reported that the total lysine utilization by the PDV was largely 
unaffected by low-protein feeding. 12 The investigation of the response of 
first-pass threonine utilization by the PDV to a low protein intake was the 
first objective of our study. 
Uniquely, the mucosal cells receive substrates directly both from the 
diet and from the mesenteric circulation and previous studies showed a 
compartmentalization of amino acids by the intestinal tissues. 8,10,12,20,21 
The proportion of visceral threonine metabolism derived from the luminal 
and the arterial site is not known. Therefore, the determination of the 
relative rates of arterial and dietary first-pass threonine metabolism in 
the PDV was the second objective of this study. Once taken up by 
intestinal cells, substrates can be used for different metabolic fates, 
including catabolism for intestinal energy generation. If the predominant 
fate of dietary threonine in the enterocyte is oxidation, then the first-
pass metabolism by the intestine is a source of nutritional inefficiency. 
The first-pass oxidation of threonine by the PDV was the third aim of this 
study. 
In summary, we report the utilization of dietary and systemic 
threonine by the PDV in 4-week old piglets receiving iso-energetic diets 
containing either a high (HP)- or low-protein (LP) content. By using the 
dual isotope methodology, we were able to measure: 1) first-pass 
intestinal uptake of dietary threonine, 2) systemic threonine uptake by 
the PDV, 3) first-pass oxidation of threonine by the PDV, and 4) the 
response in intestinal and whole-body threonine metabolism to protein 
restriction.  
 
Methods 
Animals 
The Baylor College of Medicine Animal Protocol Review Committee 
approved the study. Housing and care of the animals conformed to the 
USDA guidelines. The study involved 23 four-week-old female crossbred 
piglets (Large White x Hampshire x Duroc) purchased from the Texas 
Department of Criminal Justice (Huntsville, TX). The pigs were received 
at the CNRC when they were 2 weeks old and were fed a liquid milk 
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replacer (Litterlife, Merrick, Union, WI) at a rate of 50 g/(kg·d) body 
weight. The composition  (per kg dry matter) of the milk replacer was 
500 g lactose, 100 g fat and 250 g protein. The calculated energy density 
was 18 MJ gross energy per kg dry matter. 
 
Study design 
The design has been described previously. 12,21-23 Briefly, at a postnatal 
age of 3 weeks, piglets underwent surgery after an overnight fast. 
Catheters were implanted into the stomach, the duodenum, the portal 
and jugular vein and the common carotid artery. An ultrasonic blood flow 
probe (Transonic Systems Inc., Ithaca, NY) was placed around the portal 
vein. Following surgery, the piglets received complete intravenous 
nutrition for 24-36 h. The pigs then received either regular Litterlife (HP 
diet: 12.7 g protein, 5.1 g lipid and 25.5 g carbohydrates per kilogram 
per day) or a diet that contained only 40% of the protein present in 
Litterlife (LP diet: 5.1 g protein, 7.5 g lipid and 30.4 g carbohydrates per 
kilogram per day). The protein intake during LP feeding was deliberately 
set at a rate to provide enough protein for body nitrogen maintenance. 
The diets were made iso-caloric by adding lactose (Sigma Chemical, St. 
Louis. MO) and corn oil in the same ratio as in the control (HP) diet. At 
postnatal d 28, whole body CO2 production was measured with an 
infusion of [13C]bicarbonate. The [U-13C]threonine infusion protocols 
were carried out on postnatal days 30 to 32, at which the animals had 
received full enteral feeding of the same diet (either LP or HP) for at 
least 8 days. 
 
Experimental protocol 
After an overnight fast, the pigs consumed a meal that supplied one-
seventh of the preceding daily intake, to restore intestinal motility. 
Immediately thereafter, a continuous gastric infusion of diet was started 
at a rate that provided one-fourteenth of the preceding daily intake each 
hour. On postnatal day 28, [13C]bicarbonate (99%, Cambridge Isotope 
Laboratories, Inc, Andover, MA) was infused into the jugular catheter at 
a rate of 10 µmol/(kg·h). Arterial and portal blood samples (1mL) were 
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taken 15-min intervals from 75 to 120 min of infusion. On postnatal days 
30 to 32, [U-13C]threonine 97%, Cambridge Isotope Laboratories, Inc, 
Andover MA) was infused either via the duodenal or the jugular catheter 
at a rate of 10.8 µmol/(kg·h) for 5 h. During the last hour of the tracer 
infusion, four arterial and portal blood samples were drawn at 15-min 
intervals. The animals were killed with an arterial injection of sodium 
pentobarbital (50 mg/kg) and sodium phenytoin (5 mg/kg) (Beutanasia-
D; Schering-Plough Animal Health, Kenilworth, NJ).  
 
Analysis of samples 
Small aliquots (0.2 mL) were taken for direct determination of the 
concentrations of blood gases (Chiron Diagnostics, Halstead, Essex, UK), 
glucose and lactate (YSI analyzer, Yellow Springs, OH). An aliquot of 
whole blood (0.2 mL) was taken for subsequent analysis of amino acid 
concentrations by reverse-phase high performance liquid 
chromatography of their phenylisothiocyanate derivatives (Pico Tag; 
Waters). An aliquot of whole blood (1.0 mL) was placed in a 10-mL 
vacutainer (Becton Dickinson, Franklin Lakes, NJ) and 0.5 mL perchloric 
acid (10% wt/wt) was added. The vacutainer was placed on ice. Room 
air (8 mL), filtered through soda lime (Sodasorb, Grace container 
products, Lexington, MA) to remove carbon dioxide, was injected into the 
vacutainer and removed into a gas tight syringe. This air was transferred 
to a second vacutainer for subsequent analysis of isotopic enrichment of 
carbon dioxide on a continuous flow gas isotope ratio mass spectrometer 
(ANCA, Europa Instruments, Crewe, UK). The blood/perchloride acid 
mixture was centrifuged at 3,000 x g for 10 min and the supernatant 
stored at –20ºC. For analysis, the supernatant was thawed and brought 
to pH≤4 with KOH (4 mol/L). After centrifugation, the amino acids in the 
supernatant were bound to a 1 mL column of  Dowex 50 Wx8 (H+ form), 
eluted with 2 mL of 3 mol/L NH4OH, and dried under vacuum.  
Mass spectrometric analysis of threonine was conducted with a tri-
fluoro-acetyl-methylester derivative. 24,25 The isotopic enrichment was 
measured on a gas chromatograph (Hewlett Packard, Palo Alto, CA) 
connected to a combustion oven (850ºC) an isotope ratio mass 
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spectrometer (Europa Instruments, Crewe, UK). The atom percent 
enrichment was converted to mol percent threonine enrichment, after 
accounting for the 1.5-fold dilution of carbon in the derivative and the 
measured 13C-abundance (97%) of the threonine tracer.   
 
Calculations 
Previous studies from our and other laboratories have used a steady 
state, whole-body model of amino acid metabolism that was developed 
as described by Waterlow et al. 26 This model assumes a common 
metabolic amino acid pool through which all amino acids move, either as 
dietary amino acids or from protein breakdown, or to exit for protein 
synthesis or oxidation. This movement through the metabolic pool is 
called flux. From the measurements of arterial and portal enrichments of 
isotopically labeled tracers, arterial and portal amino acid concentrations, 
and portal blood flow, the uptake of substrates across the PDV can be 
calculated. 12,21-23 A schematic model of the different fluxes through the 
PDV is shown in Figure 1. To obtain the results we used the following 
equations: 
 
Net portal mass balance across the PDV = C - B   
Net utilization of threonine = A – (C – B) 
First-pass appearance of dietary threonine intake (E) = A – D 
Arterial utilization of tracer (F) = G – B 
Recycling (H) = C – E – G 
The equations are detailed in the Appendix. 
 
Statistics 
All concentrations, isotopic enrichments and portal balances are 
presented as the mean values for samples taken over the last hour of the 
tracer study ± SEM. Balances were tested against zero by one-tailed t-
tests. Fractional balances are the means of the ratios. Differences 
between the balances of the animals fed the HP or LP diet were tested by 
two-tailed t-tests. A value of P < 0.05 was taken as significant. 
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Figure 1. Schematic representation of the metabolic fate of dietary and 
arterial threonine by the PDV  
 
A, dietary intake of threonine; B, arterial flux of threonine through the PDV; C, 
portal outflow of threonine; D, unidirectional, first-pass uptake of dietary 
threonine by the PDV; E, dietary threonine that is not metabolized in first-pass by 
the PDV; F, unidirectional uptake of arterial threonine by the PDV ; G, arterial 
threonine that is not metabolized by the PDV; H, recycled threonine that is 
derived from proteolysis or reabsorption of previously synthesized and secreted 
endogenous proteins but not derived from the diet.  
 
Results 
Before surgery, the pigs were gaining weight at a rate of 56 ± 12 
g/(kg·d). There was no difference in weight at the day of surgery 
between both feeding groups [mean: 5.46 ± 0.62 kg]. Following surgery, 
the average weight gain in the HP-piglets was 46 ± 7 g/(kg·d) vs. 21 ± 7 
g/(kg·d) in LP-piglets (P < 0.0001), which resulted in a significant 
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difference in body weight at postnatal day 32 when the pigs were killed 
[HP: 8.95 ± 1.24 vs. LP: 7.07 ± 0.44 kg,  P < 0.0001]. 
Neither the whole-body CO2 production [mean: 59.7 ± 8.0 
mmol/(kg·h)], nor the CO2 production by the PDV [mean: 7.5 ± 3.5 
mmol/(kg·h)], were significantly affected by protein restriction. On 
average, the PDV accounted for 14% of the total whole-body CO2 
production. 
The arterial threonine concentrations were significantly lower during 
LP-feeding as compared to HP-feeding. The portal mass balance of 
threonine was significantly lower in LP-fed piglets, and even more 
interestingly, was not different from zero [mean HP: 140 ± 49 
µmol/(kg·h) vs. mean LP: -16 ± 55 µmol/(kg·h), P < 0.05].  
 
Table 1. The portal blood flows (PBF), doses, and arterial and portal 
enrichments in piglets receiving an HP- or a LP-diet in combination with 
an intravenous (iv) or intraduodenal (id) infusion of [U-13C]threonine 
 
Tracer 
experiment 
PBF 
L/(kg·h) 
Arterial IE 
MPE 
Portal IE 
MPE 
Tracer balance 
µmol/(kg·h) 
HP iv n=6 4.8 ± 0.8 0.776 ± 0.051 0.681 ± 0.041 -4.87 ± 1.70 
LP iv n=5 4.9 ± 0.4 0.899 ± 0.049 0.863 ± 0.043 -0.68 ± 0.57 
HP id n=7 4.0 ± 0.7 0.811 ± 0.092 0.833 ± 0.088 2.19 ± 1.13 
LP id n=5 4.0 ± 0.4 1.071 ± 0.136 1.088 ± 0.137 -0.35 ± 1.21 
 
Values are expressed as mean ± SEM; MPE, mole percent excess. 
 
Table 1 summarizes the results obtained during the intravenous and 
intraduodenal [U-13C]threonine tracer infusions in both feeding groups. 
During both protein intakes and intravenous tracer administration, the 
portal isotopic enrichment of threonine was lower than the arterial 
isotopic enrichment, and higher during the enteral tracer administration. 
Thus, there was net uptake of systemic threonine during both feeding 
periods. The fractional utilization of systemic threonine by the PDV was 
10% during HP-feeding, and decreased to 3% during LP-feeding.  
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Table 2. The threonine intake, first-pass and systemic utilization of 
threonine by the PDV, the threonine recycling, and the total threonine 
utilization by the PDV in piglets receiving either a high-protein (HP) or a 
low-protein (LP) diet 
 
Diet Intake 
 
µmol/(kg·h) 
First-pass 
utilization 
µmol/(kg·h)
Systemic 
utilization 
µmol/(kg·h)
Recycling 
 
µmol/(kg·h)
Total 
utilization 
µmol/(kg·h) 
HP 934 459 ± 53 497 ± 93 162 ± 94 765 ± 57 
LP 374 367 ± 19  61 ± 30 37 ± 41 355 ± 48 
Diet 
effect 
 NS P < 0.01 NS P < 0.001 
 
Values are expressed as mean ± SEM.  
 
Table 2 shows the threonine kinetics by the PDV during both feeding 
intakes. During HP-feeding, the PDV utilized threonine both from the diet 
and from the systemic circulation in almost equimolar amounts. The total 
threonine utilization by the PDV was significantly lower during protein 
restriction [HP: 765 ± 57 vs. LP: 355 ± 48 µmol/(kg·h)]. However, the 
first-pass threonine utilization from the diet was not significantly affected 
by a lower protein intake, almost 98% of the total utilization derived 
from the diet. In other words, the equivalent of the total dietary 
threonine intake is retained by the PDV during LP-feeding. The amount of 
threonine in the portal vein that derived from intracellular proteolysis or 
from re-absorbed, previously secreted intestinal (glyco-)proteins, so 
called recycled threonine contributed for approximately 2% to the overall 
threonine outflow from the PDV in both feeding groups [HP: 2 ± 1 vs. 
LP: 2 ± 2%]. 
In order to determine the metabolic fate of the utilized threonine, 
we examined the threonine oxidation rates by the PDV (Table 3). During 
HP-feeding, the PDV oxidized both dietary and systemic threonine in 
almost equimolar amounts. The total whole-body threonine oxidation 
was 117 ± 18 µmol/(kg·h); thus the intestinal threonine oxidation 
represented one-third of the whole-body threonine oxidation. The whole-
body threonine oxidation was significantly affected by protein restriction, 
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and decreased significantly as a result of the lower protein intake [LP: 61 
± 6 µmol/(kg·h), P < 0.05]. In contrast, the PDV maintained to oxidize 
both dietary and systemic threonine during a LP-feeding.  
 
Table 3. Effect of a low protein intake on first-pass threonine oxidation by 
the PDV 
 
 First-pass oxidation 
Diet dietary  
µmol/(kg·h) 
systemic 
µmol/(kg·h) 
total 
µmol/(kg·h) 
HP 23 ± 7 15 ± 7 42 ± 14 
LP 6 ± 3 28 ± 10 34 ± 12 
Diet effect NS NS NS 
 
Values are expressed as mean ± SEM. 
 
Neither the whole-body non-oxidative threonine disposal (NOTD; an 
estimate of protein synthesis) nor the whole-body protein degradation 
(TRP) was significantly affected by a lower protein intake [NOTD HP: 
1,316 ± 140 vs. NOTD LP: 1,188  ± 61 µmol/(kg·h), TRP HP: 958 ± 102 
vs. TRP LP: 1,236 ± 40 µmol/(kg·h), Table 4]. Despite the lower protein 
intake, the threonine utilization by the gut is still roughly 30 to 34% of 
the whole-body protein synthesis. Also, even though the TRP is not 
statistically different, the value is 30% in the LP than HP pigs. However, 
the whole-body threonine balance (WB bal), calculated from the 
difference between non-oxidative disposal and whole-body degradation, 
was significantly affected by protein restriction, and was not significantly 
different from zero during a LP-diet [WB bal HP: 358 ± 18 vs. WB bal LP: 
-54 ± 4 µmol/(kg·h)]. 
 
Discussion 
Threonine is an important limiting amino acid for growth and 
maintenance in diets for pigs. 27 Moreover, its oxidation represents an 
irreversible loss for whole-body proteins, as it cannot be synthesized de 
novo. Several investigators studying protein metabolism concluded that 
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the utilization of a limiting amino acid is not constant over a wide range 
of intakes. 28-30 Therefore, conservation of threonine from oxidation is 
important to maintain whole-body protein homeostasis during restricted 
dietary protein intake. In addition, threonine is of critical importance for 
the intestinal function because it is essential to the structural protein 
mucous layer lining of the gastrointestinal tract. The aim in the present 
study was to investigate the effect of protein restriction on first-pass 
intestinal and whole-body threonine metabolism in piglets. We found 
that, irrespective of the dietary protein intake, the PDV extracted a very 
large amount of dietary threonine. Furthermore, whole-body threonine 
oxidation and balance were significantly decreased by a lower protein 
intake, while the threonine oxidation by the PDV was not affected by 
protein restriction. 
 
Table 4. Effect of a low protein intake on whole-body threonine kinetics 
 
Diet NOTD 
µmol/(kg·h) 
TRP 
µmol/(kg·h) 
Oxidation 
µmol/(kg·h) 
Balance 
µmol/(kg·h) 
HP 1,316 ± 140 958 ± 102 117 ± 18 358 ± 18 
LP 1,188 ± 61 1,236 ± 40 61 ± 6 -54 ± 4 
Diet effect NS NS P < 0.05 NS 
 
Values are expressed as mean ± SEM. NOTD indicates non-oxidative disposal of 
threonine, TRP indicates threonine release of proteins. 
 
For an effective nutritional support in neonates with respect to 
growth, it is necessary to evaluate the amount of amino acids that is 
actually available from the diet for absorption. This is not an easy task, 
as the flow of amino acids delivered to the small intestines is comprised 
of microbial proteins, and proteins secreted by the intestinal mucosa 
cells. The contributions of endogenous secretions account for 15-25% of 
the total protein outflow of the lumen. In addition, the profile of amino 
acids ultimately appearing into the portal blood is altered by gut 
metabolism. There are four possible fates of dietary amino acids during 
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the absorption process: 1) direct transport into the systemic circulation, 
2) use for gut protein synthesis, 3) complete oxidation and 4) conversion 
to other metabolites.  
In recent years, there has been growing recognition that a very 
large proportion of certain non-essential amino acids (e.g. aspartate, 
glutamate, and glutamine) from the diet  are utilized by the intestine and 
do not appear in the systemic circulation. 9,10 Likewise, we previously 
showed in piglets that the net portal balance of lysine is significantly less 
than the dietary intake, indicating that the PDV tissues utilize a 
considerable amount of dietary lysine. 12 Moreover, we showed that in 
HP-fed pigs, most of the lysine used by the PDV is derived from the 
systemic circulation, but this shifts to an increased first-pass use during 
protein restriction. In contrast to these studies in lysine, the current 
studies imply that the first-pass utilization of dietary threonine 
represents nearly half the total PDV use in HP-fed pigs and is nearly the 
exclusive source of PDV threonine use in protein restricted pigs. The total 
PDV threonine utilization represents 30 to 34% of the whole-body protein 
synthesis, regardless of the dietary protein intake. These findings 
strongly suggest that there is a high obligatory requirement for threonine 
by the PDV tissues, mainly the gut.  
It is noteworthy that intestinal secretions are rather rich in threonine 
and that intestinal oxidation in HP-fed pigs represented only 6% of the 
absorbed threonine. Therefore, it appears that most threonine used by 
the intestine is for tissue and secretory protein synthesis. Considering 
the relatively large surface of the small intestine with its substantial 
mucus layer, dietary threonine seems to be obligatory for maintaining 
intestinal mucosal mass and integrity. Law et al. reported that pigs fed a 
threonine deficient diet had a lower gut weight, villus height, mucin 
content, and overall had diarrhea. 31,32 Furthermore, there is evidence 
that mucin production is impaired in pigs fed a threonine deficient diet, 
and administration of parenteral threonine does not restore normal 
mucin production. 33,34 It is conceivable that a lower mucin production 
leads to an impairment of intestinal mucosa disease resistance, and a 
higher risk of infections. Thus, as the first-pass threonine utilization 
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increased during a lower protein intake, the threonine needs may even 
be greater during periods of recovery from gut stress, such as infection, 
or chemotherapy. 
In terms of amino acid economy, systemic amino acid availability 
will not be impaired as long as the sloughed cells and secretions are 
efficiently reabsorbed. In a previous study we showed that intestinal 
recycling of amino acids contributes significantly to the systemic 
availability of amino acids. 23 During the present 5-h study we measured 
only a small amount of threonine recycling by the PDV. This might be an 
underestimation, as the degradation process of mucins takes a 
considerable longer time. Therefore, we assume that the threonine 
utilized for intestinal (glyco-)protein synthesis eventually becomes 
available for the peripheral tissues through an efficient reabsorption 
process.  
The second observation in this study that requires comment is the 
first-pass and whole-body threonine oxidation. Threonine is catabolized 
mainly by two routes: 1) through threonine dehydratase which oxidizes 
threonine to ketobutyric acid to propionic acid and CO2, and 2) through 
threonine dehydrogenase that catabolizes threonine to glycine and acetyl 
CoA. Threonine is traditionally considered not to be oxidized by the 
intestinal mucosa because of the reported absence or negligible activity 
of initial or other rate-controlling enzymes, e.g. threonine 3-
dehydrogenase, threonine dehydratase and threonine aldolase. 35 As 
suggested by Wu et al., the validity of the reported lack of catabolic 
enzymes in the intestinal tissues should be re-examined, because of the 
used preparation techniques. 36 The present results indicate that the 
intestinal oxidation of threonine under normal feeding conditions 
accounts for one-third of the whole-body threonine oxidation, and this 
first-pass threonine oxidation is not suppressed during protein 
restriction. In contrast to our previous findings regarding intestinal lysine 
oxidation, the PDV oxidizes both threonine from the mesenteric artery 
and from the luminal site. 12 Based upon these results, and previous 
work 14 there seems to be a intestinal channeling of amino acids to 
specific metabolic end-products depending whether the amino acid 
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enters the enterocyte from the basolateral membrane or the luminal 
side. These findings challenge the traditional concept that threonine is 
not catabolized by the intestinal mucosa, and therefore further 
enzymological work is required to establish biochemical bases for 
intestinal catabolism of dietary threonine.  
Regarding whole-body threonine oxidation, our results are in 
contrast to the data reported by Chu and Hegsted. They observed no 
changes in threonine dehydratase activity in rats fed protein-free or 
threonine-free diets, and concluded that no adaptation is achieved in 
whole-body protein metabolism when threonine is specifically lacking. 
28,37 In contrast to their findings, we found a substantially decreased 
whole-body threonine oxidation during protein restriction. However, the 
measurement of 13C-labeled CO2 probably underestimates threonine 
oxidation because of sequestration of two C-atoms of threonine into 
glycine as shown by  Ballevre et al. who developed and validated a 
multitracer method in pigs allowing the calculation of the partition of 
both threonine pathways. 38 Nevertheless, the whole-body threonine 
oxidation was significantly lowered by protein restriction, suggesting a 
protein sparing adaptive mechanism. 
In conclusion, the present study demonstrates that during protein 
restriction the PDV maintain a high rate of metabolism and continue to 
consume the equivalent of the total dietary threonine intake. We suggest 
that the considerable first-pass utilization of dietary threonine 
contributes significantly to the threonine-rich intestinal mucins. The 
results also show that the level of protein intake affects the site of 
threonine utilization by the PDV, as it switches from dual threonine use 
(i.e. dietary and systemic) to nearly exclusive luminal utilization of 
threonine when dietary protein becomes limiting. In addition, the 
threonine oxidation by the PDV accounted for one-third of the whole-
body threonine oxidation. In contrast, this first-pass threonine oxidation 
was completely suppressed during protein restriction. Taken together, 
the results highlight the important role of the intestine in modulating 
dietary amino acid availability to the body and points to the obligatory 
intestinal requirement of threonine for maintaining intestinal integrity.  
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Appendix 
Threonine calculations 
Arterial thr input [µmol/(kg·h)] = arterial thr conc x PBF [1] 
in which thr concentration is expressed in µmol/liter, and PBF is 
expressed in liter/(kg·h).  
Portal thr output [µmol/(kg·h)] = portal thr conc x PBF [2] 
Net portal thr balance [µmol/(kg·h)] = Eq.2 - Eq.1  [3] 
Net utilization of thr by PDV [µmol/(kg·h)] =  
dietary intake - Eq.3    [4] 
Fractional utilization of thr by PDV (fraction of intake) =  
  Eq.4      [5] 
       dietary intake 
Substituting the threonine concentration with the tracer 
concentration will give the tracer kinetics: 
Arterial thr tracer input [µmol/(kg·h)] =  
arterial thr tracer conc x PBF     [6] 
Portal thr  tracer output [µmol/(kg·h)] =  
portal thr  tracer conc x PBF   [7] 
Portal thr  tracer balance = Eq.7 - Eq.6   [8] 
The percentage of arterial thr that is utilized by the PDV is measured 
during the intravenous tracer study and is calculated as follows: 
Fractional arterial thr utilization = Eq.6 - Eq.7   [9] 
    Eq.6 
The amount of arterial thr that is utilized by the PDV is calculated 
with the following equation: 
Arterial utilization of thr by the PDV [µmol/(kg·h)] = 
Eq.9 x Eq.1     [10] 
The amount of dietary threonine utilized in first-pass by the intestine 
has to be corrected by the amount of dietary threonine that appears in 
the portal vein (and thus is not metabolized by the PDV), and then re-
enters the PDV, but now from the arterial site. This threonine will be 
utilized by the PDV in the same proportion as the intravenous 
administered tracer (Eq.9). Thus, during the intraduodenal tracer 
infusion, the equation is:  
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Fract ent thr utilization = 
dietary tracer intake - Eq.7 - [(1 - Eq.9) x Eq.6] [11] 
  dietary tracer intake 
Thus, the amount of dietary thr that is utilized by the PDV is calculated 
by:  
First-pass thr utilization by PDV [µmol/(kg·h)] = 
Eq.11 x dietary intake    [12] 
Direct absorption of dietary threonine is not the sole source of portal 
threonine, as threonine can also be released from intracellular proteolysis 
and from the digestion and re-absorption of secreted (glyco-)proteins 
previously synthesized by the intestines. It is also possible that threonine 
synthesized by the gut flora might contribute to portal threonine. In the 
present paper, we term threonine appearing in the portal vein that is not 
derived from the diet as recycled threonine (H in Fig. 1). It was 
calculated as follows, with results from both the intravenous and the 
intraduodenal tracer studies: 
Recycled thr appearing in portal vein [µmol/(kg·h)] =  
Eq.2 - (dietary intake - Eq.12) - (Eq.1 - Eq.10) [13] 
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Background & Aims: Animal studies have shown that more than half of 
the dietary protein intake is utilized by the gut and that a large 
proportion of this utilization is devoted to (glyco-)protein synthesis. 
Recycling of these secretions may play a critical role in the regulation of 
overall dietary amino acid bioavailability. Methods: Four piglets (age 32 
d, 8-10 kg) bearing portal, arterial and duodenal catheters and a portal 
flow probe were infused with a complete diet via the duodenum for 12 
h, followed by 12 h of fasting. The portal balance of glucose and amino 
acids was measured throughout the 24-h period. The animals also 
received duodenal and intravenous infusions of different lysine and 
threonine tracers. Measurements of intestinal tracer utilization and 
reappearance in the portal blood were used to calculate intestinal 
amino acid utilization and recycling. Results: From 0 to 6 h one-third of 
the protein intake appeared in the portal blood. As feeding continued, 
the portal glucose balance (60% of intake) was constant, but the net 
amino acid portal balance became progressively more positive. 
Significant net amino acid absorption continued for at least 6 h after the 
cessation of feeding. Over 24 h, 52% of the dietary protein intake 
appeared in the circulation and one-third of this derived from recycled 
intestinal secretions. Conclusions: Intestinal recycling of amino acids 
contributes significantly to their systemic availability and may be a 
critical factor in amino acid nutrition. 
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he portal-drained viscera (PDV; i.e. the intestine, pancreas, spleen 
and stomach) have a high rate of both energy expenditure and 
protein synthesis. 1-3  
Therefore, these tissues have high nutrient requirements, one result 
being the disproportionately high utilization of the dietary protein 
intake by the gut itself. Because the rate of amino acid utilization by 
the intestine determines the amino acid systemic availability, intestinal 
metabolism can thus be an important regulator of whole-body growth.   
In previous studies we have shown that although milk proteins are 
efficiently digested, 4,5 not all the dietary amino acids appear in the 
portal circulation during the first hours of feeding. 6,7 This low systemic 
amino acid availability reflects the use of absorbed amino acids for the 
synthesis of mucosal cellular proteins, for oxidative purposes, and for 
secretion of (glyco-)proteins. In contrast to our earlier conclusions, 7 
we postulate that the majority of the utilized amino acids are 
incorporated into (glyco-)proteins that are secreted into the intestinal 
lumen. After secretion into the lumen, the synthesized proteins are 
either digested and reabsorbed, or they are passed to the colon, where 
they are degraded, fermented and lost from the body. Previous studies 
in piglets 8,9 showed that 12% of the intestinal endogenous secreted 
(glyco-)proteins were lost to the colon following secretion, implying 
that a large majority of the secreted (glyco-)proteins might be digested 
and reabsorbed. However, given that dietary amino acids are utilized in 
first-pass by the intestine, there is no assurance that reabsorbed, 
previously secreted amino acids will appear in the portal circulation. 
This is important information because the nutrient requirements of the 
portal-drained viscera might have a critical impact on the systemic 
availability of nutrients.  
Studying nutrient use by the gut, and especially the intestinal 
mucosa, is particularly difficult. A complicating factor is that the 
intestinal mucosa receives nutrients from two sources, the diet (brush 
border membrane) and the systemic circulation (basolateral 
membrane). We have developed a portal catheterized piglet model 10 
to study visceral metabolism in growing, conscious and fed animals. In 
T 
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previous studies, we have used this model, in combination with enteral 
and intravenous infusions of stable isotopically labeled tracers, to 
quantify the first-pass metabolism of dietary amino acids. 6,11,12 In 
order to evaluate the contribution of recycling to overall systemic 
amino acid availability, we used our arteriovenous organ tracer-balance 
piglet model in a 24-h study protocol in the present study. The 
experiment was based on the combination of the intravenous and 
intraduodenal infusions of stable isotopically amino acid tracers with 
the quantification of the amino acid mass (to measure total net 
absorption) and tracer (to measure either luminal or arterial absorption 
of two specific amino acids: lysine and threonine) balance across the 
PDV of fed and fasted piglets.  
Our main objective was to determine the magnitude and pattern 
of secretory (glyco-)protein recycling. Therefore, we quantified the net 
portal appearance of all amino acids, glucose and lactate during a 12-h 
feeding period and a subsequent 12-h fasting period. The reason 
underlying the experimental design was that if the secreted (glyco-
)proteins are transferred to the systemic circulation as amino acids 
then (a) there will be a progressive increase in the portal appearance 
of amino acids during prolonged continuous feeding and (b) this portal 
amino acid appearance will continue for a considerable time following 
the end of feeding. In addition, in order to determine the exact rate of 
recycling of two amino acids of specific nutritional importance, lysine 
and threonine, we simultaneously administered six stable isotopically 
labeled tracers of lysine and threonine by both intravenous and 
intraduodenal routes. By using these different tracers at different times 
during the feeding period and by measuring the net portal tracer mass 
balances, we were able to calculate the extent of recycling of lysine 
and threonine by the PDV. 
 
Methods     
Animals 
The Baylor College of Medicine Animal Protocol Review Committee 
approved the study. Housing and care of the animals conformed to 
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current US Department of Agriculture guidelines. The study involved 
four 4-week-old female crossbred piglets (Large White x Hampshire x 
Duroc) obtained from the Texas Department of Criminal Justice, 
Huntsville, TX. Two-week-old pigs were received at the Children’s 
Nutrition Research Center and fed a liquid milk replacer diet (Litter Life, 
Merrick, Middleton, WI) at a rate of 50 g/(kg·d) body weight. The 
composition (per kg dry matter) of the milk replacer was 500 g lactose, 
100 g fat and 250 g protein.  
 
Figure 1. Schematic outline of the 24-h protocol 
 
 
 
 
 
 
 
 
 
 
 
A, represents [15N]threonine and [2H4]lysine intravenously; B, [U-13C]threonine 
and [U-13C]lysine intraduodenally and C, [U-13C, 15N]threonine and [e-15N]lysine 
intraduodenally. 
 
Study Design 
At a postnatal age of 3 weeks, the piglets underwent surgery after an 
overnight fast. Under isoflurane anesthesia and strict aseptic 
conditions, catheters were implanted into the duodenum, the portal 
and the common carotid artery. An ultrasonic flow probe (Transonic 
Systems Inc, Ithaca, NY) was implanted around the common portal 
vein. This procedure allowed us to sample from the arterial and portal 
blood and to measure the blood flow through the portal-drained 
viscera. Furthermore, by means of continuous duodenal infusion, we 
blood sampling
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could control the exact dietary intake independent of gastric emptying. 
The piglets received complete parenteral nutrition for 24 h and 
achieved full enteral feeding on the second postoperative day. All 
piglets were weighed daily, and sampling catheters were flushed with 
sterile, heparinized saline to maintain patency. Piglets and cages were 
cleaned daily.  
The 24-h protocol (Figure 1) was carried out 8 days after surgery 
when the piglets weighed 8.8 ± 0.9 kg. The 24-h study period was 
divided into two 12-h metabolic periods; 12 h of continuous feeding (a 
liquid milk replacer diet supplying 5.7 mmol/(kg·h) lactose and 8.3 
mmol/(kg·h) amino acids) and 12 h of fasting. This design was 
implemented to achieve two requirements; first we wanted to obtain 
portal mass balances of all amino acids and glucose during the fasted 
and the fed state and, second, we wanted to determine the exact rate 
of recycling of two specific essential amino acids, lysine and threonine 
by using different stable isotopically labeled tracers. During the 12-h 
feeding period, constant intravenous and intraduodenal infusions of 
labeled lysine and threonine were given as described below. Our 
purpose was to minimize the potential for recycling of the tracer (i.e., 
its return to plasma via protein proteolysis) by using different tracers 
at different time points. 
The animals were deprived of food from 18.00 h the night 
preceding the study. After this overnight fast, baseline arterial and 
portal blood samples were drawn at 7.00 h, after which the pigs 
received a single bolus meal that supplied two-fourteenths of their 
preceding daily intake (186 ml/(kg.d) Litter Life). This meal served to 
initiate an adequate pattern of intestinal motility. Immediately 
thereafter, a continuous duodenal infusion of the diet was started at an 
hourly rate of one-fourteenth of their preceding daily intake for the 
next 12 h. At 19.00 h, the duodenal infusion was stopped, the 
duodenal contents were removed by aspiration and the animals were 
fasted for a further 12 h. At the end of the 24-h study, the pigs were 
killed with an intra-arterial injection of pentobarbital sodium (50 mg/kg 
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body wt) and sodium phenytoin (5 mg/kg; Beutanasia-D; Schering-
Plough Animal Health, Kenilworth, NJ).  
 
Tracer and Amino Acids Protocol 
[2H4]lysine ([H4]lysine, 98% 
2H), [U-13C]lysine ([13C6]lysine, 97% 
13C), 
and [e-15N]lysine ([e-15N]lysine, 98% 15N), [15N]threonine 
([15N]threonine, 98% 15N), [U-13C]threonine ([U-13C4]threonine, 97% 
13C), and [U-13C,15N]threonine ([13C,15N]threonine, 97% 13C,15N) were 
purchased from Cambridge Isotopes (Woburn, MA). Just before the 
start of each infusion, a prime dose of [2H4]lysine (7 µmol·kg
-1), 
[15N]threonine (50 µmol/kg), [U-13C]lysine (5 µmol/kg), [U-
13C]threonine (5 µmol/kg), [e-15N]lysine (30 µmol/kg), and [U-
13C,15N]threonine (50 µmol/kg) was administered over ≈ 1 min. 
Immediately thereafter an intravenous or intraduodenal infusion of 
[2H4]lysine, [
15N]threonine, [U-13C]lysine, [U-13C]threonine, [e-
15N]lysine, and [U-13C,15N]threonine (7, 50, 5, 5, 30, and 50 
µmol/(kg·h), respectively) were started by intravenous or 
intraduodenal route. Figure 1 depicts the design of the 24-h tracer 
protocol, including the different time points for the different tracers; 
[D4]lysine and [
15N]threonine intravenously from 2 tot 12 h of feeding, 
[U-13C]lysine and [U-13C]threonine intraduodenally from 2 to 6 h of 
feeding, and [e-15N]lysine and [U-13C,15N]threonine intraduodenally 
from 8 to 12 h of feeding. For all piglets, the prime and infusion doses 
were nominally the same (although the exact infusion rate was 
determined for each infusion from the amount of infusate infused and 
the concentration of each label).  
During the 24-h period, portal blood flow was measured 
constantly. Blood samples (0.4 ml) for amino acids, glucose and lactate 
analysis were collected hourly for the whole 24-h period. In addition, 
three half hourly samples were withdrawn from 5.5 to 6.5 h of feeding, 
three half hourly from 11 to 12 h of feeding and seven blood samples 
over the first 2 h of fasting. 
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Sample analysis 
Small aliquots (0.2 ml) were taken for the determination of glucose 
and lactate (YSI analyzer; YSI Incorporated, Yellow Springs, OH). For 
analysis of amino acid concentrations, an aliquot of whole blood (0.2 
mL) was mixed with an equal volume of an aqueous solution of 
methionine sulfone (0.5 mmol/L) and centrifuged at 10,000 x g for 10 
min at room temperature through a 3-kDa cutoff filter. The filtrate was 
dried and the amino acids were analyzed by reverse-phase high 
performance liquid chromatography of their phenylisothiocyanate 
derivatives (Pico Tag, Waters, Woburn, MA). Mass spectrometric 
analysis of lysine and threonine was conducted with the tri-fluoro-
acetyl-methylester derivative. 13,14 The 13C-isotopic enrichment was 
measured on a gas chromatograph (Hewlett-Packard, Palo Alto, CA) 
connected to a combustion oven (850°C) and an isotope ratio mass 
spectrometer (ANCA, Europa Instruments, Crewe, UK) The atom 
percentage 13C-enrichment was converted to mole percentage of 
[13C]lysine and [13C]threonine enrichment, after accounting for the 
dilution of carbon in the derivative and the measured 13C abundance 
(97%) of the tracers. The atom percentage 15N-enrichment and 2H4-
enrichment was converted to mole percentage of [15N]lysine, 
[2H4]lysine, and [
15N]threonine enrichment, after accounting for the 
dilution of nitrogen and hydrogen in the derivative and the measured 
15N and 2H4 abundance (98%) of the tracers.  
 
Calculations 
Previous studies from our and other laboratories have used a steady-
state, whole-body model of amino acid metabolism that was developed 
as described by Waterlow et al. 15 This model assumes a common 
metabolic amino acid pool through which all amino acids move, either 
as dietary amino acids or from protein breakdown, or to exit for protein 
synthesis or oxidation. This movement through the metabolic pool is 
called flux. From the measurements of arterial and portal enrichments 
of [13C, 15N or 2H4]tracers, arterial and portal amino acid 
concentrations, and portal blood flow, the uptake of substrates across 
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the PDV can be calculated. 6 A schematic model of the different fluxes 
through the PDV is shown in Figure 4. To obtain the results we used 
the following equations: 
 
Net portal mass balance across the PDV = C - B 
 Net utilization of lysine/threonine = A – (C – B) 
First-pass appearance of dietary intake (E) = A – D 
Arterial utilization of tracer (F) = G – B 
Recycling (H) = C – E – G 
 
The equations are detailed in the Appendix. 
 
Statistics 
All concentrations and portal balances are presented as mean values 
plus or minus the inter-animal SEM. Balances were tested against zero 
by one-tailed t tests. For balances that are expressed as a proportion 
of intake, the values are the mean of the ratios. A value of P < 0.05 
was taken as statistically significant.  
 
Results 
Glucose and lactate utilization 
The portal blood flow did not differ significantly between the fed and 
the fasted state (fed 6.09 ± 0.59 vs. fasted 5.40 ± 0.75 L/(kg·h)). 
Immediately before the start of feeding (i.e. after an overnight fast) 
the net portal mass balance across the PDV of glucose was negative. 
As shown in Figure 2, within one hour after the onset of the continuous 
12-h feeding, both the net glucose and lactate portal mass balances 
reached a steady state, which was maintained throughout the feeding 
period. Over a 24-h period, 60 ± 3% of the glucose intake appeared in 
the portal circulation. Within two hours after the end of the feeding the 
net portal glucose mass balance across the PDV fell to zero again. The 
net portal lactate mass balance did not reach zero until 4 h after the 
end of feeding. 
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Figure 2. The mean net portal mass balance of glucose and lactate 
during a 24-h period 
 
Amino acid utilization 
The 24-h pattern of appearance in the portal circulation of three 
individual amino acids, lysine, leucine and threonine, is shown in Figure 
3. The appearance of both essential and not-essential amino acids in 
the portal vein rose immediately after the feeding was started. 
However, in contrast to glucose (net utilization rate of >30%), the net 
utilization rate of non-essential and essential amino acids during the 
first 6-h of continuous feeding, was 61% and 70% of the dietary 
protein intake, respectively. There was a also significant (P < 0.01) and 
progressive (2% per h) increase in the portal appearance of the amino 
acids from 6 to 12 h of feeding, for the total amino acids. Sixty percent 
of dietary amino acid intake became systemically available during the 
last period of feeding.  
In agreement with our previous data, 6 there was a wide variation 
in the net utilization rate of specific essential amino acids during 
continuous feeding. This ranged from approximately 75% of the intake 
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for threonine and isoleucine during the first 6 h of feeding, to only 20% 
of the intake for leucine and methionine during the second 6 h of 
feeding. In marked contrast to glucose, the mean portal mass balance 
of all essential amino acids remained significantly greater than zero for 
at least 8 h after the cessation of feeding.  
 
Figure 3. The mean net portal mass balance of lysine, leucine and 
threonine during a 24-h period 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are means ± SEM, n = 4. Figure 3A represents lysine, Figure 3B 
represents leucine, and Figure 3C represents threonine. 
 
Regarding the non-essential amino acids, the utilization rates by 
the PDV expressed as a percentage of intake also varied widely during 
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both 6-h intervals (Table 1). On average, 61% of the total non-
essential amino acid intake was utilized by the PDV during the first 6 h 
of feeding. As feeding progressed, the fraction of total non-essential 
amino acid intake utilized by the PDV decreased to 41%, although this 
decrease did not reach statistical significance. As we have found 
consistently in previous studies, almost all aspartate, glutamate and 
glutamine was utilized by the gastrointestinal tissues (on average more 
than 90% of dietary intake, Table 1). On the other hand, the fraction of 
intake utilized by the PDV of some amino acids after 12 h of continuous 
feeding (alanine, arginine, glycine and tyrosine) exceeded 100%, 
indicating a net production by the PDV.  
As shown in Table 2, the proportional contribution to the total 
appearance in the portal circulation during 24-h of each specific amino 
acid and glucose was calculated for the different periods. For each 
essential amino acid, this fractional appearance increased as feeding 
progressed, specifically for methionine, whose fractional appearance 
had nearly doubled by the end of the feeding period. Tryptophan 
utilization values as a fraction of intake are not reported, but only as a 
fraction of total 24-h portal mass balance, because tryptophan is 
destroyed by acid hydrolysis prior to analysis of the formula. 16  
The total net portal mass balance of the essential amino acids 
across the PDV increased by 12% during the last 6-h of feeding when 
expressed relative to the total net portal mass balance over 24-h. 
During the fasting period, the portal appearance of essential amino 
acids accounted for a further 14% of the total essential amino acid 
portal mass balance over 24-h. On average for all essential amino 
acids, this suggests that recycling was responsible for 26% of the total 
24-h appearance of essential amino acids. In other words, 
approximately one-third (35%) of the utilized essential amino acids 
was recycled.  
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Table 1. Systemic availability of amino acids and glucose by the PDV 
during 12-h of feeding 
 
 Systemic availability 
 µmol/(kg·6h)            % 
0-6 h 
Systemic availability 
 µmol/(kg·6h)              % 
6-12 h 
Isoleu 1,345 ± 168 22 ± 3 * 1,535 ± 91 33 ± 2 
Leu 2,564 ± 483 43 ± 8 * 3,545 ± 652 79 ± 15 
Lys 1,564 ± 248 38 ± 6 * 2,236 ± 347 72 ± 11 
Met 354 ± 69 38 ± 7 * 644 ± 74 82 ± 5 
Phe 613 ± 70 30 ± 3 823 ± 141 54 ± 9 
Tryp 311 ± 94  288 ± 25  
Thr 1,757 ± 337 24 ± 5 1,965 ± 278 35 ± 5 
Val 1,768 ± 237 29 ± 4 2,875 ± 903 63 ± 20 
Ala 4,764 ± 384 78 ± 6 * 5,045 ± 505 110 ± 11 
Arg 715 ± 96 86 ± 12 * 1,029 ± 82 165 ± 13 
Asp 187 ± 29 3 ± 1 288 ± 66 7 ± 2 
Glu/Gln 440 ± 107 
-407 ± 199 
6 ± 1 
-5 ± 3 
705 ± 190 
93 ± 223 
12 ± 3 
2 ± 4 
Gly 1,484 ± 537 37 ± 13 3,119 ± 1,598 103 ± 53 
Pro 1,263 ± 238 30 ± 6 * 1,687 ± 319 54 ± 10 
Ser 1,388 ± 119 33 ± 3 * 1,949 ± 331 62 ± 11 
Tyr 534 ± 51 95 ± 9 920 ± 239 219 ± 57 
Total AA 20,333 ± 2,040 31 ± 3 28,456 ± 5,080 60 ± 12 
     
Gluc 24,317 ± 1,531 53 ± 3 23,360 ± 1,932 70 ± 7 
 
Data are expressed in micromoles per kilogram per 6-h and expressed as a 
percentage of intake during a 6-h feeding period. Values are means ± SEM; *  
indicates significant difference between  0–6 h and 6–12 h at P < 0.05; n = 4. 
Isoleu, isoleucine; leu, leucine; lys, lysine; met, methionine; phe, 
phenylalanine; tryp, tryptophan; thr, threonine; val, valine; ala, alanine; arg, 
arginine; asp, aspartate; glu, glutamate; gln, glutamine; gly, glycine; pro, 
proline; ser, serine; tyr, tyrosine; total AA, total amino acids; gluc, glucose.  
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Table 2. Proportional contribution to overall systemic availability of 
amino acids and glucose for the different time periods 
 
 Total  
availability 
µmol/(kg·d) 
0–24 h 
Total 
availability 
% 
0–24 h 
Contribution to  
overall availability 
% 
  0-6 h          6-12 h          12-24 h 
Isoleu 3,276 ± 336 30 ± 3 41 ± 3 48 ± 4 § 11 ± 5 
Leu 6,925 ± 1,212 66 ± 12 37 ± 4 * 51 ± 2 § 12 ± 2 
Lys 4,665 ± 543 64 ± 7 33 ± 8 * 48 ± 4 § 19 ± 3 
Met 1,227 ± 172 75 ± 10 29 ± 3 * 55 ± 9 § 17 ± 8 
Phe 1,735 ± 210 49 ± 6 36 ± 4 47 ± 3 § 17 ± 4 
Thr 4,273 ± 833 33 ± 6 42 ± 3 50 ± 8 § 8 ± 10 
Tryp 613 ± 143  50 ± 4 49 ± 7 1 ± 4 
Val 5,431 ± 1,076 51 ± 10 34 ± 5 50 ± 5 § 16 ± 4 
Ala 12,005 ± 1,172 112 ± 11 40 ± 4 42 ± 1 § 18 ± 4 
Arg 2,264 ± 259 156 ± 18 31 ± 2 * 46 ± 2 § 23 ± 3 
Asp 581 ± 102 6 ± 1 33 ± 3 * 48 ± 3 § 19 ± 4 
Glu/Gln 1,438 ± 293 
-2,234 ± 256 
10 ± 2 
-16 ± 2 
30 ± 2 
16 ± 9 
46 ± 8 
6 ± 11 § 
24 ± 9 
91 ± 18 
Glyc 6,301 ± 2169 89 ± 31 23 ± 1 * 43 ± 7 34 ± 7 
Pro 3,183 ± 599 43 ± 8 40 ± 1 * 53 ± 2 § 7 ± 1 
Ser 3,735 ± 499 51 ± 7 38 ± 3 * 52 ± 3 § 10 ± 2 
Tyr 1,645 ± 283 168 ± 29 34 ± 4 * 54 ± 4 § 12 ± 2 
Total 
AA 
56,452 ± 7,641 48 ± 7 37 ± 3 50 ± 3 § 14 ± 3 
      
Gluc 47,751 ± 2422 60 ± 3 51 ± 3 49 ± 2 § 0 ± 3 
 
Data are expressed in micromoles per kilogram per day and as a fractional 
appearance in the portal circulation of total 24-h appearance of amino acids and 
glucose; values are means ± SEM; * indicates significant difference between 0–
6 h and 6–12 h at P < 0.05; § indicates significant difference between 6-12 h 
and 12-24 h at P < 0.05; n = 4. 
 
We found a comparable pattern for the non-essential amino acids. 
During the last 6-h of feeding, there was a 13% increase in the portal 
appearance of non-essential amino acids. During the fasting period, the 
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portal appearance of essential amino acids accounted for a further 13% 
of the total non-essential amino acid portal mass balance over 24-h. 
Thus, as with the essential amino acids, recycling was responsible for 
26% of the total 24-h appearance of non-essential amino acids, with 
glutamine being the only exception. Virtually all the glutamine, when 
expressed as a fraction of the total 24-h appearance, appeared in the 
portal circulation during fasting. 
 
Table 3. Arterial and portal enrichments and portal balances of different 
tracers 
 
Tracer Infused Tracer/tracee, mol% 
Arterial           Portal 
Tracer Balance 
µmol/(kg·h)      % of input 
[D4]lys 
iv 2-12 h 
0.0125 ± 
0.0017 
0.0109 ± 
0.0018 
-2.8 ± 1.6 -7 ± 6 
[U-13C]lys  
id 2-6 h 
0.0075 ± 
0.0008 
0.0081 ± 
0.0010 
4.7 ± 1.3  45 ± 13 
[15N]lys 
id 8-12 h 
0.0484 ± 
0.0061 
0.0515 ± 
0.0037 
34.3 ± 18.4     71 ± 38 * 
[15N]thr 
iv 2-12 h 
0.0784 ± 
0.0112 
0.0723 ± 
0.0106 
-13.9 ± 18.7 -3 ± 4 
[U-13C]thr  
id 2-6 h 
0.0065 ± 
0.0010 
0.0070 ± 
0.0009 
4.2 ± 2.3  39 ± 21 
[U-13C,15N]thr  
id 8-12 h 
0.0551 ± 
0.0067 
0.0581 ± 
0.0064 
38.0 ± 15.7      65 ± 27 * 
 
Values are means over last three hours of tracer infusion ± SD, *  indicates 
significant difference between  4–6 h and 10–12 h at P < 0.05; n = 4. id, 
intraduodenal; iv, intravenous; mol%, mole percent excess. 
 
Tracer utilization 
As described in the Methods section, we administered six stable 
isotopically labeled tracers of lysine and threonine by both intravenous 
and intraduodenal routes to quantify the actual rate of recycling of 
these two amino acids. The arterial and portal enrichments and portal 
balances of the six different tracers are shown in Table 3. The net 
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absorption of both the enteral lysine tracers as the enteral threonine 
tracers increased significantly as feeding progressed.  
A schematic representation of the recycling rate of lysine in the 
PDV at two different periods is depicted in Figure 4. Approximately 
50% of the lysine exiting to the portal vein was derived from recycling 
after 6-h of continuous feeding. At the end of the feeding period, 61% 
of the lysine appearing in the portal vein was derived from recycling. 
Interestingly, no labeled threonine was found to be recycled to any 
extent over the 15 hours of direct measurement of the threonine 
isotopic enrichment in the portal vein. This is of substantial quantitative 
significance, since 67% of the total daily threonine intake was utilized 
by the PDV.  
 
Discussion 
The present study utilizing dual mass and tracer balance was 
conducted to investigate the 24-h kinetics and the recycling pattern of 
amino acids. The first conclusion to be reached from this study is that 
approximately 50% of the dietary amino acid intake is utilized by the 
PDV during a 24-h period including 12-h of feeding and 12-h of fasting. 
In the first hours after the start of feeding only 30% of the dietary 
protein intake appeared in the portal circulation and hence was 
available for whole-body growth. The portal appearance of amino acids 
showed a significant and continuous rise during prolonged continuous 
feeding, resulting in a fractional systemic availability as a percentage 
intake of 57% during the last 6-h of feeding.  
Our second conclusion is that, over a 24-h period including a fed 
and a fasted state, 26% of the dietary protein intake reappeared in the 
portal vein by way of recycling of previously secreted (glyco-) proteins. 
So, intestinal recycling of amino acids contributes significantly to their 
overall systemic availability.  
A critical factor in interpreting the physiological significance of our 
results, is the metabolic fate of amino acids once they are absorbed by 
the intestinal cells. Absorbed amino acids can either be used for de 
High metabolic cost of a functional gut 
 71  
novo synthesis of proteins, for catabolic processes, or for incorporation 
into proteins.  
 
Figure 4. Schematic representation of the metabolic fate of enteral and 
systemic lysine in the PDV at t = 6 h and t = 12 h 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A, dietary intake of lysine; B, arterial flux of lysine through the PDV; C, portal 
outflow of lysine; D, unidirectional, first-pass uptake of dietary lysine by the 
PDV; E, dietary lysine that is not metabolized by the PDV in first-pass; F, 
unidirectional uptake of arterial lysine by the PDV ; G, arterial lysine that is not 
metabolized by the PDV; H, recycled lysine that is derived from proteolysis or 
the reabsorption of previously synthesized and secreted endogenous proteins, 
but not derived from the diet. Values are means and expressed in µmol/(kg·h), 
n = 4. The bold numbers are values at t = 6 h and the normal numbers are 
values at t = 12 h. 
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We found previously that less than 20% of intestinal amino acid 
utilization was used for constitutive gut growth by the intestinal 
mucosa. 7 Thus, for nutritionally indispensable amino acids, secretory 
(glyco-)protein synthesis appears to be a major metabolic fate. 
Moreover, although some essential amino acids are known to be 
catabolized, 6,11,17 the catabolism of essential amino acids does not 
account for their high utilization rate. The question of intestinal (glyco-
)protein secretion and recycling is of particular importance with regards 
to the protective function of the gut in general and for the nutrition of 
threonine in particular. Structurally, the mucosa is protected by a 
complex network of (glyco-)proteins (mucus), of which two mucins 
MUC-2 and MUC-3 are important components. 18 The highly 
glycosylated domains of small intestinal mucins have been isolated, 
and the core-proteins of these molecules contain large amounts of 
threonine. In view of this, it is, perhaps, not surprising that the 
systemic availability of threonine is remarkably low. More than two-
third of the enteral threonine intake was utilized by the PDV, a result 
that we have obtained in all of our previous studies of intestinal amino 
acid utilization, 6,7 and this high utilization rate of threonine represents 
in our view the consequence of a significant mucin production. Our 
results are in agreement with a study done by Bertolo et al., which 
investigated the threonine requirement during both parenteral and 
enteral feeding in neonatal piglets. 19 That study demonstrated that the 
threonine requirement of neonatal piglets is reduced by 45% during 
parenteral nutrition, and support the concept that threonine is required 
especially by a functional gut that secretes a lot of mucins. It appears 
therefore, that intestinal (glyco-)protein secretion probably makes a 
substantial contribution to maintenance amino acid needs in general, 
and to threonine needs in particular.  
Perhaps more importantly, we were not able to detect any 
statistically significant recycling of threonine from mucins the whole 
study period, suggesting either that mucins are resistant to digestion 
or that threonine released from mucins degradation is immediately, 
and quantitatively, reincorporated into secretory (glyco-)proteins.  
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In contrast to what we found for threonine, after 6 h of feeding 
46% of the lysine in the portal vein was derived from secreted protein 
recycling. It is, of course, possible that the first-pass lysine utilization 
is underestimated by tracer techniques. Specifically, separate studies 
in rats, pigs and humans reveal that there is a significant microbial 
synthesis of lysine within the gastrointestinal tract. 20-23 This lysine is 
made available to the host through release via microbial protein 
breakdown and its subsequent intestinal uptake. Lysine produced via 
this way will also appear in the portal vein and will, of course, be 
accounted for as “non-utilized” lysine in our model. Under the 
assumption that this occurs, the measured recycling rate would not 
include a contribution made by intestinally synthesized lysine and 
therefore our isotopically labeled tracer technique would underestimate 
the recycling rate of lysine. To fully resolve this issue, similar studies 
on the metabolic fates of the essential amino acids entering the 
gastrointestinal tract and the contribution made by the microbial flora 
to host tissue amino acid metabolism will be required in animals 
without micro bacterial flora. 
Given the high rate of intestinal protein metabolism, it is essential 
that as the enterocytes are initially exposed to the diet, their 
requirements are met first. From different studies we know that 
intestinal energy production is largely derived from the oxidation of 
glutamate, glutamine, aspartate and glucose. 7,11,12 In addition, some 
essential amino acids (lysine, leucine, and phenylalanine) are known to 
be used for oxidative purposes by the intestinal tissues as well, 6,11 
which is a nutritional loss. Furthermore, results from studies done in 
piglets have shown that the portal outflow varies widely among amino 
acids, indicating a heterogeneity in the intestinal metabolic fate among 
essential amino acids during the absorptive process. 6 For example, the 
portal appearance of phenylalanine as a fraction of intake was 
significantly lower as compared to the portal appearance of tyrosine as 
a fraction of intake. Phenylalanine oxidation is associated with its 
hydroxylation to tyrosine as a first step. The total 24-h phenylalanine 
utilization by the PDV (51%) determined in this study is similar to that 
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found in a study involving dual intravenous/intragastric infusions of 
labeled phenylalanine in fed humans (58% of dose), 24 but is lower 
than that measured in the postprandial state (29%). 25 We concluded 
from that study on splanchnic phenylalanine metabolism in pigs that 
catabolism is an important metabolic fate of enteral phenylalanine in 
the intestinal mucosa. 26 Our observed low appearance of 
phenylalanine and the high appearance of tyrosine supports these 
results, indicating a high rate of hydroxylation of phenylalanine to 
tyrosine.  
Interestingly, almost all aspartate, glutamate and glutamine were 
extracted by the gastrointestinal tissues (on average more than 90% of 
dietary intake). Apart from the indication that these three amino acids 
are extensively utilized within the splanchnic tissues, the results also 
highlight the fact that systemic aspartate, glutamate and glutamine are 
almost exclusively derived from synthesis within the body. Based upon 
previous studies, we assume that a large part of these utilized amino 
acids are metabolized by the PDV for oxidative purposes and energy 
generation. 11,12 Glutamate, together with cysteine and glycine, also 
serves as a precursor for the biosynthesis of glutathione, 27 and for 
mucosal nucleic acids. 28 On the other hand, the utilization of some 
amino acids expressed as a percentage of intake after 12-h of 
continuous feeding (alanine, arginine, glycine and tyrosine) exceeded 
their intake, indicating that the intestinal tissues are nutritionally 
significant site of de novo synthesis of alanine, arginine, glycine and, 
especially, tyrosine. Indeed, studies in vitro 29 and in vivo 12 have 
found net arginine synthesis in the small intestine of piglets and there 
is also indirect evidence for this in humans. 30 The physiological and 
nutritional importance of this arginine pathway is strikingly illustrated 
by the fact that massive gut resection renders arginine a fully essential 
amino acid. 31 
Limited experimental information exits about the appearance of 
amino acids in the portal circulation during a prolonged feeding period 
and during fasting in piglets. Thus, measurements of net portal amino 
acid balance during a 24-h period gives information on the proportion 
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and, perhaps more importantly, the pattern of dietary amino acids that 
are available for the support of whole-body metabolism. As the feeding 
period progressed, the portal appearance of amino acids showed a 
significant increase while the food intake was not changed. This 
observation holds regardless of the decelerating effect of gastric 
emptying on the absorption of amino acids by the intestine. By feeding 
the piglets continuously with an intraduodenal catheter we avoided that 
the slow gastric emptying would delay the absorption of dietary 
nutrients. Following cessation of the continuous feeding the mean 
portal mass balance of all essential amino acids remained significantly 
different from zero for an 8-h period. The continuation of a net positive 
amino acid mass balance in the portal circulation during fasting for 
several hours presumably reflects an ongoing release of amino acids 
from recycled proteins. The only two exceptions were glutamine and 
tryptophan, nearly all the utilized glutamine appeared in the portal 
circulation during fasting. During fasting protein breakdown is 
increased which leads to a higher nitrogen release, and because 
glutamine plays an instrumental role in nitrogen homeostasis, the high 
net release of glutamine by the PDV during fasting could be an exit of 
metabolic nitrogen into glutamine as found by Remesy et al. 32 Our 
balance study showed that tryptophan was not recycled within the gut, 
since the portal mass balance was not significantly different from zero 
during the fasted state. From a study done by Cvitkovic et al., it seems 
that tryptophan requirement is not increased during enteral nutrition 
as compared to parenteral nutrition, indicating that there is no 
additional specific need for tryptophan during feeding. 33 This again 
explains the lack of recycling in our study, presumably indicating that 
there is hardly any tryptophan incorporated in (glyco-)proteins that are 
secreted into the intestinal lumen. The utilized tryptophan might well 
be utilized as a precursor for the biosynthesis of serotonin within the 
intestinal epithelium since this tissue is highly innervated. 34 
In conclusion, we have shown that during a prolonged feeding 
period, the PDV maintain a high rate of metabolism by continuing to 
use a disproportionately large amount of the dietary protein intake. 
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The results also show that during a fasted state the portal mass 
balance of all essential amino acids remains significantly greater than 
zero for at least 8-h. Our findings strongly support the idea that 
intestinal metabolism has a substantial effect on the availability of 
dietary amino acids for the support of whole-body growth, and that 
intestinal recycling of amino acids is an important regulatory 
mechanism of the gut for systemic amino acid availability. In other 
words, the intestine is not “merely” an organ of nutrient assimilation, 
but one that uses substantial quantities of amino acids to maintain 
functions of critical physiological importance. 
 
Appendix 
Arterial amino acid (AA) input [µmol/(kg·h)] = 
arterial AA conc x PBF    [1] 
in which AA means amino acid which can be substituted by lysine or 
threonine, the amino acid concentration is expressed in µmol/liter, and  
PBF is expressed in liter/(kg·h).  
Portal AA output [µmol/(kg·h)] = 
portal AA conc x PBF    [2] 
Net portal AA balance [µmol/(kg·h)] = Eq.2 - Eq.1 [3] 
Net utilization of AA by PDV [µmol/(kg·h)] = 
dietary intake - Eq.3    [4] 
Fractional utilization of AA by PDV 
(fraction of intake) = Eq.4   [5] 
    dietary intake 
Substituting the amino acid concentration with the tracer concentration 
will give the tracer kinetics. 
Arterial tracer AA input [µmol/(kg·h)] = 
arterial tracer AA conc x PBF     [6] 
Portal tracer AA output [µmol/(kg·h)] = 
portal tracer AA conc x PBF   [7] 
Portal tracer AA balance = Eq.7 - Eq.6   [8] 
The percentage of arterial AA that is utilized by the PDV is measured 
during the intravenous tracer study and is calculated as follows. 
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Fractional arterial AA utilization = Eq.6 - Eq.7 [9] 
          Eq.6 
The amount of arterial AA that is utilized by the PDV is calculated with 
the following equation. 
Arterial utilization of AA by the PDV [µmol/(kg·h)] = 
Eq.9 x Eq.1     [10] 
The amount of dietary lysine or threonine utilized in first-pass by the 
intestine has to be corrected by the amount of dietary lysine or 
threonine that appears in the portal vein (and thus is not metabolized 
by the PDV) and then reenters the PDV but now from the arterial site. 
This lysine or threonine will be utilized by the PDV in the same 
proportion as the intravenous administered tracer (Eq.9). Thus, during 
the intraduodenal tracer infusion, the equation is  
Fract enteral AA utilization = 
dietary tracer intake-Eq.7-[(1 - Eq.9) x Eq.6]  [11] 
dietary tracer intake 
Thus, the amount of dietary AA that is utilized by the PDV is calculated 
by  
First-pass AA utilization by PDV [µmol/(kg·h)] = 
Eq.11 x dietary intake     [12] 
As stated in Figure 4, some of the lysine or threonine appearing in 
the portal vein is neither derived from the diet nor from the artery. 
This so-called recycled lysine or threonine is derived from proteolysis, 
either intracellular or luminal, or from bacterial production. It was 
calculated as follows, with results from both the intravenous and the 
intraduodenal tracer studies. 
Recycled AA appearing in portal vein [µmol/(kg·h)] =  
Eq. 2 - (dietary intake - Eq.12) - (Eq.1 - Eq.10) [13] 
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Background & Aims: Previous studies indicate that amino acids and 
glucose are the major oxidative substrates for intestinal energy 
generation. We hypothesized that low protein feeding would lower the 
contribution of amino acids to energy metabolism, thereby increasing 
the contribution of glucose. Methods: Piglets, implanted with portal, 
arterial and duodenal catheters and a portal flow probe, were fed 
isocaloric diets of either a high protein (0.9 g/(kg·h) protein, 1.8 
g/(kg·h) carbohydrate, and 0.4 g/(kg·h) lipid) or a low protein (0.4 
g/(kg·h) protein, 2.2 g/(kg·h) carbohydrate and 0.5 g/(kg·h) lipid) 
content. They received enteral or intravenous infusions of [1-
13C]leucine (n=17), [U-13C]glucose (n=15) or enteral [U-13C]glutamate 
(n=8). Results: CO2 production by the splanchnic bed was not affected 
by the diet. The oxidation of leucine, glutamate and glucose accounted 
for 82% of the total CO2 production in high protein-fed pigs. Visceral 
amino acid oxidation was substantially suppressed during a low protein 
intake. Although glucose oxidation increased to 50% of the total 
visceral CO2 production during a low protein diet, this increase did not 
compensate entirely for the fall in amino acid oxidation. Conclusions: 
Although low protein feeding increases the contribution of enteral 
glucose oxidation to total CO2 production, this adaptation is insufficient. 
To compensate for the fall in amino acid oxidation other substrates 
become increasingly important to intestinal energy generation. 
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ven though the portal-drained viscera (PDV; the intestines, 
pancreas, spleen and stomach) contribute less than 5% of body 
weight, they utilize between 10 and 20% of whole-body energy 
expenditure and contribute up to 50% of the whole-body turnover 
of some essential amino acids. 1-3  
Furthermore, because the small intestinal mucosa is the first tissue 
with the capability of amino acid metabolism to be exposed to the diet, 
dietary amino acid utilization by the intestine could have a substantial 
effect on the systemic availability of essential amino acids. Intestinal 
metabolism could therefore have a regulatory influence on whole-body 
protein deposition. It is also clear from studies in a number of 
mammalian species, including human beings, that dietary essential 
amino acids are directly utilized by the intestines for protein synthesis 
and other biosynthetic pathways. 4-6 
The most extensive information on intestinal carbon metabolism in 
vivo was obtained in a series of experiments with isolated, in situ, 
vascularly perfused loops of rat small intestines. 7-11 In summarizing 
these experiments, Windmueller and Spaeth 12 concluded that 
aspartate, glutamate and glutamine were the major oxidative 
substrates used by the small intestinal mucosa and that glucose was a 
minor oxidative substrate in animals that had been fed up to the 
initiation of the study. Recently, we performed studies in pigs using 
13C-labeled tracers of glutamate, glutamine and glucose. 13 In 
confirmation of earlier studies, 7-11 we concluded that dietary glutamate 
was the single most important source of energy for the portal-drained 
viscera in the fully-fed conscious animal. Glucose accounted for 
approximately 30% and glutamine for 15% of total CO2 production by 
the PDV. 
However, the oxidation of glutamate, glutamine and glucose 
accounted for neither the total CO2 production nor the production of 
alanine and ammonia by the PDV. Subsequently, we found that 
intestinal lysine oxidation accounted for one-third of whole-body lysine 
oxidation. 14 When this result was taken together with our previous 
observations and unpublished results on leucine oxidation, we 
E 
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concluded that amino acids in general are the major contributors to 
mucosal oxidative energy generation in adequately nourished animals.  
An important question posed by these results is, whether the 
intestinal tissues have an obligatory requirement for amino acids as 
energy generating substrates or whether the results that we had 
obtained reflected the prior (protein-rich) diet of the experimental 
animals. If the intestinal catabolism of amino acids is obligatory, then 
this pathway would have a critical effect on amino acid nutrition under 
conditions of a low protein intake. Therefore, the first objective of the 
present study was to quantify the effects of low protein intake on the 
oxidation of dietary glutamate and leucine as representatives of amino 
acids which metabolism occurs via different portions of central 
pathways of intermediary metabolism. 15 On the basis of some recent 
results in vitro 16 we hypothesized firstly, that the amino acid oxidation 
in the intestinal tissues adapts to a low protein intake and secondly, 
under this condition that there is an up-regulation of glucose 
catabolism to compensate for the lower rate of the amino acid 
oxidation. 
One unique feature of the intestinal metabolism is that in the fed 
state the mucosal cells receive substrates directly from both the 
mesenteric circulation and from the diet. Previous studies 16-19 have 
shown that both systemic and dietary amino acids and glucose are 
utilized by the PDV, but the relative contribution of systemic and first-
pass utilization of dietary amino acids and glucose has received 
relatively little attention even though it has potentially regulatory 
implications, particularly in relation to systemic availability. The second 
objective of the experiments was to quantify the effect of low protein 
feeding on the relative contributions of the metabolism of systemic and 
enteral substrates to the overall intermediary metabolism of the PDV. 
In the present experiments we have measured, with enteral and 
intravenous infusions of 13C-labeled glucose, leucine or glutamate, the 
oxidative metabolism by the PDV in 4-week-old piglets receiving iso-
energetic diets and either a high (HP 12.7 g/(kg·d)) or a low (LP 5.1 
g/(kg·d)) protein intake. The low protein intake was deliberately set at 
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40% of the normal intake, in an attempt to keep the animals in 
nitrogen equilibrium. We used piglets because of their well-established 
homology to infants in terms of gastrointestinal development and 
function, body composition, and metabolism. 20-22 
The results generally confirmed our primary hypothesis by 
showing a substantial suppression of visceral amino acid oxidation 
under conditions of a low protein intake. However, although there was 
an increase in the contribution of glucose oxidation to total CO2 
production, this incompletely compensated for the fall in the 
contribution of amino acid oxidation in order to generate energy to the 
PDV. 
 
Methods 
Animals 
The Baylor College of Medicine Animal Protocol Review Committee 
approved the study. Housing and care of the animals conformed to the 
current USDA guidelines. The study used 4-week-old female crossbred 
piglets (Large White x Hampshire x Duroc) obtained from the Texas 
Department of Criminal Justice, Huntsville, TX. Two-week-old pigs were 
received at the CNRC and for a 7 d adjustment period they were fed a 
liquid milk replacer diet (Litter Life, Merrick, Middleton, WI) at a rate of 
50 g/(kg·d) body weight. The composition (per kg dry matter) of the 
milk replacer is 500 g lactose, 100 g fat and 250 g protein.  
 
Study design 
The study design is depicted in Figure 1. At postnatal age of 3 weeks, 
the piglets underwent surgery after an overnight fast. Catheters were 
implanted into the stomach, duodenum, the portal and jugular vein 
and the common carotid artery. An ultrasonic flow probe (Transonic 
Systems Inc, Ithaca, NY) was implanted around the common portal 
vein. Following surgery, the piglets received total parental nutrition for 
24-36 h. Following this period of parenteral nutrition, the piglets 
received either regular Litter Life (HP diet) or a diet that contained only 
40% of the protein present in Litter Life (LP diet). The low protein fed 
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piglets were deliberately set at a feeding rate that on the basis of 
current recommendations would be expected to maintain body protein 
balance and homeostasis. 23 The diets were made isocaloric by adding 
lactose (Sigma Chemical, St Louis, MO) and corn oil in the same ratio 
as in the HP diet. The pigs were offered 50% of their preceding daily 
intake on the second postoperative day and resumed full feed intake 
on the third postoperative day. Three piglets did not survive the direct 
postoperative period. The animals were weighed daily for one week 
prior to surgery and during the whole post surgical period. At a 
postnatal age of 4 weeks, all animals (n = 24) received an intravenous 
infusion of NaH13CO2 in order to measure whole-body CO2 production. 
Animals were randomly assigned to receive the infusions of [U-
13C]glutamate (HP n = 4, LP n = 4), [1-13C]leucine (HP n = 9, LP n = 
8) and [U-13C]glucose ( HP n = 8, LP n = 7) on postnatal days 29-31. 
 
Figure 1. Schematic presentation of  study design 
 
 
 
 
 
 
 
 
 
 
Surgery indicates placement of catheters in jugular and portal vein, carotid 
artery, stomach and duodenum and placement of ultrasonic flow probe around 
portal vein. 
 
Tracer Protocol  
The tracer protocol is shown in Figure 2. After an overnight fast, 
arterial and portal baseline blood samples were obtained, and the pigs 
were offered a single bolus meal that supplied one-fourteenth of their 
daily intake (186 ml/(kg·d) Litter Life). This meal served to initiate an 
weaned surgery studies
Age (d): 14 21 28-32 0
HP
HP LP
HPHigh Protein n=14
Low Protein n=10
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adequate pattern of gastric emptying. Immediately thereafter, a 
continuous duodenal infusion of diet was started at a rate of one-
fourteenth of their daily intake for the next 12 h. This feeding protocol 
allowed us to feed the animals for 12 h and fast them the other 12 h 
before starting the next study on the following day. Thus, the piglets 
fed the HP diet received 14.4 kcal/(kg·h), 0.9 g/(kg·h) protein, 1.8 
g/(kg·h) carbohydrate, and 0.4 g/(kg·h) lipid, while the piglets fed the 
LP diet received 14.4 kcal/(kg·h), 0.4 g/(kg·h) protein, 2.2 g/(kg·h) 
carbohydrate, and 0.5 g/(kg·h) lipid. Tracer infusion commenced 2 h 
after the initiation of feeding. The enteral tracers were administered via 
an intraduodenal or intragastric catheter. On postnatal day 28, [1-
13C]bicarbonate (99 mol% 13C; Cambridge Isotopes,Woburn, MA) was 
infused into the jugular catheter at a rate of 10 µmol/(kg·h). Arterial 
and portal blood samples (3 mL) were drawn after 90, 105 and 120 
min and at 15-min intervals during the last hour of tracer infusion.  
 
Figure 2. Schematic presentation of tracer protocol. Numbers of piglets 
per specific tracer infusion: [U-13C]glucose HP n = 8 vs. LP = 7; [U-
13C]glutamate HP n = 4 vs. LP n = 4 and [1-13C]leucine HP n = 9 vs. LP n 
= 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tracer infusion id or iv
Time (h):  0 2 4
Blood gases 
13CO2 dilution 
Amino acid concentrations 
[U-13C]glucose, [U-13C]glutamate, or [1-13C]leucine dilution 
Portal blood flow was measured constantly
6 
Chapter 4 
 90 
On postnatal day 29, randomly assigned piglets received a 
constant infusion of [U-13C]glutamate (91 mol% U-13C; Ajinomoto, 
Tokyo, Japan) providing approximately 30 µmol/(kg·h) via the 
duodenal catheter. On postnatal day 30, randomly assigned piglets 
received a constant infusion of  [U-13C]glucose (92 mol% U-13C); 
Cambridge Isotopes, Woburn, MA) and [2H2]glucose (99 mol% D2; 
Cambridge Isotopes, Woburn, MA) at a rate of 180 µmol/(kg·h) via 
either the duodenal catheter or the jugular catheter. On postnatal day 
31, randomly assigned piglets received a constant infusion of [1-
13C]leucine (98.6 mol% 13C; Cambridge Isotopes, Woburn, MA) 
providing approximately 8 µmol/(kg·h) via either the intragastric 
catheter or the jugular catheter.  On postnatal days 29-31, arterial and 
portal blood samples (3 mL) were drawn after 90, 105 and 120 min 
and at 15-min intervals during the last hour of tracer infusion. Blood 
gases (Chiron Diagnostics, Halstead, Essex, UK), glucose and lactate 
(YSI analyzer, Yellow Springs, OH) were determined immediately in all 
samples. An aliquot of whole blood (0.2 mL) was mixed with an equal 
volume of an aqueous solution of methione sulfone (0.5 mmol/L) and 
directly frozen in liquid nitrogen. This was taken for subsequent 
analysis of amino acid concentrations. Another aliquot of EDTA-blood 
(0.5 mL) was taken for the analysis of its ammonia concentration, and 
0.7 mL of whole blood was taken to measure blood 13CO2, as described 
before. 14 
The animals were then killed with an intra-arterial injection of 
pentobarbital sodium (50 mg/kg body wt) and sodium phenytoin (5 
mg/kg; Beutanasia-D; Schering-Plough Animal Health, Kenilworth, NJ) 
after 6 h of tracer infusion and the intestines were removed and 
weighed. 
 
Sample analysis 
Plasma ammonia was measured with the Beckman spectrophotometer 
(Raichem/Sigma Diagnostics, St Louis, USA) with the manufacturer’s 
protocol. Blood samples were prepared for amino acid analysis and 
mass spectrometry as described previously.5,13,14 Gas chromatography-
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mass spectrometry was performed with the pentacetate derivative of 
glucose, the hepta-fluoro-butyramide derivative 24,25 of glutamate and 
the tri-fluoro-acetyl-methylester derivative 14 of leucine. The between-
sample standard deviation for gas chromatograph mass spectrometer 
measurements was 0.1 MPE. 13CO2 enrichment was measured on 
isotope ratio mass spectrometer as described before. 14 The between-
sample standard deviation of isotope ratio mass spectrometer 
measurements was 0.001 atom percent excess (1‰). Amino acid 
concentrations were measured with reverse-phase high performance 
liquid chromatography of their phenyl-isothiocyanate derivatives (Pico 
Tag, Waters, Woburn, MA). The 13C enrichments are reported as mole 
percent excess after subtracting the baseline 13C content measured 
from samples obtained before the start of the tracer infusion. 
 
Calculations 
Previous studies from this and other laboratories have used a steady 
state, whole-body model of amino acid metabolism that developed in 
large part from work by Waterlow et al. 26 This model assumes a 
common metabolic amino acid pool through which all amino acids 
move, either to enter as dietary amino acids or from protein 
breakdown, or to exit for protein synthesis or oxidation. This 
movement through the metabolic pool is called flux. From the 
measurements of arterial and portal enrichments of the [13C]tracers, 
arterial and portal amino acid concentrations, and portal blood flow, 
the uptake of substrates across the PDV can be calculated. 14 
Corrections were made for the recycling of the enteral administered 
tracer that entered the PDV from the systemic circulation. By 
measurement of the 13CO2 production across the PDV in a similar 
fashion, the oxidation of 13C-labelled substrates can be calculated. 14 
Again a correction was made for the recycling of the [13C]tracer that 
was originally administered enterally, and subsequently underwent 
oxidation. Because the present experimental conditions were identical 
as those used previously 14 (except for the different tracers used, e.g. 
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glucose, glutamate and leucine instead of lysine), we used the same 
equations. 
 
Statistics 
The data are expressed as the mean values obtained from samples 
taken over the last hour of tracer infusions ± the inter-animal SD. 
Balances were tested against zero by one-tailed t-tests. The differences 
in proportion of the dietary and systemic amino acids and glucose 
oxidized by the splanchnic bed were tested with a two-tailed grouped t-
test.  A value of P <  0.05 was taken as statistically significant. 
 
Table 1. Mean body weights, gut masses, and CO2 production in piglets 
fed the two different diets 
 
Diet Body 
weight  
 
kg 
Gut 
mass  
 
g/kg 
CO2 
production 
PDV  
mmol/(kg·h) 
CO2 
production 
whole-body 
mmol/(kg·h) 
% CO2 
production 
PDV 
HP 7.8 ± 1.0 44 ± 7 8.13 ± 2.41 64.0 ± 16.9 13.0 ± 3.9 
LP 7.0 ± 1.1 42 ± 5 6.88 ± 3.44 59.6 ± 7.2 11.2 ± 6.8 
Diet 
effect 
NS NS NS NS NS 
 
Values are means ± SD. 
 
Results 
The portal blood flow, body weights, gut masses, CO2 production by 
the PDV and total CO2 production are shown in Table 1. Prior to 
surgery the rate of weight gain was not significantly different between 
the two study groups (HP: 50 ± 4 g/(kg·d) vs. LP: 52 ± 7 g/(kg·d)). 
The daily weight gain over the postoperative period (10 ± 1 days) 
differed  (P < 0.001) between the two groups (HP: 45 ± 3 g/(kg·d) vs. 
LP: 26 ± 5 g/(kg·d)). At the time of the tracer infusions, the piglets 
weighed 7.8 ± 1.0 kg (HP) and 7.0 ± 1.1 kg (LP), the difference 
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between the mean weight of the animals at the time of the study 
periods were related to their growth rates. The contribution of the 
intestines to total body weight was not significantly different (HP: 44 ± 
7 vs. LP: 42 ± 5 g/kg). Low protein feeding did not significantly affect 
portal blood flow (PBF) and whole-body CO2 production (HP: 64 ± 17 
vs. LP: 60 ± 7 mmol/(kg·h)) as measured by [1-13C]bicarbonate 
infusion. As found in our earlier studies, the CO2 production by the PDV 
accounted for more than 10% of the total CO2 production and was not 
significantly affected by the diet composition (HP: 8.1 ± 2.4 vs. LP: 6.9 
± 3.4 mmol/(kg·h)). 
 
Mass balance of substrates and their products 
Table 2 shows the net portal balances of the primary substrates over 
the last hour of the study. The net portal mass balances and the 
fractional mass balance (mass balance divide by intake) were 
significantly lower in the LP group for leucine and glutamate.  
 
Table 2. Arterial and portal concentrations and net portal mass balance 
of primary substrates 
 
Substrate Flux Portal mass balance 
 Arterial Portal   
 mmol/(kg·h) Mmol/(kg·h) mmol/(kg·h) % of input 
Leu HP 2.49 ± 0.80 3.03 ± 0.88 0.48 ± 0.12 68 ± 16 
Leu LP 0.91 ± 0.17 1.07 ± 0.23 0.14 ± 0.04 50 ± 13 
Diet effect P < 0.001 P < 0.001 P < 0.001 P < 0.05 
Glu HP 1.57 ± 0.49 1.74 ± 0.59 0.10 ±  0.02 10 ± 2 
Glu LP 0.68 ± 0.12 0.70 ± 0.12 0.02 ± 0.02 5 ± 4 
Diet effect P < 0.05 P < 0.05 P < 0.001 P < 0.05 
Gluc HP 45.61 ± 8.74 51.21 ± 8.91 5.21 ± 1.92 92 ± 34 
Gluc LP 28.19 ± 3.80 30.22 ± 6.74 4.98 ± 1.00 74 ± 15 
Diet effect P < 0.01 P < 0.05 NS NS 
 
Values are means ± SD; leu, leucine; glu, glutamate; gluc, glucose. 
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Table 3 summarizes the portal mass balances of ammonia, 
alanine, aspartate, glutamine and lactate in both groups. In the HP 
group the ammonia production accounted for 11% of the total nitrogen 
intake, while the fraction of ammonia production of the total nitrogen 
intake was decreased by nearly 50% in the LP group. During LP feeding 
the portal appearance of alanine was significantly decreased. The fall in 
ammonia and alanine production both indicate a markedly lower rate of 
amino acid oxidation by the PDV. The aspartate balance was essentially 
zero in both groups. Both during a high and a low protein intake the 
net portal balance of glutamine was slightly negative, indicating a net 
uptake of glutamine by the PDV. For lactate, the appearance in the 
portal circulation was decreased by nearly 80% during LP feeding. 
 
Table 3. Portal mass balance of metabolic end products of glutamate 
and glucose metabolism 
 
Product Flux 
         Arterial                  Portal 
mmol/(kg·h) 
Portal Balance 
 
mmol/(kg·h) 
Amm HP 0.72 ± 0.07 1.79 ± 0.97 1.15 ± 0.05 
Amm LP 0.07 ± 0.35 0.38 ± 0.44 0.27 ± 0.01 
Diet effect P < 0.0001 P < 0.0001 P < 0.0001 
Ala HP 4.02 ± 1.97 4.70 ± 2.34 0.65 ± 0.33 
Ala LP 2.62 ± 0.98 3.01 ± 1.14 0.32 ± 0.13 
Diet effect NS NS P < 0.01 
Asp HP 0.25 ± 0.07 0.29 ± 0.07 0.04 ± 0.01 
Asp LP 0.09 ± 0.04 0.10 ± 0.02 0.01 ± 0.00 
Diet effect P < 0.01 P < 0.01 P < 0.01 
Gln HP 3.44 ± 2.07 3.32 ± 1.81 -0.01 ± 0.10 
Gln LP 1.07 ± 0.49 1.02 ± 0.46 - 0.06 ± 0.04 
Diet effect P < 0.05 P < 0.01 P < 0.01 
Lact HP 6.30 ± 3.88 8.09 ± 5.04 1.73 ± 1.25 
Lact LP 5.48 ± 2.29 5.92 ± 2.55 0.37 ± 0.21 
Diet effect NS NS P < 0.05 
 
Values are means ± SD; amm, ammonia; ala, alanine; asp, aspartate; gln, 
glutamine; lact, lactate. 
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The arterial and portal enrichments of the of [13C]tracers is shown in 
Table 4. We detected no [U-13C]glutamate in the portal or arterial 
circulation both during HP and LP feeding, indicating a complete first-
pass removal of the glutamate tracer. The net absorption of enteral [1-
13C]leucine did not differ significantly between the groups. Ninety 
percent of the enteral dose of [U-13C]glucose appeared in the portal 
circulation and while the portal appearance of [U-13C]glucose (72% of 
infusion) was lower during a low protein intake, the difference was not 
significant.  
 
Glutamate oxidation  
The glutamate metabolism by the portal-drained viscera is depicted in 
Figure 3. During a generous protein intake 47% of the enteral dose of 
[U-13C]glutamate appeared as portal 13CO2, whereas 32% of the 
enteral dose was oxidized during an low protein intake. Subsequently, 
and due to the lower glutamate intake during low protein feeding, the 
oxidation of glutamate in the LP group was significantly lower as 
compared to the HP group and the contribution of enteral glutamate to 
total CO2 production by the splanchnic bed dropped significantly (HP: 
32 ± 15% vs. LP: 10 ± 3%, P < 0.05) during LP feeding (Table 5). 
 
Figure 3. Glutamate metabolism by the PDV. The white bar represents 
the HP group and the black bar represents the LP group; * indicates a 
significant difference between HP- and LP-fed piglets at P < 0.05 
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Table 4. Arterial and portal enrichments and portal balances of 
[13C]tracers 
 
Tracer Arterial 
enrichment 
MPE 
Portal 
enrichment 
MPE 
Tracer 
balance 
µmol/(kg·h) 
% of 
input 
[1-13C]leu id HP 1.0460 ± 
0.1306 
1.2298 ± 
0.1588 
794 ± 214 46 ± 21 
[1-13C]leu id LP 1.5998 ± 
0.2037 
1.7728 ± 
0.1703 
499 ± 151 37 ±10 
Diet effect P < 0.05 P < 0.05 NS NS 
[1-13C]leu iv HP 1.0858 ± 
0.2956 
0.8638 ± 
0.2957 
60 ± 213 2 ± 12 * 
[1-13C]leu iv LP 1.4985 ± 
0.2029 
1.2505 ± 
0.0544 
-75 ± 153 - 
Diet effect P < 0.05 P < 0.05 P < 0.05 P < 0.05 
[U-13C]glu id HP 0.0004 ± 
0.0003 
0.0003 ± 
0.0003 
0.3 ± 0.5 - 
[U-13C]glu id LP 0.0018 ± 
0.004 
0.0056 ± 
0.011 
-5 ± 16 1 ± 2 
Diet effect P < 0.05 NS NS NS 
[U-13C]gluc id HP 0.0256 ± 
0.001 
0.0252 ± 
0.001 
160 ± 51 90 ± 29 
[U-13C]gluc id LP 0.0163 ± 
0.0002 
0.0175 ± 
0.0004 
129 ± 46 72 ± 26 
Diet effect P < 0.05 P < 0.05 NS NS 
[U-13C]gluc iv HP 0.0216 ± 
0.002 
0.0245 ± 
0.002 
-84 ± 56 - 
[U-13C]gluc iv LP 0.0231 ± 
0.003 
0.0185 ± 
0.003 
-33 ± 25 - 
Diet effect NS NS NS NS 
 
Values are means ± SD; id, intraduodenal; iv, intravenous; MPE, mole percent 
excess; leu, leucine; glu, glutamate; gluc, glucose; * expressed as a percentage 
of input of arterial [1-13C]leucine by the PDV.   
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Leucine oxidation  
Details of the leucine metabolism are shown in Figure 4. During HP 
feeding both arterial and enteral leucine were oxidized in almost equal 
amounts by the PDV. Total leucine oxidation contributed for 18% to 
overall CO2 production by the PDV (Table 5). The oxidation of both 
arterial and enteral leucine oxidation by the PDV fell to zero in the LP 
group. Leucine oxidation by the splanchnic tissues accounted for 50% 
of whole-body leucine oxidation during a high protein intake, while 
whole-body leucine oxidation was significantly lower during LP feeding 
as compared to HP feeding (HP: 252 ± 64 vs. LP: 200 ± 42 
µmol/(kg·h), P < 0.01). 
 
Table 5. Oxidation and fraction of contribution of different substrates to 
CO2 production by the PDV 
 
 HP LP 
 Oxidation Fract CO2 
prod by 
PDV 
Oxidation Fract CO2 
prod by 
PDV 
 µmol/(kg·h) % µmol/(kg·h) % 
PDV CO2 prod 8,129 ± 2,408 100 6,881 ± 3,975 100 
Leu enteral 696 ± 508 12 ± 10 55 ± 307 - 
Leu systemic 432 ± 702 6 ± 8 -70 ± 81 - 
Glu enteral 2,349 ± 1,363 32 ± 15 771 ± 604 10 ± 3 
Gluc enteral -1,754 ± 556  1,983 ± 2,681 25 ± 30 
Gluc systemic 3,714 ± 851 39 ± 10 1,170 ± 500 25 ± 7 
Miscellaneous  11  40 
 
Values are means ± SD. 
 
Glucose oxidation 
In the HP group, the intestine oxidized arterial glucose at a rate of 619 
± 142 µmol/(kg·h), and there was no net oxidation of enteral glucose 
after correction of the secondary metabolism of the recycled [U-
13C]glucose (Figure 5). The oxidation rate from arterial glucose 
decreased by more than 75% to 209 ± 60 µmol/(kg·h) in response to a 
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low protein diet. However, in the LP group there was an increase in the 
first-pass oxidation of enteral glucose in the LP fed pigs (330 ± 447 
µmol/(kg·h)), so that the total glucose oxidation by the PDV in the LP 
group (540 µmol/(kg·h)) was not significantly different from the total 
oxidation in the HP group.  
  
Figure 4. The leucine metabolism by the PDV. The white bar represents 
the HP group and the black bar represents the LP group; * indicates a 
significant difference between HP- and LP-fed piglets at P < 0.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
CO2 production by the different substrates 
The contributions of the different substrates to total CO2 production by 
the splanchnic tissues are presented in Table 5. During HP feeding 
arterial glucose and enteral glutamate were the most important 
sources of energy (glucose iv 39% and glutamate id 32%) and a high 
proportion (89%) of the total CO2 production by the PDV could be 
accounted for by direct measurements. During the low protein intake 
period, amino acid oxidation accounted for only 10% of the total CO2 
production by the PDV. Although the fractional contribution of the 
glucose oxidation rose to 50%, the sum of amino acid and glucose 
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oxidation accounted for no more than 60% of the measured CO2 
production by the PDV. 
 
Figure 5. The glucose oxidation rates by the PDV. The white bar 
represents the HP group and the black bar represents the LP group. * 
indicates a significant difference between the HP-and the LP-fed pigs at 
P < 0.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
In our previous work, we showed that under high protein feeding 
conditions, intestinal energy production is largely derived from the 
oxidation of glucose, glutamate, glutamine and aspartate. 13 In this 
previous study, dietary glutamate was the single most important 
oxidative substrate for the intestinal mucosa. This is in contrast to the 
general believe that glutamine is the most important energy substrate, 
a conclusion that is based upon the earlier reports of measurements in 
isolated loops of rat. 7,8,11 However, much of the more recent literature 
on splanchnic metabolism has ignored two other observations made by 
same authors, i.e., first, that the metabolism of luminal glutamate was 
even more extensive than that of arterial glutamine; and second, that 
the presence of high concentrations of glutamate in the intestinal 
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lumen had only a small (25%) effect on the intestinal utilization of 
glutamine. 9 In other words, these two closely related amino acids may 
have different functional roles in the splanchnic tissues. In subsequent 
studies 14 we showed that the PDV also oxidize lysine and the present 
study extends these observations to leucine, a result that confirms Yu’s 
work in the dog. 17 The present study was designed primarily to test 
two hypotheses (I) that when protein becomes the limiting nutrient 
then there is an adaptation in the oxidation of amino acids by the PDV 
and (II) that under this circumstance an up-regulation of glucose 
oxidation compensates for the fall in the contribution of amino acids to 
intestinal energy generation.  
In discussing the results it is important to emphasize two aspects 
of the study design. First, the lower level of protein intake was set at a 
value that held the animals in whole-body nitrogen equilibrium. 27 
Second, that the overall energy intake of the low protein fed animals 
was kept constant, and that also the relative contribution of 
carbohydrate (lactose) and lipid (corn oil) was unaltered. The first 
result of interest was that although the overall nitrogen balance across 
the PDV of the LP group was close to zero, this appeared to be the 
resultant of continuing protein gain in the intestinal tissues and a small 
protein loss from the rest of the body. This confirms previous work by 
us 27 and suggests that the continuing weight gain of the low protein 
fed animals consisted largely of body lipid. In addition, as we have 
shown in a previous report, 14 the impact of low protein feeding on the 
overall utilization of dietary protein by the intestinal tissues was 
minimal, and presumably because the intestine was supplied with 
adequate quantities of non-protein energy substrates, the rates of 
visceral CO2 production and oxygen consumption were not significantly 
different between the high and low protein-fed animals. However, 
despite the maintenance of normal rates of energy expenditure, the 
low protein intake was associated with a virtually complete suppression 
of leucine oxidation and, on the basis of the portal ammonia and 
alanine outflow, a 75% decrease in overall amino acid catabolism. 
Nevertheless, it was of considerable interest that the utilization of 
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glutamine continued in proportion to intestinal tissue mass and that the 
fall in glutamate oxidation was in proportion to the reduction in 
glutamate intake. In other words, the metabolic importance of both 
glutamate and glutamine was maintained, even though protein was in 
substantial deficit. 
With regards to intestinal glucose metabolism the present data in 
the HP group confirmed our previous observations 13 in demonstrating 
that in this group the oxidation of arterial glucose supported about 
40% of intestinal CO2 production. In addition, the present results also 
confirmed the complete lack of first-pass oxidation of enteral glucose in 
high protein-fed animals. It was notable however, that despite the 
higher lactose intake of the LP group, the portal balance of glucose was 
essentially the same in the two feeding groups. Furthermore, because 
only 30% of the utilized glucose by the PDV appeared as CO2, the PDV 
of the LP group were utilizing more glucose for anabolic purposes, 
presumably for lipid and glycoprotein synthesis.  
It was of considerable interest that in the LP group not only the 
contribution of glucose oxidation to total CO2 production was increased 
to some extent, but that the increase associated with low protein 
feeding was a reflective of an increase in the oxidation of enteral 
glucose in first pass. This “switch” towards an increased reliance in 
first-pass metabolism was also observed in our previous study of 
intestinal lysine utilization in the low protein fed animals. Together the 
results imply that there are adaptive changes in both the apical and 
basolateral amino acid and glucose transporters associated with the 
prolonged consumption of a diet which contains less protein. Studies in 
rats showed that during a low protein intake the expression of the CAT-
1 transportersystem, an intestinal amino acid transportersystem, was 
up-regulated in liver cells. 28 It remains to be investigated to what 
extent the amino acid transport is handled in first-pass by the 
transporters in the apical and basolateral membrane of the intestinal 
enterocytes during a low protein intake. 
Although the contribution of the oxidation of enteral glucose to the 
total CO2 production was somewhat higher in the low protein fed 
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animals, the increase did not compensate for the fall in overall amino 
acid catabolism by the PDV. In fact, while in the HP group more than 
89% of the output of CO2 by the PDV derived from the oxidation of 
glucose, glutamate and leucine, in the LP group the measurements 
could only account for 60% of the output of CO2 by the PDV. Thus, 
other substrates must have assumed an increased importance. In this 
context it is important to emphasize the fact that the dietary 
substitution consisted of a combination of lactose and corn oil so that 
the overall lipid intake of the LP animals was also increased and 
presumably the PDV became more reliant on lipid oxidation. Whether 
this represents the oxidation of free fatty acids, ketones or short-chain 
fatty acids is unknown, although it should be noted that the intestinal 
tissues are capable of oxidizing all three alternative substrates. 11,29 
Moreover work in mice receiving isocaloric diets deferring in the 
lipid:carbohydrate ratio has suggested that the intestinal mucosal cells 
are able to readily substitute these substrates to potential sources of 
ATP. 
In conclusion, we have shown that during a low protein intake the 
splanchnic tissues maintain a high rate of energy expenditure by 
increasing the oxidation rate of dietary glucose. Under the conditions of 
the present study, intestinal adaptation appears to favor the systemic 
availability of amino acids by reducing the amino acid oxidation, 
although the anabolic utilization of essential amino acids is altered to 
only a small extent. However, the oxidation of glucose and amino acids 
does not provide enough substrate for the energy need of the PDV. 
Therefore the gut has to use other substrates like fatty acids or ketone 
bodies to keep up the high mucosal metabolism. At this stage, the 
mechanism that underlies the preferential choice of the gut for 
substrates as fuel source during a low protein supply is not clear and 
merits further examination. 
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Background & Aims: In clinical studies, the oxidation of [13C]labeled 
substrates to 13CO2 and the measurement of the appearance of excess 
13CO2 in expiratory air has progressed to an increasingly common method 
as it is noninvasive and lacks the radiation exposure associated with the 
use of 14C. The collection of respiratory CO2 currently used, occurs via 
trapping of CO2 in sodium hydroxide (trapping method) sometimes in 
conjunction with indirect calorimetry. The aim of the present study was to 
determine the accuracy of our direct naso-pharyngeal sampling method 
for the collection of breath samples in preterm infants compared with the 
currently used trapping method. Methods: We present a method that 
simplifies the collection of breath samples in preterm infants. Seven 
preterm infants with a gestational age of 26-29 wk were studied on 
different postnatal days (range: 8-52 days) while receiving full enteral 
feeding. A primed constant 3-h intragastric infusion of [13C]bicarbonate 
was given and breath samples were collected by means of direct naso-
pharyngeal sampling and by a sodium hydroxide trap simultaneously. 
Results: The 13C isotopic enrichment in breath rose rapidly to reach a 
plateau by 120 min with <5% variation of plateau in both methods. 13CO2 
breath isotopic enrichments obtained by the direct naso-pharyngeal 
sampling method correlated highly (r = 0.933 and P < 0.0001) with the 
trapping method. The Bland-Altman analysis showed no significant 
variability between both methods and demonstrated that the 95% 
confidence interval is within ± 4.68 δ‰. Conclusion: These findings 
validate the simple method of direct naso-pharyngeal sampling of expired 
air in neonates. 
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ver the last three decades, stable isotopes have been extensively 
used to investigate whole-body protein metabolism in adults, children 
and newborns. 1-3  
To determine the rate of substrate oxidation, the excretion of 13CO2 in 
expired air must be quantified. The rate of oxidation is calculated by 
multiplying the enrichment of 13CO2 in breath by the total rate of CO2 
excreted, correcting for the incomplete recovery of 13C during an infusion 
of [13C]bicarbonate. 1 This correction factor has to be used to adjust for 
the fractional recovery of CO2. 
4,5 In addition, the total CO2 production 
(VCO2) needs to be measured.  
Several methods are known to quantify VCO2, but closed circuit 
indirect calorimetry is the most commonly performed method and serves 
as gold standard for the estimation of VCO2. This procedure requires the 
patient to breathe via a mouthpiece with the nares occluded or via a 
hood that catches all expired CO. 
6 However, particular circumstances 
make the use of the results obtained from indirect calorimetry difficult. 
For instance, results are difficult to interpret when there is an 
unmeasured loss of expired gasses due to the use of uncuffed leaking 
endotracheal tubes in mechanically ventilated neonates. 7 In addition, 
there is an increased possibility of error in the indirect calorimeter 
determination of VO2 and VCO2 with the low volumes of respiratory gas 
exchanged in small neonates, 8 and the higher FiO2 used in critically ill 
patients. 9 This error is of such a significant degree that the use of 
indirect calorimetry is not recommended in patients receiving more than 
0.60 FiO2. 
10  
Another method for measuring VCO2 involves the infusion of a 
[14C]labeled substrate and the measurement of its specific activity and 
the rate of excretion of 14CO2 in breath over a period at isotopic steady 
state. 11 However, the use of radioactive isotopes in children is 
prohibited. 
Numerous studies described the use of isotopic dilution of CO2 
during the infusion of [13C]bicarbonate to predict CO2 production, which 
avoids the quantification of total expired air. 4,12 However, this tracer 
technique uses a relatively complicated method to collect expired air. 
O 
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Breath samples must be collected using a closely fitted facemask and an 
inlet/outlet system with a low dead volume. Thereafter, the collected 
expired air has to pass an all-glass spiral condenser, containing sodium 
hydroxide. After liberating CO2 by adding phosphoric acid to the solution, 
the CO2 can be stored in a septum-capped tube until analysis. 
13 During 
all these procedures to liberate CO2, the fraction of 
13CO2 might be 
decreased, resulting in an underestimation of the substrate oxidation. 
To collect breath samples from preterm infants in a suitable manner, 
we applied the direct naso-pharyngeal sampling technique previously 
described by Perman et al. 14 This method has been used in older 
children for the non-invasive diagnosis of sucrose or lactose 
malabsorption by a H2 breath test, and in preterm infants for the 
collection of expiratory air after administration of 13C-labeled substrates. 
14-16 However in preterm infants, the direct naso-pharyngeal sampling 
method has never been validated for the use in substrate oxidation 
studies. The direct sampling approach offers the advantage of being 
simple and non-time consuming, therefore, possibly appropriate for the 
use in preterm infants in combination with [13C]bicarbonate stable 
isotope dilution technique for the estimation of CO2 production. 
Validation of such a method would provide a technique that could be 
utilized in a variety of clinical investigations in neonates and children. 
The purpose of this study was to determine whether the direct naso-
pharyngeal sampling technique for the collection of expired air could be 
used to estimate CO2 production in preterm infants. We validated this 
technique to the method using CO2 trapping in sodium hydroxide for 
collection of expiratory air after [13C]bicarbonate infusion in preterm 
infants. 
 
Methods 
Subjects 
Subjects included seven preterm infants admitted to the neonatal 
intensive care unit of the Erasmus MC-Sophia Children's Hospital. The 
study protocol was reviewed and approved by the Erasmus-MC 
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Institutional Review Board and written and informed consent was 
obtained from the parents of the preterm infants. 
 
Direct naso-pharyngeal sampling method and trapping 
method 
The collection of expired air was obtained by two different methods, i.e. 
the direct naso-pharyngeal sampling method and the trapping method. 
In the direct naso-pharyngeal sampling technique for the collection of 
expired air, we used a 6 Fr gastric tube (6 Ch Argyle; Sherwood Medical, 
Tullamore, Ireland) as a collection device which was placed carefully for 
1 to 1.5 cm into the nasopharynx. When the infant received 
supplemental oxygen by nasal prong, the oxygen air had to pass a 
sodalime filter (Erich Jaeger GmbH & Co. KG, Wurzburg, Germany) 
before entering the nasopharynx in order to supply CO2 devoid air. While 
observing the patient’s normal breathing pattern, the examiner 
repeatedly aspirated 1 ml of each tidal volume late in the expiratory 
phase from the nasal prong connected to a 10 ml plastic syringe until 10 
ml was obtained. Aliquots were transferred by syringe to a 10 ml 
vacutainer (Van Loenen Instruments, Zaandam, The Netherlands).  
The trapping method has been described for CO2 production 
measurements in neonates. 13,17 In this method, breath samples are 
collected via a closely fitted facemask or canopy which is placed around 
the head and chest of the neonate. The baby's head and neck were 
placed under the transparent perspex canopy, and a partial seal is 
created by tucking the attached flexible material beneath the body and 
mattress in order to prevent any air leaks. We used a canopy as is used 
for indirect calorimetry studies in infants. 18 An inlet/outlet system with a 
low dead volume is used to avoid dilution of the carbon dioxide <1.5-
2.0%. Next, the collected expired air has to pass a sample of air leaving 
the ventilated hood through an all-glass spiral condenser, containing 10 
ml of 1 M sodium hydroxide (Merck, Darmstadt, Germany). After 
liberating CO2 by adding phosphoric acid (Merck, Darmstadt, Germany) 
to the solution, the CO2 can be stored in septum-capped tubes until 
analysis. 
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Validation of the collection method 
To demonstrate that the isotopic enrichment in the expired air collected 
by the direct naso-pharyngeal sampling method showed a consistent 
relationship and to show that this collection of expired air is a reliable 
technique, comparison with the trapping method was performed. 
Validation of direct naso-pharyngeal sampling technique and the trapping 
method was achieved by obtaining simultaneously duplicate paired 
samples of expired air in seven clinically stable preterm infants without 
ventilatory support. 
 
Figure 1. Schematic overview of study protocol 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tracer protocol 
After baseline expired breath samples were obtained according both 
methods (Figure 1), a primed (10.02 µmol/kg), 3-h continuous 
intragastric infusion (10.02 µmol/(kg·h)) of sterile pyrogen-free 
[13C]sodium bicarbonate (99 mol% 13C; Cambridge Isotopes, Woburn, 
MA) was administered. Five sets of duplicate CO2 breath samples were 
collected at 15-min intervals over the last hour of infusion by using both 
sampling techniques. Breath isotopic enrichment was plotted against 
•
Time 
(min) 
Breath samples via 
direct sampling 
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Tracer 
Breath samples via 
trapping in NaOH 
0 12060 180 
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-15 
• • • 
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time, and the plateau defined according to the convention of taking four 
or more consecutive points with a coefficient of variation of <5%. 
 
Calculations 
Isotopic enrichment of expired CO2 was measured by monitoring ions at 
m/e 44 and 45 with a continuous flow isotope ratio mass spectrometer 
(ABCA; Europa Scientific, Van Loenen Instruments, Leiden, The 
Netherlands). 19 The ratio of the signals from the ionized species 13CO2 
and 12CO2 each focused on one of the dual spectrometers is recorded and 
compared with the natural abundance of CO2 gas of known isotopic 
composition relative to the standard Pee Dee Belemnite (PDB). The 
results of this differential measurement are expressed as the del per mil 
(δ‰) difference between the 13CO2/12CO2 ratio of the sample and 
standard. 20  
  δ13C  (‰) = Ru - Rs x 1,000  [1] 
                               Ru 
where Ru is the difference between the 
13CO2/
12CO2 ratio of the 
sample, and Rs is the difference between the 
13CO2/
12CO2 ratio of the 
standard. 
Steady state values were obtained by determining the average CO2 
isotopic enrichment after reaching plateau as previously described. 21 
RaCO2 was calculated using the standard steady state equation: 
22  
RaCO2 = iB x [(IEI/ IEB) -1]   [2] 
where iB is the infusion rate of [
13C]sodium bicarbonate 
(µmol/(kg·h)), IEI is the enrichment (mole percent excess) of 
[13C]bicarbonate in the bicarbonate infusate and IEB is the 
13CO2 
enrichment in expiratory air at plateau during the [13C]sodium 
bicarbonate infusion (mole percent excess). 
 
Statistics 
All values are expressed in means ± SD. Statistical analyses were 
performed by ANOVA, t-test, and Pearson correlation. Significance was 
determined as P < 0.05. Bland-Altman analysis was performed to test 
the variability between the two sampling methods. 23 
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Results 
All infants were appropriate for gestational age (median gestational age 
28 wk, range: 26 –29 wk, Table 1). Seven patients who breathed 
spontaneously were studied, six of them received supplemental oxygen 
by a nasal prong. All infants were clinically stable at the time of the 
study. The median body weight at the time of study period was 1.2 kg 
(range: 1.0 – 1.5 kg), and the median postnatal age was 28 d (range: 8 
– 52 d).  
 
Table 1. Clinical characteristics 
 
Patient Gender Birth 
weight
GA Study 
weight 
Postnatal 
age 
Ventilation 
  kg wk G d  
1 F 0.62 29 1.06 52 None 
2 M 0.96 26 1.48 52 Nasal prong 
3 F 1.11 28 1.38 29 Nasal prong 
4 F 0.46 27 0.60 18 Nasal prong 
5 F 0.88 28 0.98 21 Nasal prong 
6 M 1.29 28 1.19 16 Nasal prong 
7 M 0.99 27 1.35 36 Nasal prong 
Median  1.01  28  1.18  28   
 
GA, gestational age. 
 
Isotopic steady state was achieved during NaH13CO3 infusion with a 
coefficient of variation of 4.1% in the direct sampling method and 4.8% 
in the trapping method (Figure 2). More importantly, the del per mil 
(δ‰) difference determined from the direct naso-pharyngeal sampling 
method correlated highly (r = 0.933, P < 0.0001) with the del per mil 
(δ‰) difference obtained by the trapping technique. As shown in Figure 
3, a linear regression equation relating the measurement of del per mil 
(δ‰) from the [13C]bicarbonate infusion quantified with the direct naso-
pharyngeal sampling technique and the dynamic trapping method was 
found to be highly significant. Furthermore, Bland-Altman analysis 
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(Figure 4) demonstrated agreement between the two methods to within 
± 4.68 δ‰, i.e. 95% confidence interval. 
 
Figure 2. Isotopic plateau of 13CO2 enrichment in breath following a 
primed constant intragastric [1-13C]bicarbonate infusion collected with 
the direct naso-pharyngeal sampling method (dark circles) and collected 
with the trapping method (white circles). An isotopic steady state was 
achieved by 120 min with less than 5% variation of the plateau in both 
methods. 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
The present study describes a methodology for the collection of expired 
air in preterm infants after administration of 13C-labeled material. In 
preterm neonates, isotopic steady state of 13CO2 in breath obtained by 
our direct naso-pharyngeal sampling technique after a [13C]bicarbonate 
infusion is accurately related to isotopic steady state obtained by the 
trapping technique. This is demonstrated by the highly significant 
correlation between the measured values acquired from both methods. 
Therefore, in neonates the direct naso-pharyngeal sampling technique 
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can be used to obtain expired air for the estimation of CO2 production 
and the quantification of oxidation of labeled substrates. 
 
Figure 3. Linear regression analysis between 13CO2 enrichment in breath 
following a primed constant infusion of NaH13CO3 by the direct naso-
pharyngeal sampling technique and by the trapping in NaOH method in 
seven preterm infants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to determine the accuracy and precision of our technique in 
each individual subject in comparison with the trapping method we used 
the Bland-Altman analysis. Furthermore, by using this analysis we could 
assess the variability between both methods. 23 As shown in Figure 4 the 
95% confidence interval of the two methods vary within an acceptable ± 
4.68 δ‰. In other words, there is less then 5% probability that the two 
methods differ more than this amount.    
r = 0.933, P < 
0.0001 
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Figure 4. Bland-Altman analysis showing the difference between the 
direct naso-pharyngeal sampling method and the trapping method 
measurements of 13CO2 enrichment in breath is in agreement to within ± 
4.68 δ‰. CI indicates confidence interval 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Whole-body flux and oxidation rates of nutrients can be quantified in 
adults and infants from primed constant infusion studies using 13C-
labeled substrates with the collection of expired air. 1-3 The methodology 
for measuring in vivo oxidation of substrates with the use of [13C]labeled 
material in clinical studies has been developed with isotope ratio mass 
spectrometry. The excretion of labeled CO2 in breath after administration 
of [13C]labeled substrates is a function of the physical parameters 
involved in CO2 metabolism, the kinetics of metabolism, and the delay 
associated with the passage through the whole-body bicarbonate pool 
before its expiration in the breath. 24 For example, the labeled CO2 is 
temporarily retained in the bicarbonate pool of the bone, into larger 
organic molecules, and in small portions in feces, sweat and urine. 24 
That this bicarbonate pool is limited is shown by an almost complete 
95% CI = 
± 4.68 δ‰ 
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recovery of CO2 during an extended infusion (24-48h) and collection of 
expired air. 25 In short lasting studies in neonates, the CO2 retention 
varies between 70 and 84% and is correlated with the energy intake, 
metabolic rate and CO2 production. 
5 Therefore, to determine the rate of 
oxidation of a labeled substrate, a correction factor is commonly used in 
the calculations. 5 However, in previous studies in preterm infants 
without signs of infection or respiratory distress, we have shown that in 
case of a constant CO2 production over a few hours and a combination of 
a [13C]bicarbonate and a [13C]labeled amino acids infusion no correction 
factor is needed. 13,17   
We conclude that the presently described direct naso-pharyngeal 
sampling method for the collection of expired air in preterm neonates is 
as good as the previously described methods for the calculation of 
substrate oxidation. This method is simple to use, and should provide 
new opportunities to study metabolism of various substrates in preterm 
infants, children, and adults. 
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Background & Aims: Lysine is the first limiting essential amino acid in 
the diet of newborns. The first-pass metabolism by the intestine of 
dietary lysine has a direct effect on the systemic availability. We 
investigated whether first-pass lysine metabolism in the intestine is 
high in preterm infants, particularly at a low enteral intake. Methods: 
Six preterm infants (birthweight 0.9 ± 0.1 kg) were studied during two 
different periods [A (n=6): 40% of intake administered enterally, 60% 
parenterally; lysine intake 92 ± 6 µmol/(kg·h), and B (n=4): 100% 
enteral feeding; lysine intake 100 ± 3 µmol/(kg·h)). Dual stable isotope 
tracer techniques were used to assess splanchnic and whole-body 
lysine kinetics. Results: The fractional first-pass lysine uptake by the 
intestine was significantly higher during partial enteral feeding [A: 32 ± 
10 vs. B: 18 ± 7%, P < 0.05]. The absolute uptake was not significantly 
different. Whole-body lysine oxidation was significantly decreased 
during full enteral feeding [A: 44 ± 9 vs. B: 17 ± 3 µmol/(kg·h), P < 
0.05] so that whole-body lysine balance was significantly higher during 
full enteral feeding [A: 52 ± 25 vs. B: 83 ± 3 µmol/(kg·h), P < 0.05]. 
Conclusions: Fractional first-pass lysine uptake was much higher during 
partial enteral feeding. Preterm infants receiving full enteral feeding 
have a lower whole-body lysine oxidation, resulting in a higher net 
lysine balance, compared with preterm infants receiving partial enteral 
feeding. Hence, parenterally administered lysine is not as effective as 
dietary lysine in promoting protein deposition in preterm infants. 
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he primed constant intravenous infusion of amino acids labeled with 
stable isotopes has become the reference method for studying 
whole-body protein dynamics. 1-3  
By measuring  oxidation rates of specific amino acids directly, 
conclusions can be drawn about the excessive supply of a particular 
amino acid. In healthy infants, an excessive intake of a specific amino 
acid will lead to a high oxidation rate. Because of limitations in 
studying nutrient metabolism in preterm neonates, several studies in 
neonatal animals have been performed to quantify protein metabolism 
in vivo. These studies have shown that the portal-drained viscera 
(PDV: intestine, pancreas, spleen and stomach) utilize more than 50% 
of the dietary protein intake for protein synthesis and biosynthetic 
pathways, 4-7 and is a major site of lysine oxidation. 8 Of particular 
importance is the utilization rate by the intestine of essential amino 
acids. A high utilization rate of essential amino acids by the intestine 
results subsequently in a lower systemic availability of essential amino 
acids and could perhaps influence whole-body growth. We were 
specifically interested in lysine, an essential amino acid that is the first 
limiting amino acid in milk-fed mammalian newborns. 9 Thus, if the 
pattern of amino acids in the diet is not ideal, the rate of protein 
synthesis and growth will be determined by lysine. Previously, we have 
found in piglets under normal high-protein-feeding conditions that 
about half of the dietary lysine intake was utilized by the PDV, and that 
this utilization fraction even increased during dietary protein 
restriction. 8 Subsequently, the systemic availability of dietary lysine 
decreased significantly during a restricted dietary protein supply.  
The neonatal piglet is generally considered to be a good model for 
the human infant with respect to rate and pattern of gastrointestinal 
tract development. 10 In addition, amino acid patterns are similar 
between piglets and infants with respect to both plasma concentrations 
and requirements. 11,12 However, no data on lysine kinetics in infants or 
children are available, while in adults the splanchnic lysine uptake has 
been found to vary between 5% and 35% of the lysine intake. 7,13  
T 
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Largely as a result of their immature gastrointestinal tract, all 
preterm infants face a period of compromised enteral intake in their 
first weeks of life, and they frequently receive a combined parenteral 
and enteral nutrient supply. Based upon our finding that the absolute 
lysine utilization by the intestine of neonatal pigs appears to be 
independent of their lysine intake, 8 we postulated that the fractional 
first-pass lysine utilization would be much higher during partial enteral 
feeding than during full enteral feeding. Importantly, this would result 
in a lower systemic availability of dietary lysine. To evaluate this 
hypothesis, we measured the first-pass lysine uptake in response to 
two different enteral intakes in neonates. 
Apart from the first-pass lysine utilization, the magnitude of 
intestinal lysine catabolism is also important to the nutrition of preterm 
newborns. The energy needed to sustain the high rate of protein 
turnover in the gut is largely derived from the oxidation of non-
essential amino acids. 4,14 However, some essential amino acids, 
including lysine, are oxidized as well, which leads to an irreversible 
loss. 8,15,16 Despite the general belief that the intestinal mucosa does 
not possess lysine catabolic enzymes, 17,18 we showed that the 
intestinal oxidation of dietary lysine in pigs receiving a high protein diet 
accounted for approximately 30% of the whole-body lysine oxidation. 8 
Whether dietary lysine is oxidized by the splanchnic tissues in humans 
has not yet been investigated. Neither has the effect of increasing the 
dietary protein supply on whole-body lysine oxidation been studied. We 
hypothesized that the catabolic utilization of lysine within the 
splanchnic tissues would significantly influence the requirements of 
lysine. Therefore, quantification of the response of splanchnic and 
whole-body lysine oxidation on the level of enteral protein intake in 
preterm infants was the second objective of this study. 
 
Methods 
Subjects  
The study protocol was approved by the Erasmus University 
Institutional Review Board. Written, informed consent was obtained 
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from the parents. Splanchnic and whole-body lysine kinetics were 
quantified in preterm infants during partial enteral feeding (period A) 
and during full enteral feeding (period B). Patients eligible for this 
study were premature infants with a birthweight ranging from 750 to 
1250 g who were appropriate for gestational age according to the 
charts of Usher and McLean. 19 Excluded from the study were infants 
who had congenital anomalies, or gastrointestinal or liver diseases. 
CRIB-scores 20 on the first day of life were all below 5. The clinical 
characteristics of the neonates are shown in Table 1. They received a 
nutrient regimen according to our neonatal intensive care feeding 
protocol; a combination of breast feeding or formula (Nenatal®, 
Nutricia, Zoetermeer, The Netherlands) and parenteral nutrition 
containing glucose, amino acids (Primene® 10%, Clintec Benelux NV, 
Brussels, Belgium), and lipids (Intralipid® 20%, Fresensius Kabi, Den 
Bosch, The Netherlands). Nenatal® was given as sole enteral nutrition 
12 h before the start of the study and during the study days. 
 
Protocol  
The study design consisted of two periods of two consecutive 
study days (Figure 1; period A: study days 1 and 2, and period B: 
study days 3 and 4); during period A the infants received 40% enteral 
feeding and 60% parenteral feeding, and during period B they received 
full enteral feeding. During period A the infants were implanted with 
both an arterial and an intravenous catheter for the infusion of tracers 
and withdrawal of blood samples. During period B, a peripheral 
intravenous catheter was available for the infusion of tracers, blood 
samples were collected by heelstick. Withdrawing blood via an heelstick 
is withdrawing blood from arterial capillaries, while the heel is heated 
before collection in order to assure easy collection. Therefore, we 
assume that similarly to the heated hand box technique there is no 
difference in plasma enrichment. 21 
In order to collect breath samples from these infants, we 
employed the method described by Perman et al., who used a nasal 
tube. 22 This method has been used in children for a non-invasive 
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diagnosis of sucrose malabsorption by H2 breath tests, 
22 and in 
preterm infants for the collection expiratory CO2 recovery after 
administration of 13C-labeled substrates. 23,24 We have validated this 
technique for the use of oxidation studies in preterm infants (Van der 
Schoor, unpublished data). Briefly, a 6 Fr gastric tube (6 Ch Argyle; 
Sherwood Medical, Tullamore, Ireland) was placed for 1 to 1.5 cm into 
the nasopharynx, and a sample of 15 mL end-tidal breath was taken 
slowly with a syringe. Duplicate aliquots of expired air from each 
sampling point were stored in vacutainers for analysis. 
Three different stable isotope infusions were performed during 
each study day in both periods. First, a primed, continuous 2-h infusion 
[10.02 µmol/kg and 10.02 µmol/(kg·h)] of [13C]sodium bicarbonate 
(99.0 mol% 13C; Cambridge Isotopes, Woburn, MA) dissolved in sterile 
saline was administered at a constant rate. The 13C-labeled bicarbonate 
infusion was immediately followed by two primed, continuous 5-h 
infusions [9.77 µmol/kg and 9.77 µmol/(kg·h)] of [U-13C]lysine (97.0 
mol% 13C; Cambridge Isotopes, Woburn, MA) and [9.31 µmol/kg and 
9.31 µmol/(kg·h)] of [2H4]lysine (98.0 mol% 
2H; Cambridge Isotopes, 
Woburn, MA) designed to assess whole-body and splanchnic lysine 
kinetics. During both period A and period B we administered the 
tracers in the following order: On study days 1 and 3, [U-13C]lysine 
was given via an intravenous catheter and [2H4]lysine via the 
intragastric catheter. On study days 2 and 4 the intravenous and 
intragastric routes were switched; [2H4]lysine was infused 
intravenously and [U-13C]lysine was given intragastrically. All isotopes 
were tested and found to be sterile and pyrogen-free before use in our 
studies. At time zero, baseline blood and breath samples were 
collected. During the last hour of each tracer infusion, breath samples 
were collected at 15-min intervals (T 60, 75, 90, 105, 120, 360, 375, 
390, 405, 420 min), and blood samples were obtained at 390 and 420 
min. The total amount of blood withdrawn during a study day was 1.5 
mL, which is less than 2% of blood volume in a 1000-g infant. Blood 
was centrifuged immediately and stored at –70°C for further analysis. 
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Figure 1. Schematic overview of study days 1 and 2 during period A, 
and study days 3 and 4 during period B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[13C]bic, [13C]sodiumbicarbonate; [2H4]lys, [2H4]lysine; [U-13C]lys, [U-13C]lysine; 
iv, intravenous; and  ig, intragastricly. 
Study day 1
Time 
(min) 
Breath 
samples 
Blood 
samples 
[13C]bic iv [U-13C]lys iv
[2H4]lys ig
TPN feeding  (60%)
enteral feeding (40%)
0 120 360 420
↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ 
• • •
Feeding 
Tracer
60 
Study day 2
[13C]bic iv [U-13C]lys ig 
[2H4]lys iv 
TPN feeding (60%) 
enteral feeding (40%) 
0 120 360 420 
↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ 
• • • 
60
Study day 3
[13C]bic iv [U-13C]lys iv
[2H4]lys ig
Tracer
Time 
(min) 
Breath 
samples 
Blood 
samples 
enteral feeding (100%)
0 120 360 420
↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ 
• • •
Feeding 
60 
Study day 4
[13C]bic iv [U-13C]lys ig 
[2H4]lys iv 
enteral feeding (100%) 
0 120 360 420 
↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ 
• • • 
60
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Analytical methods 
Small aliquots of plasma (100 µL) were taken for the measurement of 
plasma lysine concentrations by the Amino Acid Analyser (Amino Acid 
Analyser, Biochrom Ltd, Cambridge, England). Enrichments of [U-
13C]lysine and [2H4]lysine in plasma were determined by GCMS as the 
N(O,S)-methoxycarbonylmethylester (MCM) derivative according to 
Husek 25 with minor modifications. Breath samples were analyzed for 
enrichment of 13CO2 on an isotope ratio mass spectrometer (ABCA; 
Europa Scientific, Van Loenen Instruments, Leiden, The Netherlands).26  
 
Calculations  
The rate of lysine turnover was calculated by measuring the tracer 
dilution at steady state as modified for stable isotope tracers, as 
previously described. 27,28  
The lysine flux was calculated according to the following equation: 
 Eq.1 
Q iv = iL x [(Ei / Ep) – 1]   [1] 
where Q iv is flux of the intravenous lysine tracer (µmol/(kg·h)), iL is 
the lysine infusion rate (µmol/kg·h)), Ei and Ep are the enrichments 
(mol percent excess) of [U-13C or 2H4]lysine in the lysine infusate and 
in plasma at steady state, respectively. 
The first-pass lysine uptake was calculated according to the 
expression: 
 Eq.2 
U = [(Q ig – Q iv) / Q ig] x I   [2] 
where U is the first-pass lysine uptake (µmol/(kg·h)), Q ig is the flux of 
the intragastric lysine tracer (µmol/(kg·h)) and I is the enteral lysine 
intake (µmol/(kg·h)). 
In a steady state the amount of lysine entering the plasma pool 
should be equal to the amount of lysine leaving the pool. Lysine can 
enter the pool either by being released from proteins as result of 
breakdown or through the diet. Lysine leaving the pool may be either 
oxidative disposal or non-oxidative disposal (lysine used for synthesis). 
In equation: 
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 Eq.3  
Q = I + LRP = Ox + NOLD   [3] 
where Q is flux of the lysine tracer (µmol/(kg·h)), LRP is the amount of 
lysine released from protein via protein breakdown (µmol/(kg·h)), Ox 
is the rate of lysine oxidation (µmol/(kg·h)) and NOLD is the rate of 
non-oxidative lysine disposal (a measure of protein synthesis rate, 
µmol/(kg·h)). 
Net lysine balance, an index of protein deposition, was calculated 
as follows: 
Eq.4 
  B = NOLD – LRP    [4] 
where B is lysine balance (µmol/(kg·h)).    
Whole-body CO2 production was estimated as follows: 
 Eq.5 
Body CO2 production = iB x [(EiB / IEB) -1] [5] 
where iB is the infusion rate of [
13C]sodium bicarbonate (µmol/(kg·h)), 
EiB is the enrichment (mol percent excess) of [
13C]bicarbonate in the 
bicarbonate infusate and IEB is the 
13CO2 enrichment at plateau during 
the [13C]sodium bicarbonate infusion (mol percent excess). This 
equation does not correct for retention of [13C]bicarbonate in different 
body pools and will overestimate CO2 production rate. However, the 
same correction factor has to be applied to quantify the lysine 
oxidation rate (Eq.6). Consequently, lysine oxidation rate is not 
overestimated. 29 
As described before, lysine oxidation was calculated by multiplying 
the recovery of the [13C]lysine in the expiratory air with the rate of 
appearance of lysine. 25 The fraction of lysine oxidized was measured 
according to the following equation, assuming a constant VCO2 (rate of 
CO2 production) during the study, that lasted 7 hours: 
29 
Eq.6 
  Fraction of lysine oxidized = 
[IEL  x iB] / [IEB x iL x 6]   [6] 
where IEL and IEB are the 
13CO2 enrichments (mol percent excess) at 
steady state during the intravenous [U-13C]lysine and [13C]sodium 
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bicarbonate infusion. The iL is multiplied by factor 6 to account for the 
number of C-atoms that are labeled. 
Whole-body lysine oxidation was then calculated as follows: 
 Eq.7 
  Whole-body lysine oxidation = Eq.6 x Eq.1 [7] 
The calculation of the metabolism of enterally administered [U-
13C]lysine to CO2 is complicated by the fact that some of the lysine 
tracer is absorbed and thereby labels the arterial pool. Thus, the non-
first pass oxidation of [13C]labeled lysine that was administered 
enterally but was absorbed and entered the body at study day 2 can be 
calculated as follows: 
Eq.8 
Non-first pass oxidation of enterally administered lysine =  
(IE13C ig  / IE13C iv) x Eq.7   [8] 
where IE13C ig is the 
13C enrichment (mol percent excess) in plasma 
during the intragastric [13C]lysine infusion at study day 2, and IE13C iv is 
the 13C enrichment (mol percent excess) in plasma during the 
intravenous [13C]lysine infusion at study day 1. 
The total lysine oxidation at study day 2 is calculated as described 
before: 
Eq.9 
 Total lysine oxidation = Recovery (Eq.6) x Q iv [9] 
where Q iv is the flux of the intravenous [
2H4]lysine tracer 
(µmol/(kg·h)). 
The first-pass lysine oxidation can thus be calculated with the 
following equation: 
 Eq.10 
  First-pass lysine oxidation = Eq.9 - Eq.8 [10] 
 
Statistics  
The data are expressed as the mean values obtained from samples 
taken over the last hour of each tracer infusion ± SD. Statistical 
comparisons were performed with a Student t test. A value of P < 0.05 
was taken as statistically significant. 
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Results 
Six patients were studied during period A, whereas four of them 
were studied during period B (Table 1). The body weight at the time of 
period A was 1.0 ± 0.1 kg, and 1.3 ± 0.2 kg during period B. All 
infants were clinically stable, and they had no clinical signs of 
septicaemia. Routine blood chemistry and hematology were all within 
normal limits, and there were no significant changes in these 
parameters for 24 h before and after the study. During period A five 
out of six infants received supplemental oxygen by a nasal prong, while 
during period B none of the four infants needed supplemental oxygen.  
 
Table 1. Subject characteristics 
 
S GA BW CRIB 
score 
PA 
 A 
PA 
B 
SW 
A 
SW 
B 
 wk kg  d d kg kg 
1 26 1.05 2 7 39 1.1 1.5 
2 30 0.92 1 11 22 0.9 1.0 
3 29 1.24 2 5 12 1.1 1.5 
4 31 1.22 1 4 9 1.1 1.2 
5 29 0.95 4 10  0.8  
6 26 0.90 1 5  0.9  
 29 ± 2 0.9 ± 0.3 2 ± 2 7 ± 4 21 ± 13 1.0 ± 0.1 1.3 ± 0.2 
 
Values are means ± SD. S, subject; GA, gestational age; BW, birth weight; PA, 
postnatal age; SW, study weight; A, Period A; and B, Period B. 
 
The mean lysine, protein, glucose, fat and energy intakes during 
period A and B are presented in Table 2. By design, the total lysine, 
total protein, and total glucose intake was not significantly different 
between both periods. The energy intake differed significantly among 
both periods [A: 92 ± 4 vs. B: 123 ± 2 kcal/(kg·d), P < 0.05], because 
of a significant higher fat intake. 
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Table 2. Lysine intake (µmol/(kg·h)), protein intake (g/(kg·d)), 
carbohydrate intake (g/(kg·d)), fat intake (g/(kg·d)), and energy 
intake (kcal/(kg·d)) during period A and period B 
 
 Period A period B 
Total lysine intake 92 ± 13  100 ± 6  
enteral   33 ± 5  100 ± 6 
parenteral  59 ± 15  - 
Total protein 
intake 
3.4 ± 0.3  3.5 ± 0.2  
enteral  1.2 ± 0.2  3.5 ± 0.2 
parenteral  2.2 ± 0.6  - 
Total carbohydrate 
intake 
10.6 ± 2.2  11.5 ± 0.7  
enteral  3.7 ± 0.6  11.5 ± 0.7 
parenteral  6.9 ± 2.0  - 
Total fat intake 4.1 ± 0.9 *  6.5 ± 0.4  
enteral  2.0 ± 0.3  6.5 ± 0.4 
parenteral  2.0 ± 0.9   
Total energy intake 92 ± 11 *  123 ± 4  
enteral  38 ± 7  123 ± 4 
parenteral  52 ± 10  - 
 
Means ± SD, n = 6 in period A and n = 4 in period B, and * indicates significant 
difference at P < 0.05. 
 
Isotopic plateau  
Lysine kinetics were calculated from the plateau enrichment values for 
plasma lysine and breath carbon dioxide (Table 3). The background 
recovery of the [13C]label in expiratory air was not significantly 
different between both periods [A: –19.80 ± 1.28 vs. B: –20.24 ± 0.99 
13C Pee Dee Belemnite]. There was also no difference in the 
background recovery of the [13C]label in expiratory air between the two 
consecutive study days of each period (period A: day 1: -20.61 ± 1.23 
vs. day 2: –18.99 ± 1.43 PDB, and period B: day 1: -21.58 ± 0.35 vs. 
day 2: -18.89 ± 2.59 PDB). Although we took two blood samples after 
4 hours of tracer infusion, we are sure that isotopic steady state was 
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reached since we found an isotopic plateau in CO2 excretion. Before a 
plateau in breath is reached, a plateau has to be reached at the site of 
lysine oxidation, i.e. intracellularly. The 13CO2 enrichment in breath 
during [13C]sodium bicarbonate infusion rose rapidly during the first 
hour of infusion in both periods, to become constant in all infants by 
120 min, with <5% variation of the plateau [A: 4.1 ± 1.0 (n=6) vs. B: 
3.4 ± 0.8% (n=4)]. The coefficient of variation of breath [13C]lysine 
enrichment above baseline at plateau was 6.2 ± 1.5% (n=6) during 
period A and 6.8 ± 1.6% (n=4) during period B.  
 
Table 3. Baseline and steady-state plasma isotopic enrichments on 
study days 1 and 2 during period A and on study days 3 and 4 during 
period B 
 
SD [U-13C]lysine [2H4]lysine 
baseline Plateau baseline Plateau 
mol % mol % mol % mol % 
1 0.0010 ± 0.0006 0.0345 ± 0.0042 0.0019 ± 0.0008 0.0201 ± 0.0045 
2 0.0019 ± 0.0007 0.0315 ± 0.0040 0.0042 ± 0.0019 0.0360 ± 0.0067 
3 0.0018 ± 0.0005 0.0372 ± 0.0100 0.0028 ± 0.0008 0.0324 ± 0.0061 
4 0.0059 ± 0.0065 0.0362 ± 0.0074 0.0031 ± 0.0005 0.0461 ± 0.0094 
 
Values are means ± SD, n = 6 at study days 1 and 2, and n = 4 at study days 3 
and 4, and SD, study days. On study days 1 and 3 [U-13C]lysine was 
administered intravenously and [2H4]lysine intragastricly, and on study days 2 
and 4 [U-13C]lysine was given intragastricly and [2H4]lysine intravenously. 
 
Lysine kinetics 
The plasma lysine concentration was significantly higher during partial 
enteral feeding compared to full enteral feeding [A: 231 ± 108 vs. B: 
133 ± 48 µmol/(kg·h), P < 0.05]. As expected, the whole-body lysine 
fluxes were higher for the oral than for the intravenous tracer group 
during both periods [A: flux ig 396 ± 49 vs. flux iv 267 ± 35 
µmol/(kg·h), B: flux ig 279 ± 42 vs. flux iv 231 ± 40 µmol/(kg·h)]. The 
first-pass lysine uptake as a fraction of dietary lysine intake was 
significantly higher during a restricted enteral lysine intake [A: 32 ± 10 
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vs. B: 18 ± 7%, P < 0.05]. However, the splanchnic lysine uptake in 
absolute amounts was not significantly different during a full enteral 
intake [A: 10 ± 3 vs. B: 18 ± 6 µmol/(kg·h), P = 0.17]. The splanchnic 
tissues did not oxidize dietary lysine, neither during partial enteral 
feeding nor during full enteral feeding [A: -4 ± 23 vs. B –18 ± 20 
µmol/(kg·h)].  
 
Figure 2. Whole-body lysine oxidation and balance in absolute amounts 
(µmol/(kg·h)) 
 
 
 
 
 
 
 
 
 
 
 
 
 
During period A: n=6, and during period B: n=4. * Indicates a significant 
difference at P < 0.05 
 
Whole-body lysine oxidation was significantly lower during full 
enteral feeding (Figure 2). The whole-body lysine oxidation accounted 
for 50 ± 19% of the total lysine intake during partial enteral nutrition, 
whereas only 17 ± 3% of the total lysine intake was oxidized during 
full enteral feeding (P < 0.05). The non-oxidative disposal of lysine 
[NOLD; A: 222 ± 36 vs. B: 169 ± 36 µmol/(kg·h)] and lysine release 
of protein breakdown [LRP; A: 214 ± 39 vs. B; 131 ± 38 µmol/(kg·h)] 
were not significantly different during both periods. The resulting net 
lysine balance was significantly higher during full enteral feeding 
(Figure 2).  
A B B A
*
* 
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Discussion 
The main purpose of this study was to measure lysine kinetics in 
preterm infants in order to gain insight into the importance of the 
splanchnic tissues in relation to whole-body lysine kinetics. In addition, 
we wanted to quantify the first-pass lysine metabolism during both full 
enteral feeding and a significant lower enteral intake. Our data 
demonstrate that in preterm infants receiving full enteral feeding, 
whole-body lysine oxidation is significantly lower and lysine balance is 
significantly higher, than in preterm infants receiving partial enteral 
feeding. Approximately one-third of the dietary lysine is removed by 
the splanchnic region during partial enteral feeding, compared to a 
lower fraction (18%) during full enteral feeding. Furthermore, we could 
not detect any first-pass lysine oxidation by the splanchnic tissues in 
either feeding period. 
It is of interest to note our results in neonatal pigs receiving a low 
protein diet 8 with regard to the high fractional first-pass lysine uptake 
observed under a restricted enteral amino acid supply in preterm 
infants. The high splanchnic extraction as a fraction of dietary intake in 
preterm infants with partially enteral feeding is also consistent with the 
high values of protein turnover observed in immature rats, 30 with a 
maximal contribution of the intestine to whole-body protein synthesis 
attained at weaning. 
A high first-pass uptake might as well be caused by an incomplete 
digestion and absorption of dietary proteins and amino acids. However, 
studies in adults and infants have shown a high digestibility of 
approximately 98% of milk proteins and cereal protein. 31,32 This 
indicates that probably all dietary milk proteins are absorbed by the 
intestinal mucosa and are not lost in the faeces. And thus, lysine that 
does not appear in the systemic circulation, is utilized by the intestine, 
and is not lost via the faeces.  
Indeed, Stoll et al. have demonstrated in neonatal pigs that the 
splanchnic tissues have high requirements for amino acids and are 
proving to be an important modulator of whole-body amino acid 
availability. 6 A possible explanation for our high fractional first-pass 
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lysine extraction, is the considerable secretion of (glyco-)proteins and 
high proliferation rate of the gut mucosa of newborns. The high 
splanchnic lysine extraction in preterm infants in their first weeks of life 
might be necessary to provide amino acids for their high intestinal 
protein synthesis during a period of rapid adaptation to enteral feeding. 
It is well known, for example, that the presence of nutrients in the 
intestinal lumen provides a marked stimulus to intestinal growth. 33   
In contrast to our finding in piglets, intraluminal lysine or lysine 
taken up by the splanchnic tissues is apparently not oxidized, implying 
that intestinal lysine metabolism in preterm infants only includes 
protein synthesis. In other words, these results suggest that the 
premature gut has a most efficient use of the essential amino acid 
lysine, and plays an important role in channeling dietary amino acids to 
the peripheral tissues. 
Our second aim was to determine the whole-body lysine 
kinetics in relation to two different enteral lysine supplies. Surprisingly, 
in preterm infants on full enteral feeding, whole-body lysine oxidation 
was significantly lower in comparison with infants fed partially enteral. 
The decreased whole-body lysine oxidation suggests a protein sparing 
mechanism during full enteral feeding in preterm infants. 
Consequently, the lysine balance increased significantly as the dietary 
lysine intake was augmented. In concordance with these oxidation 
results, the plasma lysine concentration was significantly higher during 
partial enteral feeding. During this feeding period, amino acids were 
administered both via the venous circulation and via the stomach, in 
contrast to full enteral feeding. The higher plasma lysine concentration 
during partial enteral feeding might be a result of our direct 
intravenous infusion and a significant lower first-pass lysine uptake by 
the gut. In addition, the observed lower whole-body lysine oxidation 
during partial enteral feeding may have contributed to a higher plasma 
lysine level. Another explanation for this observation might be that the 
total amino acid intake was nutritionally better balanced during full 
enteral feeding, which resulted in an improved lysine balance. In other 
words, it might indicate that lysine is not the first limiting essential 
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amino acid in the diet under the circumstances of partial enteral 
feeding. Otherwise, the lysine oxidation would have been lower during 
partial enteral feeding. 
It is of interest to note that the apparent lower whole-body lysine 
oxidation and higher lysine balance during full enteral feeding is similar 
to the values obtained by Duffy et al. 34 Duffy's study compared the 
effect of feeding route (iv or enteral) on protein metabolism of the 
neonate and concluded that orally fed neonates utilize amino acids for 
synthesis more efficiently than TPN fed infants. 34 Early parenteral 
supply of amino acids is given to prevent protein loss, but the present 
study clearly shows that enteral feeding is a far more efficient way to 
feed preterm infants. Unfortunately, intestinal immaturity often impairs 
early full enteral feeding, but our data suggest that maximal effort 
should be paid to initiate enteral feeding as soon as possible in preterm 
infants. 35 
There are some limitations with respect to the study design 
that should be discussed. Energy intake is one of the factors that 
influence protein synthesis rate. As shown in Table 2, although lysine 
intakes during both feeding periods were virtually identical, the energy 
intake was significantly different between both feeding periods. The 
intake of metabolic energy by partial enteral fed infants was 74% of 
the intake of enterally fed infants. Parenterally fed neonates appear to 
require only 75% of the energy of enterally fed infants to achieve the 
same growth rate, 36 because of the lower energy expenditure of the 
splanchnic tissues during parenteral nutrition. In addition, enterally-fed 
infants have some energy losses in stool due to malabsorption. In a 
previous study, we found no significant effect of reducing the energy 
intake from 120 to 100 kcal/(kg.d) on nitrogen excretion and protein 
deposition in preterm infants. 37 Denne et al., using [1-13C]leucine in 
preterm neonates with enteral or parenteral feeding, showed that the 
overall pattern of fuel utilization was unaffected by the mode of 
feeding. 38 Therefore, we speculate that the higher energy intake 
during full enteral feeding did not significantly influence the net lysine 
oxidation and balance.  
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Another issue relevant to the different feeding periods is the 
different postnatal ages at both study periods. The infants were older 
at period B, which might influence the lysine kinetics. However, it was 
not feasible in our study design to put the infants on full enteral 
feeding already at day 7. On the other hand, it was not ethically 
justified to put them on partial enteral feeding at a postnatal age of 3 
weeks for a period of at least 5 days in order to adjust them to the 
reduced enteral feeding rate and to perform the stable isotope studies. 
In addition, we wanted to evaluate lysine kinetics in preterm infants 
who were treated according to the standard neonatal intensive care 
feeding regiments.  
In conclusion, we have shown that the splanchnic tissues have 
a high rate of metabolism and use almost a third of dietary lysine 
intake in preterm infants with partial enteral feeding. However, 
although lysine is catabolized by the whole-body to a great extent 
especially during partial enteral feeding, it is not catabolized by the 
splanchnic tissues in first-pass in preterm infants. Furthermore, the 
lysine balance was much higher during full enteral feeding as compared 
to partial enteral feeding. Taken together, the results indicate that 
parenterally administered lysine is not as effective as dietary 
administered lysine in promoting protein deposition in preterm infants 
in their first weeks of life. 
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Background & Aims: Threonine is an essential amino acid that is 
abundantly present in intestinally produced (glyco-)proteins. We 
hypothesized that intestinal first-pass threonine metabolism is high in 
preterm infants, particularly during a restricted enteral protein intake. 
Methods: Eight infants (birthweight 1.1 ± 0.1 kg, gestational age 29 ± 2 
weeks) were studied during two different periods [A: 40% of total 
intake administered enterally 60% parenterally; total threonine intake 
58 ± 6 µmol/(kg·h), and B: full enteral feeding; total threonine intake 
63 ± 6 µmol/(kg·h)]. Dual stable isotope tracer techniques were used 
to assess splanchnic and whole-body threonine kinetics. Results: The 
fractional first-pass threonine uptake by the intestine was remarkably 
high under both circumstances: 70 ± 6% during full enteral feeding, 
and 82 ± 6% (P < 0.01) during partial enteral feeding. Hardly any 
threonine was oxidized in first-pass during either period [A: 0 ± 8 vs. B 
3 ± 4 µmol/(kg·h)]. Whole-body threonine balance was not affected by 
the route of feeding. Conclusion: In preterm infants, the splanchnic 
tissues extract a very large amount of the dietary threonine intake, 
which is not oxidized. This indicates a high obligatory visceral need for 
threonine presumably for purposes of synthesis. 
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uring the first few weeks of life, preterm infants are faced with the 
challenge of doubling their body weight. 1 The relatively high growth 
rate of the newborn infant puts significant pressure on the intestine 
to digest and absorb nutrients efficiently.  
This occurs at a time when the neonatal intestine is adapting to the 
enteral route of nutrition after a prenatal period in which amino acids 
were delivered via the umbilical route. Therefore, it might be 
speculated that a large quantity of amino acids is needed for the 
growth and maintenance of the premature gut, for optimal function 
and integrity. 
Given the key role of the gut in the maintenance of neonatal 
health, there has been considerable interest in the significance of first-
pass intestinal metabolism of dietary amino acids.2-5 Enterally absorbed 
amino acids can be used for incorporation into mucosal cellular 
proteins, for catabolic processes, or for conversion via transamination 
into other amino acids, metabolic substrates and biosynthetic 
intermediates. It is known in animals that less than 20% of intestinal 
amino acid utilization is used for constitutive gut growth by the 
intestinal mucosa, 1 and although some essential amino acids are 
known to be catabolized, 3,4,6 the catabolism of essential amino acids 
does not account for their high utilization rate. Therefore, the synthesis 
of secretory proteins by the enterocytes appears to be a major 
metabolic fate for nutritionally indispensable amino acids. 
Of particular interest is threonine, which in neonatal piglets is the 
amino acid that is used to the greatest extent by the portal-drained 
viscera (PDV: the intestines, pancreas, spleen and stomach). In 
neonatal pigs, the splanchnic extraction of threonine ranges from 60% 
to 80% of the dietary intake. 2,6 This high intestinal requirement for 
threonine might reflect the use of enterally absorbed threonine for the 
synthesis of secretory (glyco-)proteins as the major metabolic fate, 
besides its use for the synthesis of mucosal cellular proteins and for 
oxidative purposes. Indeed, Roberton et al. found that the protein 
cores of secretory mucins contain large amounts of threonine. 7 
Consistent with this finding, Bertolo et al. showed that the whole-body 
D 
Chapter 7 
 150 
threonine requirement in TPN-fed piglets is 40% of that observed in 
enterally fed piglets,8 indicating that enteral nutrition induces intestinal 
processes in demand of threonine. One might postulate that in humans 
the compromised gut barrier function associated with parenteral 
nutrition is caused by a sparse threonine availability combined with 
diminished intestinal mucin production, as has been shown in rats. 9   
In view of the central role of the gut in nutrient processing and 
metabolism, we considered it important to investigate the impact of 
the amount of enteral intake on splanchnic and whole-body threonine 
metabolism in preterm infants. Accordingly, we used two different 
stable isotope-labeled threonine tracers, i.e., [U-13C]threonine and 
[15N]threonine simultaneously, administered via intravenous and 
intragastric routes to determine the quantitative aspects of threonine 
metabolism in preterm neonates under both parenteral and enteral 
feeding conditions. This array of techniques enabled us to measure 
both the first-pass intestinal threonine uptake and oxidation and 
whole-body threonine kinetics. Previously, we found in neonatal pigs 
that the considerable first-pass threonine utilization was not 
significantly affected by a lower protein intake (Van Goudoever, 
unpublished data). Therefore, we hypothesized that the first-pass 
utilization of threonine by the splanchnic tissues would be substantial 
in preterm infants and would be independent of the dietary threonine 
intake. Hence, the present study explores the impact of the amount of 
enteral protein intake on various components of first-pass and whole-
body threonine metabolism in neonates. 
 
Methods  
Subjects 
The study protocol was approved by the Erasmus-MC Institutional 
Review Board. Written, informed consent was obtained from the 
parents. Splanchnic and whole-body threonine kinetics were quantified 
in eight preterm infants during two consecutive periods of different 
enteral and parenteral intakes. Patients eligible for this study were 
premature infants, with a birth weight ranging from 750 to 1250 g, 
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who were appropriate for gestational age according to the charts of 
Usher and McLean. 10 Excluded from the study were infants who had 
major congenital anomalies, or gastrointestinal or liver diseases. CRIB 
-scores 11 on the first day of life were all below 5. Selected relevant 
clinical variables for the infants studied are shown in Table 1. The 
infants received a standard nutrient regimen according to our neonatal 
intensive care feeding protocol: a combination of breast or formula 
feeding (Nenatal®, Nutricia, Zoetermeer, The Netherlands; 0.024 g/ml 
protein) and parenteral nutrition containing glucose, amino acids 
(Primene® 10%, Clintec Benelux NV, Brussels, Belgium; 0.1 g/ml 
protein), and lipids (Intralipid® 20%, Fresensius Kabi, Den Bosch, The 
Netherlands). Nenatal® was given as sole enteral nutrition 12 h before 
the start of the study and during the study days. 
 
Protocol 
The study design consisted of two periods of two consecutive study 
days (period A: study days 1 and 2, and period B: study days 3 and 4). 
During period A, the infants received 40% enteral feeding and 60% 
parenteral feeding, and during period B, they received full enteral 
feeding. A schematic outline of the tracer-infusion studies is shown in 
Figure 1. During period A the infants were implanted with both an 
arterial and an intravenous catheter for the infusion of tracers and 
withdrawal of blood samples. During period B, a peripheral intravenous 
catheter was available for the infusion of tracers, blood samples were 
collected by heelstick.  
In order to collect breath samples from these tiny infants, we 
employed the method described by Perman et al., who used a nasal 
tube. 12 This method has been validated and used in children for the 
non-invasive diagnosis of sucrose malabsorption by H2 breath tests, 
12 
and in preterm infants for the collection of expiratory CO2 recovery 
after administration of 13C-labeled substrates. 13,14 Briefly, a 6-Fr 
gastric tube (6 Ch Argyle; Sherwood Medical, Tullamore, Ireland) was 
carefully placed 1 to 1.5 cm into the nasopharynx, and a sample of 15 
mL end-tidal breath was taken slowly with a syringe. Duplicate aliquots 
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of expired air from each sampling point were stored in vacutainers for 
later analysis.  
 
Figure 1.  Schematic overview of study periods A and B during the four 
study days  
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Three different stable-isotope infusions were performed during 
each study day in both periods. First, a primed, continuous 2-h infusion 
[10.02 µmol/kg and 10.02 µmol/(kg·h)] of [13C]sodium bicarbonate 
(99 mol% 13C; Cambridge Isotopes, Woburn, MA) dissolved in sterile 
saline was administered at a constant rate. The purpose of this first 
isotope infusion was to determine the approximate rate of whole-body 
CO2 production. The 
13C-labeled bicarbonate infusion was immediately 
followed by two primed, continuous 5-h infusions [14.4 µmol/kg and 
14.4 µmol/(kg·h)] of [U-13C]threonine (97 mol% 13C; Cambridge 
Isotopes, Woburn, MA) and [14.7 µmol/kg and 14.7 µmol/(kg·h)] of 
[15N]threonine (95 mol% 15N; Cambridge Isotopes, Woburn, MA) 
designed to assess whole-body and splanchnic threonine kinetics. 
During both period A and period B we administered the tracers in the 
following order: On study day 1, [U-13C]threonine was given via an 
intravenous catheter and [15N]threonine via the intragastric catheter. 
On study day 2 the intravenous and intragastric routes were switched; 
[15N]threonine was infused intravenously and [U-13C]threonine was 
given intragastrically. All isotopes were tested and found to be sterile 
and pyrogen-free before use in our studies. At time zero, baseline 
blood and breath samples were collected. During the last hour of each 
tracer infusion, breath samples were collected at 15-min intervals (T 
60, 75, 90, 105, 120, 360, 375, 390, 405, 420 min), and blood 
samples were obtained at 390 and 420 min. The total amount of blood 
withdrawn during a study day was 1.2 mL, which is less than 2% of 
blood volume in a 1000-g infant. Blood was centrifuged immediately 
and stored at -70°C for further analysis. 
 
Analytical methods  
Small aliquots of plasma (100 µL) were taken for the measurement of 
amino acid concentrations by the Amino Acid Analyser (Amino Acid 
Analyser Biochrom 20, Biochrom Ltd, Cambridge, England). Plasma 
threonine enrichment was determined by gaschromatography-mass 
spectrometry. Briefly, 50 µL plasma was deproteinized with 50 µL 0.24 
M sulfosalicylic acid. After centrifugation for 8 min at 4°C and 14,000 g, 
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the supernatant was passed through an AG50W-X8, H+-column 
(Biorad, Richmond, Virginina, USA). The column was washed with 3 ml 
water and the amino acids eluted with 1.5 ml 3 M NH4OH. The eluate 
was dried at 70°C under a stream of nitrogen and finally derivatives of 
the amino acids were formed by adding 350 µL acetonitril and 10 µL N-
methyl-N-(tert-butyldimethylsilyl)-trifluoroacetamide (Pierce, Omnilabo 
Breda, The Netherlands) to the dried amino acids. 15 Analyses were 
carried out on a Carlo Erba GC8000 gaschromatograph coupled to a 
Fisons MD800 mass spectrometer (Interscience BV, Breda, The 
Netherlands) by injecting 1 µL with a split ratio of 50:1 on a 25 m x 
0.22 mm fused silica capillary column, coated with 0.11 µm HT5 (SGE, 
Victoria, Australia). Natural threonine, [15N]-threonine and [U-13C]-
threonine were measured by selective ion monitoring of masses 404, 
405, and 408, respectively. 15 Breath samples were analyzed for 
enrichment of 13CO2 on an isotope ratio mass spectrometer (ABCA; 
Europa Scientific, Van Loenen Instruments, Leiden, The Netherlands).16 
 
Calculations 
Plasma enrichments of threonine were used to calculate the rate of 
threonine turnover. The rate of threonine turnover was calculated by 
measuring the tracer dilution at steady state as modified for stable 
isotope tracers, as previously described. 17,18  
The threonine flux (iv or ig) was calculated according to the 
following equation: 
 Eq.1 
Q iv or ig = iT x [(Ei / Ep) – 1]   [1] 
where Q iv or ig is flux of the intravenous or intragastric threonine tracer 
(µmol/(kg.h)), iT is the threonine infusion rate (µmol/kg.h)), Ei and Ep 
are the enrichments (mol percent excess) of [U-13C or 15N]threonine in 
the threonine infusate and in plasma at steady state, respectively. 
The first-pass threonine uptake was calculated according to the 
following equation: 
 Eq.2 
U = [(Q ig – Q iv) / Q ig] x I   [2] 
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where U is the first-pass threonine uptake (µmol/(kg·h)), Q ig is the flux 
of the intragastric threonine tracer (µmol/(kg·h)) and I is the enteral 
threonine intake (µmol/(kg·h)). 
In a steady state the amount of threonine entering the plasma 
pool should be equal to the amount of threonine leaving the pool. 
Threonine can enter the pool either by being released from proteins as 
the result of breakdown or through the diet. Threonine leaving the pool 
may be either oxidative disposal or non-oxidative disposal (threonine 
used for synthesis) (Figure 2). We used the equation: 
 Eq.3  
Q = I + TRP = Ox + NOTD   [3] 
where TRP is the amount of threonine released from protein via protein 
breakdown (µmol/(kg·h)), Ox is the rate of threonine oxidation 
(µmol/(kg·h)) and NOTD is the rate of non-oxidative disposal of 
threonine (a measure of protein synthesis rate, µmol/(kg·h)). 
Net threonine balance, an index of protein deposition, was 
calculated as follows: 
Eq.4 
 B = NOTD – TRP    [4] 
where B is threonine balance (µmol/(kg·h)). 
Whole-body CO2 production was estimated as follows: 
 Eq.5 
Body CO2 production = iB x [(EiB / IEB) -1] [5] 
where iB is the infusion rate of NaH
13CO3 (µmol/(kg·h)), EiB is the 
enrichment (mol percent excess) of [13C]bicarbonate in the bicarbonate 
infusate and IEB is the breath 
13CO2 enrichment at plateau during the 
NaH13CO3 infusion (mol percent excess). 
As described previously, threonine oxidation was calculated by 
multiplying the recovery of the [13C]label in the expiratory air with the 
rate of appearance of threonine. 19 The fraction of threonine oxidized 
was measured according to the following equation, assuming a 
constant VCO2 (CO2 production) during the study which lasted 7 h.
19 
Eq.6 
  Fraction of threonine oxidized = 
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[IET  x iB] / [IEB x iT x 4]   [6] 
where IET and IEB are the 
13CO2 enrichments (mol percent excess) at 
steady state during the intravenous [U-13C]threonine infusion and 
NaH13CO3 infusion. The denominator is multiplied by a factor of 4 to 
account for the number of C-atoms that are labeled. 
Whole-body threonine oxidation was then calculated as follows: 
 Eq.7 
  Whole-body threonine oxidation = 
Eq.6 x Eq.1     [7] 
The calculation of the metabolism of enterally administered [U-
13C]threonine to CO2 is complicated by the fact that some of the 
threonine tracer is absorbed and transferred to the systemic 
circulation, and thereby labels the arterial pool. Thus, the non-first-
pass oxidation of [13C]labeled threonine that was administered 
enterally, but was absorbed and entered the body at study day 2, can 
be calculated as follows: 
Eq.8 
Non-first-pass oxidation of the enteral administered 
[U-13C]threonine = (IE13C ig  / IE13C iv) x Eq.7  [8] 
where IE13C ig is the 
13C enrichment (mol percent excess) in plasma 
during the intragastric [13C]threonine infusion at study day 2, and IE13C 
iv is the 
13C enrichment (mol percent excess) in plasma during the 
intravenous [13C]threonine infusion at study day 1. 
The total threonine oxidation at study day 2 is calculated as 
described previously: 
Eq.9 
 Total threonine oxidation = 
Recovery (Eq.6) x Q iv     [9] 
where Q iv  is the flux of the intravenous [
15N]threonine tracer 
(µmol/(kg·h)). 
The first-pass threonine oxidation can thus be calculated with the 
following equation: 
 Eq.10 
  First-pass threonine oxidation = Eq.9 - Eq.8 [10] 
Threonine kinetics in preterm infants 
 157 
Statistics 
The data are expressed as the mean values obtained from samples 
taken over the last hour of each tracer infusion ± SD. Statistical 
comparisons were performed with a paired Student t test. A value of P 
< 0.05 was taken as statistically significant. 
 
Table 1. Subject characteristics 
 
Patient GA BW CRIB 
Score 
SW 
A 
SW 
B 
PA 
A 
PA 
B 
 wk kg  kg Kg d d 
1 26     0.97 2 1.00 1.05 9 12 
2 27 1.08 2 1.03 1.04 8 17 
3 32 1.28 2 1.18 1.17 5 9 
4 28 0.92 2 1.00 1.00 9 11 
5 31 0.90 1 0.91 0.91 6 8 
6 29 1.25 2 1.12 1.22 5 7 
7 30 1.10 2 0.99 1.06 6 11 
8 30 0.98 1 0.92 0.98 10 13 
 29 ± 2 1.1 ± 0.1 2 ± 0.5 1.0 ± 1.0 1.1 ± 0.1 7 ± 2 11 ± 3 
 
Values are means ± SD. GA, gestational age; BW, birth weight; SW, study 
weight; PA, postnatal age; A, Period A; and B, Period B. 
 
Results 
All infants were appropriate for gestational age (mean gestational age 
29 ± 2 wk, Table 1). Eight patients were studied during both periods; 
in five of those infants, splanchnic and whole-body threonine oxidation 
was determined. During both feeding periods, one infant was 
mechanically ventilated, four infants received supplemental oxygen via 
a nasal prong, and three infants received nasal continuous positive 
airway pressure (CPAP) which did not allow us to obtain expired air. All 
infants received caffeine, and were clinically stable at the time of the 
study. Routine blood chemistry and hematology (electrolytes, calcium, 
glucose, acid base, hematocrit, thrombocyte count and white blood cell 
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count) were all within normal limits; there were no significant changes 
in these parameters for 24 h before and after the study. Intakes of 
threonine, protein, carbohydrate, fat and energy are shown in Table 2. 
No differences were found in glucose, fat and energy intake. The 
threonine intake was significantly lower during period A, but the 
difference was only 5 µmol/(kg·d) in absolute amounts. The protein 
intake during period B was significantly lower than that during period 
A, which was inevitable since we aimed at comparable total threonine 
intakes. 
 
Table 2. Threonine intake (µmol/(kg·h)), protein intake (g/(kg·d)), 
carbohydrate intake (g/(kg·d)), fat intake (g/(kg·d)), and energy 
intake (kcal/(kg·d)) during period A and period B 
 
 period A period B 
Total threonine intake 58 ± 5 *  63 ± 6  
enteral   26 ± 3  63 ± 6 
parenteral  32 ± 3  - 
Total protein intake 3.6 ± 0.4 *  2.8 ± 0.2  
enteral  1.1 ± 0.1  2.8 ± 0.2 
parenteral  2.5 ± 0.2  - 
Total carbohydrate 
intake 
11.0 ± 1.8  12.4 ± 1.7  
enteral  3.6 ± 0.4  8.9 ± 0.8 
parenteral  7.6  ± 1.7  3.4 ± 2.4 
Total fat intake 4.6 ± 0.5   5.0 ± 0.5  
enteral  2.1 ± 0.2  5.0 ± 0.5 
parenteral  2.5 ± 0.5   
Total energy intake 98 ± 8   106 ± 4  
enteral  38 ± 4  92 ± 9 
parenteral   61 ± 9   14 ± 10 
 
Means ± SD, n = 8, and * indicates significant difference at P < 0.05. 
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Isotopic plateau  
Threonine kinetics were calculated from the plateau enrichment values 
for plasma threonine, breath carbon dioxide, and rates of carbon 
dioxide production. Details of the isotopic enrichments of plasma 
threonine at baseline and plateau during periods A and B are given in 
Table 3.  
 
Table 3. Baseline and steady-state plasma isotopic enrichments on 
study days 1 and 2 during period A and on study days 3 and 4 during 
period B 
 
D [U-13C]threonine [15N]threonine 
 baseline plateau baseline plateau 
 mol % mol % mol % mol % 
1 0.0075 ± 0.0006 0.0585 ± 0.0064 0.2608 ± 0.0011 0.2726 ± 0.0077 
2 0.0123 ± 0.0003 0.0554 ± 0.0015 0.2624 ± 0.0009 0.2833 ± 0.0094 
3 0.0097± 0.0018 0.0549 ± 0.0174 0.2615 ± 0.0006 0.2772 ± 0.0074 
4 0.0164 ± 0.0055 0.0509 ± 0.0021 0.2641 ± 0.0001 0.2781 ± 0.0047 
 
Values are means ± SD; n = 8; and D, study day. On study day 1 and 3 [U-
13C]threonine was administered intravenously and [15N]threonine 
intragastrically; on study days 2 and 4 [U-13C]threonine was given 
intragastrically and [15N]threonine intravenously. 
 
The background (baseline) recovery of the [13C]label in expiratory 
air was not significantly different between the two periods (A: 1.0955 
± 0.0079 vs. B: 1.0923 ± 0.0032 APE). There was also no difference in 
the background recovery of the [13C]label in expiratory air between the 
two consecutive study days of each study period (A: study day 1: 
1.0894 ± 0.0001 vs. study day 2: 1.0924 ± 0.0001 APE, and B: study 
day 3: 1.0896 ± 0.0002 vs. study day 4: 1.0922 ± 0.0002 APE). The 
13CO2 enrichment in breath during [
13C]sodium bicarbonate infusion 
rose rapidly during the first hour of infusion in both periods, to become 
constant in all infants by 120 min, with <5% variation of the plateau 
(1.4 ± 0.4% in period A vs. 3.3 ± 1.4% in period B). The route of 
tracer administration did not affect the time it took to achieve plateau. 
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The coefficient of variation (mean ± SD) of breath [13C]threonine 
enrichment above baseline at plateau was 3.4 ± 4.4% during period A 
and 8.5 ± 0.6% during period B. We considered this variation to be 
acceptable and to permit the detection of differences in rates of 
threonine oxidation between the two feeding periods. 
 
Threonine kinetics 
The plasma concentrations of all amino acids in both feeding periods 
are presented in Table 4.  
 
Table 4. Plasma amino acid levels during period A and period B with a 
reference range of term breast-fed infants 
 
 Period A Period B Term infants 
Threonine 169 ± 111 201 ± 98 70 - 197 
Cystine 25 ± 6  20 ± 11 35 - 69 
Isoleucine 66 ± 25 52 ± 18 27 - 90 
Leucine 112 ± 31 95 ± 27 53 - 169 
Lysine 229 ± 118 * 136 ± 51 80 - 232 
Methionine 39 ± 8 34 ± 15 22 - 50 
Phenylalanine 83 ± 13 83 ± 7 22 - 72 
Valine 214 ± 64 154 ± 38 88 - 222 
Alanine 235 ± 64 207 ± 108 125 - 647 
Arginine 72 ± 27 * 49 ± 24 42 - 148 
Aspartic acid 18 ± 6 29 ± 25 5 - 51 
Aspartic 41 ± 14 48 ± 13 16 - 81 
Glutamic acid 82 ± 33 110 ± 49               24 - 243 
Glutamine 423 ± 91 * 326 ± 74 142 - 851 
Glycine 292 ± 85 265 ± 131 77 - 376 
Proline 172 ± 33 210 ± 105 83 - 319 
Serine 153 ± 39 183 ± 110 0 - 326 
Tyrosine 70 ± 77 75 ± 49 38 - 119 
Total AA 2,711 ± 767 2,440 ± 865  
EAA 911 ± 336 755 ± 219  
 
Values are means ± SD and are expressed in µmol/L. * indicates significant 
difference at P < 0.05. AA, amino acids; and EAA, essential amino acids. 
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We did not find a statistically significant difference in the plasma 
threonine concentration between the two feeding periods [period A: 
169 ± 111 vs. period B: 201 ± 98 µmol/L].  
As expected, the whole-body threonine fluxes were higher for the 
oral than for the intravenous tracer group during the two periods 
[period A: flux ig 1,473 ± 710 vs. flux iv 237 ± 38 µmol/(kg·h); period 
B: flux ig 860 ± 253 vs. flux iv 246 ± 43 µmol/(kg·h), Table 5]. This 
was due to the first-pass disappearance of the intragastrically 
administered threonine tracer within the splanchnic region. Figure 2 
illustrates the very high first-pass threonine uptake during both 
periods.  
 
Figure 2. First-pass threonine uptake in absolute amount (µmol/(kg·h)) 
and expressed as a fraction of dietary intake during period A and B  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
During both periods n=8, * indicates a significant difference at P < 0.01, and ** 
indicates a significant difference at P < 0.0001. 
 
From the data presented in Figure 2, it is clear that the first-pass 
threonine uptake, expressed as a percentage of dietary intake, was 
significantly higher during a low enteral intake. Yet, approximately 
three-quarters of the dietary intake was utilized by the splanchnic 
A B B A
** 
*
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tissues during full enteral feeding. In absolute amounts, the first-pass 
threonine uptake was significantly lower during a restricted enteral 
threonine intake [period A: 24 ± 7 vs. period B: 44 ± 4 µmol/(kg·h), P 
< 0.0001]. Despite this high first-pass threonine utilization, the 
splanchnic tissues did not oxidize dietary threonine during partial 
enteral feeding and the first-pass threonine oxidation during full enteral 
feeding was not significantly different from zero [period A: 0 ± 8 vs. 
period B: 3 ± 4 µmol/(kg·h), NS]. 
 
Table 5. Whole-body intravenous and intragastric fluxes of threonine, 
whole-body oxidation and balance of threonine in absolute amounts 
(µmol/(kg.h)) and as a fraction of threonine flux during period A and 
period B 
 
 Period A 
µmol/(kg·h)        % 
Period B 
µmol/(kg·h)        % 
Flux iv 237 ± 38  246 ± 43  
Flux ig 1,473 ± 710  860 ± 253  
Threonine oxidation 15 ± 9 6 ± 4 17 ± 13 6 ± 2 
Threonine balance 43 ± 10  44 ± 16  
 
Values are means ± SD, n = 5. 
 
There was no significant difference in the amount of threonine 
oxidized by the whole-body between the two feeding periods (Table 5). 
During both intakes, whole-body threonine oxidation accounted for 
approximately one-tenth of threonine flux [period A: 6 ± 4% vs. period 
B: 6 ± 2%]. We determined the incorporation of tracer into glycine 
(Figure 3); however, the enrichments we obtained were very low. The 
non-oxidative threonine disposal [NOTD; period A: 231 ± 46 vs. period 
B: 236 ± 41 µmol/(kg·h)] and the threonine release of protein 
breakdown [TRP; period A: 185 ± 35 vs. period B: 183 ± 41 
µmol/(kg·h)] were not significantly different between the two periods. 
Whole-body threonine balance, calculated from the difference between 
non-oxidative disposal and whole-body protein degradation, was 
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positive during both feeding periods, but was not significantly different 
between the two periods [period A: 43 ± 10 vs. period B: 44 ± 16 
µmol/(kg·h), Table 5].  
 
Discussion 
This study describes the splanchnic threonine kinetics in preterm 
infants during early postnatal life. The role of the splanchnic tissues is 
essential in the delivery of dietary amino acids to peripheral tissues. 
The splanchnic utilization of a given amino acid is a result of adequate 
transport and intracellular metabolism. Since threonine is an essential 
amino acid, a high splanchnic utilization may result in the depletion of 
the systemic plasma pool of threonine. 
Therefore, the most striking observation to emerge from this 
study was that the fractional first-pass threonine uptake by the 
intestine was very high in the first week of life in preterm infants 
during a restricted enteral intake. This observation indicates a high 
obligatory visceral need for threonine in neonates. Although the 
gastrointestinal tissues represent only 5% of body weight, they 
account for 15% to 35% of whole-body oxygen consumption and 
protein turnover due to their high rates of metabolism. 20-22 Of the 
many factors that affect neonatal gut growth and adaptation, probably 
the most physiologically significant stimulus is enteral nutrition. 23-27 
Enteral feeding acts directly by supplying nutrients for growth and 
mucosal metabolism of epithelial cells.  
The route of administration of adequate nutrition is a major issue 
in the clinical care of preterm infants, because of enteral feeding 
intolerance and associated morbidity. 28-30 To reduce the complications 
of total parenteral nutrition, and to accelerate the adaptation to full 
enteral feeding, many neonatologists often provide small volumes of 
enteral nutrition, e.g., minimal enteral feeding, in combination with 
TPN to preterm infants in their first weeks of life. 31 However, recent 
studies in neonatal piglets have shown that an enteral intake of 20% is 
necessary to prevent gut protein loss, whereas an intake of at least 
40% is needed to  maintain normal growth. 32,33 In our study, preterm 
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infants were fed 40% enterally of the total nutrient intake during 
period A, and the results show the fractional first-pass threonine 
requirements were significantly higher (82% of dietary intake) than 
those of fully-fed infants (70% of dietary intake). 
The high enteral threonine uptake observed during both partial 
and full enteral feeding reflects the use of absorbed threonine for the 
synthesis of secretory (glyco-)proteins, for the synthesis of mucosal 
cellular proteins, or for oxidative purposes. 2-5 We did not observe any 
first-pass threonine oxidation during either feeding period, indicating 
the use of enterally absorbed threonine for the other two metabolic 
pathways. Although the intestinal mucosa is a highly secretory and 
proliferatory tissue, dietary threonine is not incorporated into 
constitutive mucosal proteins to a great extent. 4 However, the 
intestinal mucosa is protected by a complex network of (glyco-) 
proteins, and the core-proteins of the highly glycosylated domains of 
small intestinal mucins contain large amounts of threonine. 34 Probably 
a significant proportion of the utilized threonine is channeled towards 
mucin production. These secretory mucins play a key role in the 
defense of the mucosa. In fact, there is evidence that mucin production 
is impaired in piglets fed threonine-deficient diets and in addition 
supplying threonine parenterally can not restore normal mucin 
production. 9,35  
An important issue in this respect is the critical gut barrier function 
in preterm neonates, especially with regard to the immaturity of the 
innate and specific immune defense mechanisms. As a consequence, 
preterm infants are susceptible to infections in their first weeks of life, 
particularly TPN-fed infants, with sepsis being a common complication 
of TPN. The high first-pass threonine uptake observed in the first 
weeks of life is probably necessary to support a normal homeostatic 
environment and balance among luminal microbes, epithelial cells and 
the immune system. Dietary threonine may, therefore play a specific 
role in the defense capacity of neonates.  
Recently, we have shown that intestinal recycling of secreted 
(glyco-)proteins contributes significantly to the systemic availability of 
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amino acids. 36 Therefore, we postulate that a large portion of utilized 
threonine is incorporated into (glyco-)proteins, which are subsequently 
reabsorbed and made available to the systemic circulation. However, 
our study protocol did not allow us to quantitate the amount of 
recycled threonine that appears in the systemic circulation. 
A second aim of this study was to determine whole-body threonine 
kinetics in neonates under two different feeding circumstances. Two 
pathways are known for the enzymatic degradation of threonine 
(Figure 3): 1) conversion of threonine to a-ketobutyrate, and 
subsequently propionate via threonine dehydratase (TDH); 2) cleavage 
of threonine to glycine and acetaldehyde depending on threonine 
aldolase and on threonine-3 dehydrogenase (TDG). 37-39 Darling et al. 
estimated that the conversion rate to glycine (TDG pathway) in 
preterm infants accounted for 44% of the total threonine degradation, 
whereas degradation via the TDH pathway accounted for 56% of 
threonine disposal. 40  
We were unable to detect significant enrichments of plasma 
glycine during the infusion of labeled threonine, suggesting that hardly 
any threonine was catabolized through the threonine dehydrogenase 
pathway. During both partial and full enteral feeding, whole-body 
threonine oxidation accounted for approximately 10% of the threonine 
flux, which is comparable to, but slightly higher than the fractional 
oxidation rates found by Darling et al in breast milk-fed infants. 41 
In addition, we could not detect any first-pass threonine oxidation 
by the splanchnic tissues in either feeding periods. Several studies in 
animal species have shown that the catabolic enzymes for threonine 
oxidation are located mainly in the liver. 37,41,42 As the splanchnic 
tissues include the intestine and liver, we speculate that threonine 
metabolism is compartmentalized in these tissues. It is possible that 
the hepatocytes are capable of only oxidizing arterially delivered 
threonine. This idea is supported by our observations of an absence of 
first-pass threonine oxidation, and by other studies showing channeling 
of amino acids to specific endproducts depending of the site of 
entrance, i.e. via the diet or via the systemic circulation. 4, 43  
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Figure 3. Schematic model of threonine metabolism 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABA, 2-aminobutyrate acid; I, threonine intake; Igly, glycine input from 
synthesis and diet; IKB, 2-ketobutyric acid input from synthesis; GLY, glycine; 
GRP, glycine release of proteins; HA, hippuric acid; KB, 2-ketobutyric acid; Ogly, 
glycine oxidation; OKB, 2-ketobutyric acid oxidation; NOGD, non-oxidative 
glycine disposal; NOTD, non-oxidative threonine disposal; TDG, threonine 
dehydrogenase pathway; TDH, threonine dehydratase pathway; THR, threonine; 
TRP, threonine release of protein. 
 
In conclusion, this study demonstrated that the splanchnic tissues 
of preterm infants utilize the dietary threonine intake to a substantial 
degree, i.e. more than three-quarters, irrespective of the amount of 
enteral threonine delivery. Surprisingly, threonine taken up by the 
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intestine apparently is not oxidized during either partial enteral 
feeding, or full enteral feeding. Furthermore, our data demonstrate 
that approximately 10% of the threonine flux is oxidized and the route 
of feeding does not affect this whole-body threonine oxidation. Overall, 
we suggest that the major metabolic fate of intestinal utilized threonine 
is mucosal (glyco-)protein synthesis, which is most likely reabsorbed 
distally in the intestine to enrich the whole-body pool of threonine. 
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Background & Aims: Glucose is a major oxidative substrate for 
intestinal energy generation in neonatal animals, while data in preterm 
infants are hardly available. However, early administration of enteral 
nutrition, including glucose, may offer an effective strategy to support 
the intestinal adaptation to extra-uterine life in preterm neonates. The 
purpose of the present study was to obtain data in human neonates by 
quantifying the first-pass uptake and oxidation of glucose by the 
splanchnic tissues in newborn infants. Methods: Eight preterm infants 
(birth weight: 1.19 ± 0.22 kg, gestational age: 29 ± 1 wk) were studied 
during two different enteral intakes [A: 40% enteral 60% parenteral, 
total glucose intake: 7.5 ± 0.5 mg/(kg·min), and B: 100% enteral, total 
glucose intake: 7.8 ± 0.4 mg/(kg·min)]. Splanchnic and whole-body 
glucose kinetics were measured by dual tracer techniques. Results: 
During both feeding periods, approximately one-third of the dietary 
glucose intake was utilized in first-pass by the intestine. More than 
three-quarters of this utilized glucose was oxidized in both periods [A: 
79% ± 36 vs. B: 84% ± 45]. The whole-body glucose oxidation was 
substantial under both circumstances, 72% ± 5 and 77% ± 6 of the 
glucose flux was oxidized during partial and full enteral feeding. 
Conclusions: We conclude that approximately one-third of the dietary 
glucose is utilized in first-pass, irrespective of the dietary intake. The 
majority of the utilized glucose is used for energy generation. 
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n utero, the fetus continuously receives nutrients via the umbilical 
vein. After birth, newborns undergo a number of physiological 
adaptations to adjust to their extra-uterine environment. In particular, 
they must adapt to a shift from glucose as the major energy source to 
a carbohydrate-fat mixture as the energy source. 1,2 Therefore, the 
neonate has to mobilize stores of carbohydrates, proteins, and lipids in 
adequate amounts to meet its substantial metabolic needs. Energy 
expenditure in neonates is approximately three times higher per unit 
body mass than in adults. 3 
Studies in a number of mammalian species have shown that the 
portal-drained viscera (PDV; the intestines, pancreas, spleen and 
stomach) account for 35% of whole-body energy expenditure, whereas 
they only contribute less than 5% of the whole-body weight. 4-6 
Matthews et al. showed in adults that the gut is the key organ in the 
process of sequestration of glutamine and glutamate for the purpose of 
oxidation, and they are key fuels for the splanchnic tissues. 7-9 In 
contrast, no studies in infants have been performed to quantify the 
substrates that are used by the intestine as fuel sources. This 
information is critical, especially in situations in which the intestine is 
damaged, e.g. by infection, chemotherapy or following ischemia due to 
a decreased splanchnic blood flow such as in case of necrotizing 
enterocolitis (NEC) or asphyxia. Moreover, identifying the substrates 
used to favor this high intestinal oxidative activity is also important for 
the atrophied intestine after periods of prolonged total parenteral 
nutrition or directly postpartum in preterm neonates. Knowing the 
required oxidative substrates can help in re-establishing a functional 
gut by supplying the appropriate substrates which might result in a fast 
recovery of the gut function. 
The extent to which orally administered nutrients are absorbed by 
the intestine, and are metabolized within the intestinal tissues or 
transported to the systemic circulation, can be determined by dual 
stable isotope tracer methodology. Recently, using this technique in 
neonatal pigs, we showed that under normal feeding conditions, the 
PDV extracted 6% of the dietary glucose intake. 10 Studies in healthy 
I 
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adult volunteers showed that a similar fraction of the oral glucose load 
(10%) was utilized by the splanchnic tissues, and 90% of the dietary 
glucose was available for the peripheral tissues. 11 In preterm 
neonates, however, little is known about the first-pass glucose uptake 
by the splanchnic tissues.  
Moreover, we found in neonatal pigs that the intestinal energy 
production during a normal protein intake is largely derived from the 
oxidation of glucose and amino acids. 10,12,13 During protein restriction, 
the splanchnic tissues maintain their high rate of energy metabolism, 
although amino acid oxidation was significantly reduced whereas 
intestinal glucose oxidation became more important. 
In an oxidation study in parenterally fed preterm infants during 
the first weeks of life, we also showed that on whole-body level, 
glucose is an important fuel source accounting for 30 to 40%, whereas 
protein oxidation accounted for 10 to 15%. The remaining 40 to 50% 
was probably due to lipid oxidation. 14,15 Whether glucose is catabolized 
by the splanchnic tissues in neonates has not been studied yet.  
In the present study, the dual stable isotope tracer technique was 
employed to examine splanchnic and whole-body glucose kinetics in 
preterm infants. Specifically, the study was designed to determine the 
first-pass glucose uptake by the intestine during two different enteral 
protein intakes. The quantification of the intestinal and whole-body 
glucose oxidation both during partial and full enteral feeding was the 
second objective of our study. To investigate the influence of postnatal 
age on splanchnic uptake and oxidation of glucose, these variables 
were studied during different postnatal ages. 
 
Methods  
Subjects 
Patients eligible for this study were premature infants with a birth 
weight ranging from 750 to 1500 g who were appropriate for the 
gestational age according to the charts of Usher and McLean. 16 
Exclusion criteria were: congenital anomalies, gastrointestinal or liver 
diseases, and maternal diabetes. The study protocol was approved by 
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the Erasmus University Institutional Review Board. Written, informed 
consent was obtained from the parents.  
Eight preterm infants were included in the study (Table 1). CRIB-
scores (indication of illness, range: 0-23) on the first day of life were 
all below two. 17 The infants received a standard nutrient regimen 
according to our neonatal intensive care feeding protocol; a 
combination of breast or formula feeding (Nenatal®, Nutricia, 
Zoetermeer, The Netherlands; 0.024 g/ml protein, 0.077 g/ml 
carbohydrate, 0.044 g/ml fat) and parenteral nutrition containing 
glucose (glucose 10%), amino acids (Primene® 10%, Clintec Benelux 
NV, Brussels, Belgium), and lipids (Intralipid® 20%, Fresensius Kabi, 
Den Bosch, The Netherlands). Nenatal® was given as sole enteral 
nutrition 12 hours before the start of the study and during the study 
days. 
 
Protocol 
To investigate the influence of enteral intake and postnatal age on 
splanchnic glucose uptake, the study was implemented on two periods 
of two consecutive study days; during period A the infants received 
40% enteral feeding and 60% parenteral feeding and they were 6 ± 1 
d old, while during period B they received full enteral feeding and were 
13 ± 2 d old (Figures 1 and 2). During period A the infants had both an 
arterial and an intravenous catheter for the withdrawing of blood 
samples and the infusion of tracers, while during period B a peripheral 
intravenous catheter was available for the infusion of tracers. During 
period B blood samples were collected by heelstick. To collect breath 
samples from these small infants, we employed the method described 
by Perman et al., who used a nasal tube. 18 This method has been 
validated and used for the non-invasive diagnosis of sucrose 
malabsorption by H2 breath tests in children. 
18  We validated this 
method for [13C]substrate studies (Van der Schoor, unpublished data), 
although this method already has been used in [13C]labeled substrate 
studies before. 19,20 Briefly, a 6 Fr gastric tube (6 Ch Argyle; Sherwood 
Medical, Tullamore, Ireland) was placed for 1 to 1.5 cm into the 
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nasopharynx, and 15 mL end-tidal breath was taken slowly with a 
syringe. Duplicate aliquots of expired air from each sampling point 
were stored in vacutainers for later analysis.  
 
Figure 1. Schematic overview of period A during study days 1 and 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[13C]bic, [13C]sodiumbicarbonate; [D2]gluc, [D2]glucose; [U-13C]gluc, [U-
13C]glucose. 
 
Isotope infusion 
13C-labeled sodium bicarbonate (NaH13CO3, 99 mol% 
13C; Cambridge 
Isotopes, Woburn, MA), uniformly labeled glucose (13C6H12O6, 99 mol% 
13C6; Cambridge Isotopes, Woburn, MA), and deuterium labeled 
glucose (C6H10D2O6, 98 mol% 6,6-D2; Cambridge Isotopes, Woburn, 
MA) were diluted in 0.9% NaCl by the hospital pharmacy and filtered 
through a 0.22-µm Millipore filter into sterile vials. 
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Figure 2. Schematic overview of period B during study days 3 and 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[13C]bic, [13C]sodiumbicarbonate; [D2]gluc, [D2]glucose; [U-13C]gluc, [U-
13C]glucose. 
Study day 3
[13C]bic iv [U-13C]gluc iv
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Three different stable isotope infusions were performed during 
each study day in both periods. First, a primed, continuous 2-h infusion 
(10.02 µmol/kg and 10.02 µmol/(kg·h)) of NaH13CO3 was administered 
at a constant rate. The 13C-labeled bicarbonate infusion was 
immediately followed by two primed, continuous 5-h infusions (10.00 
µmol/kg and 5.00 µmol/(kg·h)) of [U-13C]glucose and [D2]glucose 
designed to assess whole-body and splanchnic glucose kinetics. The 
route of tracer administration on the different study days is shown in 
Figures 1 and 2. In order to quantify the effect of postnatal age on 
whole-body and splanchnic glucose kinetics, we performed a separate 
study on the fourth study day (Figure 2). The first 5-h the infants 
received full enteral feeding simultaneously with two labeled glucose 
tracers intravenously and intragastrically; the next 5-h the infants 
received 40% enteral and 60% parenteral feeding simultaneously with 
two labeled glucose tracers intravenously and intragastrically. Blood 
samples were drawn before the infusion of the stable isotopes, at 30 
min before the end, and at the end of the labeled glucose infusions. 
The total amount of blood withdrawn during a study day was 1.2 mL, 
which is less than 2% of blood volume in a 1000-g infant. Blood was 
centrifuged immediately and stored at –70°C for further analysis. 
At time zero two duplicate baseline breath samples were collected. 
During the last hour of each tracer infusion, breath samples were 
collected at 15-min intervals (T 60, 75, 90, 105, 120, 360, 375, 390, 
405, 420 min).  
 
Analytical methods 
Blood samples were prepared for mass spectrometry as described 
previously. 10 Gas chromatography-mass spectrometry was performed 
with the pentacetate derivative of glucose. The analyses were 
performed with a 6890 series gas chromatograph linked to a model 
5973 quadrupole mass spectrometer (Hewlett Packard, Palo Alto, CA). 
Breath samples were analyzed for enrichment of 13CO2 on an isotope 
ratio mass spectrometer (ABCA; Europa Scientific, Van Loenen 
Instruments, Leiden, The Netherlands). 21  
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Calculations 
Plasma enrichments of glucose were used to calculate the rate of 
glucose turnover. Glucose turnover was calculated by dividing the 
tracer infusion by the mean of two plateau measurements at plateau of 
the stable isotope tracer enrichments (Appendix, eq.1). The first-pass 
glucose uptake was calculated by dividing both fluxes of glucose 
tracers multiplying by the enteral glucose intake (Appendix, eq.2). The 
glucose production rate (GPR) was calculated by subtracting the rate of 
glucose infusion and the first-pass glucose uptake from the glucose flux 
(Appendix, eq.3). 
The splanchnic and whole-body glucose oxidation (Appendix, eq.4-
10) were determined assuming that the CO2 production during the 
NaH13CO3 infusion was equal to the CO2 production during the [U-
13C]glucose infusion. By determining the increase in 13CO2 enrichment 
of each individual infant during both the NaH13CO3 infusion and the [U-
13C]glucose infusion, variance can be diminished and there is no need 
for correction factors that account for [13C]bicarbonate sequestration in 
the whole-body. 14,22  
 
Statistics 
The data are expressed as the mean values obtained from samples 
taken over the last hour of each tracer infusion ± SEM. Statistical 
comparisons were performed with a paired Student t test, and a Mann-
Whitney test whenever the results were not normally distributed. A 
value of P < 0.05 was taken as statistically significant. 
 
Results 
All infants were appropriate for gestational age because of the inclusion 
criteria (mean gestational age 29 ± 1 wk, Table 1). Two infants were 
mechanically ventilated during both periods, and six infants received 
supplemental oxygen by a nasal prong. All infants received caffeine 
with therapeutic plasma levels within the normal range, and were 
clinically stable at the time of the study. The infants did not receive any 
vasopressic drugs that could influence the splanchnic blood flow. Seven 
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infants had received antenatal steroids. Routine blood chemistry and 
hematology (electrolytes, calcium, glucose, acid base, hematocrit, 
thrombocyte count and white blood cell count) were all within normal 
limits for preterm infants, and there were no significant changes in 
these parameters for 24 h before and after the study. Intakes of 
glucose, and energy are shown in Table 2. By study design, no 
differences were found in protein and carbohydrate intakes during both 
feeding periods  [protein: A: 3.4 ± 0.1 vs. B: 3.2 ± 0.2 g/(kg·d), and 
glucose: A: 7.5 ± 0.5 vs. B: 7.8 ± 0.4 mg/(kg·min)]. The fat intake 
was significantly higher during full enteral feeding [A: 4.7 ± 0.3 vs. B: 
5.8 ± 0.3 g/(kg.d), P < 0.05)], which resulted in a slightly, but 
significantly higher energy intake (+11%) during period B.  
 
Table 1. Subject characteristics 
 
P GA BW CRIB 
Score 
PA 
A 
PA 
B 
SW 
A 
SW 
B 
 wk kg  d d Kg kg 
1 27 0.98 2 7 14 0.92 0.97 
2 29 1.38 1 8 13 1.34 1.32 
3 29 1.38 2 7 13 1.23 1.27 
4 29 1.11 1 5 11 1.01 1.10 
5 29 1.51 0 5 11 1.33 1.53 
6 29 1.06 2 6 16 1.01 1.05 
7 28 0.88 2 7 11 0.86 0.90 
8 30 1.25 2 8 11 1.18 1.30 
 29 ± 1 1.2 ± 0.2 1 ± 1 6 ± 1 13 ± 2 1.1 ± 0.2 1.2 ± 0.2 
 
Values are means ± SD; P, patients; GA, gestational age; BW, birth weight; PA, 
postnatal age; SW, study weight; A, Period A; and B, Period B. 
 
Isotopic plateau 
Glucose kinetics were calculated from the plateau enrichment values in 
breath and plasma. Details of the isotopic enrichments of plasma 
glucose at baseline and plateau during periods A and B are given in 
Table 3. The background (baseline) recovery of the [13C]label in 
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expiratory air was not significantly different between both periods [A: 
1.0918 ± 0.0007 vs. B 1.0883 ± 0.0018 APE].  
 
Table 2. Glucose intake (mg/(kg·min)),  and energy intake 
(kcal/(kg·d)) during period A (partial enteral feeding) and period B 
(full enteral feeding) 
 
 Partial enteral feeding (A) Full enteral feeding (B) 
Total glucose intake 7.5 ± 0.5   7.8 ± 0.4  
enteral  2.7 ± 0.3  7.1 ± 0.3 
parenteral  5.0  ± 0.4  0.7 ± 0.1 
Total energy intake 100 ± 4 *  111 ± 5  
enteral  41 ± 5  107 ± 5 
parenteral   58 ± 6   4 ± 1 
 
Means ± SD, n = 8, and * indicates significant difference at P < 0.05. 
 
Table 3. Baseline and steady-state plasma isotopic enrichments on 
study days 1 and 2 during period A (partial enteral feeding) and on 
study days 3 and 4 during period B (full enteral feeding) 
 
D Feeding [U-13C]glucose [D2]glucose 
  baseline plateau baseline plateau 
  mol % mol % mol % mol % 
1  Partial enteral 0.0192 ± 
0.0043 
0.1308 ± 
0.0610 
2.7115 ± 
0.0519 
2.7729 ± 
0.0702 
2  Partial enteral 0.0199 ± 
0.0039 
0.1135 ± 
0.0629 
2.7347 ± 
0.0720 
2.7883 ± 
0.0715 
3  Full enteral 0.0199 ± 
0.0073 
0.1309 ± 
0.0644 
2.6702 ± 
0.0735 
2.8245 ± 
0.0955 
4  Partial enteral 0.0166 ± 
0.0032 
0.1739 ± 
0.0262 
2.6725 ± 
0.0258 
2.7780 ± 
0.0430 
4  Full enteral  0.1895 ± 
0.0497 
 2.7621 ± 
0.0604 
 
Values are means ± SD; D. study day; n = 8. On study days 1 and 4 [U-13C]glucose 
was administered intravenously and [D2]glucose intragastrically; on study days 
2 and 3 [U-13C]glucose was given intragastrically and [D2]glucose intravenously. 
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Figure 3 shows the mean increase in 13CO2 enrichment in expired air at 
both enteral intakes. The 13CO2 enrichment in breath during 
[13C]sodium bicarbonate infusion rose rapidly in the first hour of 
infusion in both periods, to become constant in all infants by 120 min, 
with <3% variation in plateau values [A: 1.6 ± 0.5% vs. B: 2.0 ± 
1.1%]. The coefficient of variation (mean ± SD) of breath [13C]glucose 
enrichment above baseline at plateau was 1.2 ± 0.8% during period A 
and 1.9 ± 1.0% during period B.  
 
Glucose kinetics 
The glucose fluxes were higher for the oral than for the intravenous 
tracer group during the two periods [A: flux ig 5,537 ± 1,328 vs. flux 
iv 3,405 ± 220 µmol/(kg·h); B: flux ig 4,190 ± 614 vs. flux iv 2,885 ± 
233 µmol/(kg·h)]. This is due to the first-pass uptake of the 
intragastrically administered glucose tracer within the splanchnic 
region. Table 4 summarizes the first-pass kinetics of glucose by the 
intestine during partial and full enteral feeding. The first-pass glucose 
uptake, expressed as a percentage of dietary intake, was not 
significantly different between both feeding periods. More than one-
third of the dietary intake was utilized by the splanchnic tissues during 
both partial and full enteral feeding. The postnatal age did not 
influence the first-pass glucose uptake, at a postnatal age of 13 days 
and a restricted enteral intake, still 39 ± 8% of the dietary intake was 
utilized. During a restricted enteral intake, the intestine oxidized 
dietary glucose at a rate of 323 ± 136 µmol/(kg·h). During full enteral 
feeding, glucose oxidation by the splanchnic tissues was 573 ± 273 
µmol/(kg·h). Taken together, the first-pass glucose oxidation was not 
significantly different between both feeding periods, and accounted for 
more than three-quarters of the utilized glucose.  
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Figure 3. Time course of 13CO2 enrichment in breath after a primed 
constant NaH13CO3 and [U-13C]glucose intravenous infusion during 
period A and period B in 8 patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are presented as mean ± SD. 
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Table 4. First-pass glucose uptake and oxidation during period A 
(partial enteral feeding) and period B (full enteral feeding) 
 
 Partial enteral feeding 
(A) 
Full enteral feeding 
(B) 
FP uptake (µmol/(kg·h)  398 ± 65  825 ± 253 
Fractional FP uptake (%) 44 ± 8  32 ± 9 
FP oxidation (µmol/(kg·h)  323 ± 136 573 ± 273 
Fractional FP oxidation of 
FP uptake (%) 
79 ± 36 84 ± 45 
 
Means ± SEM, n = 8. 
 
Whole-body glucose oxidation, and glucose production rates are 
shown in Table 5. There was no significant difference in the amount of 
glucose oxidized by the whole-body between the two feeding periods. 
During both intakes, whole-body glucose oxidation accounted for 
approximately 75% of glucose flux [A: 72 ± 5% vs. B: 77 ± 6%]. 
Postnatal age did not influence the whole-body glucose oxidation, at a 
postnatal age of 13 days and a restricted enteral intake, 69 ± 5% of 
the glucose flux was oxidized. The GPR was approximately 1,500 
µmol/(kg·h) in both periods, and accounted for 40 ± 3 and 62 ± 6% of 
the glucose flux, respectively.  
 
Discussion 
To our knowledge, this is the first study that provides insight into the 
splanchnic glucose uptake as well as the splanchnic oxidative capacity 
in preterm infants. Our data indicate that the splanchnic tissues utilize 
one-third of the oral glucose intake, irrespective of the level of enteral 
feeding. This utilized glucose is oxidized for approximately 80%, 
presumably to sustain the high rate of visceral metabolism. The whole-
body glucose oxidation accounted for three-quarters of the glucose 
turnover. Given the finding that splanchnic glucose oxidation was 
substantial in the early weeks of life of preterm infants, early 
administration of enteral nutrition, including glucose, may offer an 
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effective strategy to support the intestinal adaptation to extra-uterine 
life in preterm neonates. These data demonstrate that the splanchnic 
tissues extract a disproportionate amount of dietary glucose to serve 
mainly as fuel source in the early life of preterm neonates.  
 
Table 5. Whole-body glucose kinetics in preterm infants during period A 
(partial enteral feeding) and period B (full enteral feeding) 
 
 Partial enteral  
Feeding (A) 
Full enteral 
feeding (B) 
 6 days old 13 days old 13 days old 
 µmol/(kg·h) µmol/(kg·h) µmol/(kg·h) 
Flux iv 3,405 ± 220 3,108 ± 295 2,885 ± 233 
Flux ig 5,537 ± 1,328 4,854 ± 843 4,190 ± 614 
WB oxidation  
WB oxidation of flux (%) 
2,522 ± 331 
72 ± 5 
 2,305 ± 163 
69 ± 5 
2,161 ± 101 
77 ± 6 
GPR 1,433 ± 255 1,343 ± 146 1,781 ± 221 
 
Means ± SEM, n = 8. GPR, glucose production rate; WB oxidation, whole-body 
oxidation of glucose. 
 
The neonate depends on the gastrointestinal tract for the 
acquisition of nutrients through the processes of propulsion, digestion 
and absorption of ingested food. Studies in adults demonstrated less 
than 0.5 mg of the residual glucose in gastric washings, obtained three 
hours after ingestion of 100 g oral glucose. 23 Furthermore, at least 
98% of glucose is being removed from the intestinal lumen before it 
reaches the ileum. 24 However, glucose was not the sole source of 
carbohydrates; the formula contained also lactose, maltose and 
glucose polymers. Others have shown that glucose polymers are well 
absorbed by young infants. 25,26 Kien et al. showed that lactose 
digestion from formula feeding was approximately 79%, 27 although 
there was a significant linear correlation between lactose digestion and 
post-conceptional age. Thus, most of the dietary milk carbohydrates 
are absorbed by the intestinal mucosa at a postnatal age of one week. 
And therefore, glucose that does not appear in the systemic circulation, 
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is utilized by the splanchnic tissues and is not lost via the faeces before 
being used for synthetic purposes. 
The substantial dietary glucose uptake observed during both 
partial and full enteral feeding reflects the use of absorbed glucose for 
different splanchnic metabolic fates, at least under clinically stable 
conditions and in the absence of significant intestinal diseases. 
Splanchnic glucose extraction equals the sum of intestinal and hepatic 
glucose extraction. Any combination of the following four possibilities 
could explain the lower systemic availability of the dietary glucose: 1) 
glucose is used by mucosal tissue as a energy-providing substrate, 2) 
glucose is used for the synthesis of intestinal glyco-proteins, 3) in the 
process of absorption some glucose is converted into three-carbon 
compounds, which are then released into the portal vein, and 4) 
glucose is taken up by the liver. It should be emphasized quit clearly 
that catheterization of the portal vein was not ethically feasible in the 
small infants in our study. Consequently, it was not possible to quantify 
the net hepatic uptake of dietary glucose and the relative contributions 
of intestinal and hepatic tissues to the splanchnic glucose oxidation.  
By using dual stable isotope methodology, we were able to 
measure the first-pass glucose oxidation by the intestine, and we found 
that more than three-quarters of the intestinally absorbed glucose was 
oxidized. Thus, it seems that dietary glucose is an important energy 
source for the intestinal mucosa. The present data with regards to 
intestinal glucose oxidation, are in line with our previous observations 
in protein-restricted piglets, in which we found that intestinal glucose 
oxidation accounted for approximately 50% of the total visceral CO2 
production. 10 Similarly, in vitro studies with human enterocytes 
reported that the respiratory fuels of human enterocytes include 
glucose, glutamine, and to a lesser extent, ketone bodies as indicated 
in the proportion of oxygen consumption attributed to these fuels. 28  
A second metabolic fate of first-pass utilized glucose might be 
mucin synthesis. Intestinal mucins are key components of the first line 
of host defense against intestinal pathogens. These large glyco-
proteins secreted by specialized goblet cells form viscous gels that trap 
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microorganisms and limit their diffusion to the intestinal epithelium. 
Isolated mucin has high concentrations of carbohydrates, representing 
65% of the mucin by weight. 29,30 Recently, we found in preterm 
infants that more than 80% of the dietary threonine intake was utilized 
in first-pass, which was not used for oxidative purposes but for 
synthetic purposes. (Van der Schoor SRD, unpublished data) 
Therefore, we speculate that preterm neonates have a high visceral 
need of threonine presumably for the synthesis of glyco-proteins, and 
consequently, neonates may have a high need for glucose as well.  
After the splanchnic release into the systemic circulation, glucose 
can be oxidized in the peripheral tissues, metabolized to lactate and 
recycled to glucose via gluconeogenesis, stored as glycogen, or used in 
various synthetic processes. Because glucose represents the main 
source of energy for the preterm infant during most of the neonatal 
period, it is important to determine the extent of whole-body glucose 
oxidation and its contribution to the total glucose use. This knowledge 
assists in the clinical determination of the optimal rate of glucose 
infusion for the preterm infant, which is the rate that is appropriate to 
the neonate’s capacity to oxidize glucose. In the present study we 
quantified the whole-body oxidation of glucose and the glucose 
production rate in relation to an increasing enteral intake. Our results 
show that more than 70% of the glucose turnover is oxidized, and 
these observations are similar to other studies, except for the study 
done by Cowett et al. 31 In preterm infants, we and others previously 
showed 50-65% of the whole-body glucose turnover was oxidized. 13,32-
35 Cowett et al. studied glucose oxidation in preterm infants with 
different postnatal ages and found that the fraction of glucose oxidized 
decreased with postnatal age. 31 We did not find a significant different 
effect of postnatal age on whole-body glucose oxidation, which might 
be due to a difference of only 1 week. However, the purpose of this 
part of the study was to show that there was no difference in glucose 
metabolism caused by an increasing postnatal age or feeding pattern.  
In conclusion, we have shown that the splanchnic tissues extract 
one-third of the dietary glucose intake in preterm infants in the first 
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weeks of life. A significant amount of this utilized glucose is used for 
oxidative purposes. The results also show that neither the amount of 
enteral feeding nor the postnatal age significantly affects the 
splanchnic glucose uptake and oxidation. Taken together, the results 
highlight the critical importance of the splanchnic tissues in actively 
regulating the glucose flow to the peripheral tissues, already in the first 
weeks of life in preterm neonates. 
 
Appendix 
The rate of glucose appearance (Q = flux) is calculated as follows: 
Q = IG x [(IEi / IEp) – 1]   [1] 
where Q is the rate of appearance, IG is the glucose tracer infusion rate 
in µmol/(kg·min), IEi is the isotopic enrichment of the infusate, and IEp 
is the isotopic enrichment of [U-13C or D2]glucose (m
+6, m+2) of the 
plasma. 
The first-pass glucose uptake was calculated according to the 
expression: 
U = [(Q ig – Q iv) / Q ig] x I   [2] 
where U is the first-pass glucose uptake in µmol/(kg·h), Q ig is the flux 
of the intragastric glucose, Q iv is the flux of the intravenous glucose, 
and I is the enteral glucose intake. 
Under steady state conditions, the rate of glucose appearance is 
equal to the rate of glucose disappearance. Glucose can enter the 
glucose pool by intravenous or enteral glucose infusion and by glucose 
production from other substrates, e.g. glycerol and some amino acids. 
Glucose can leave the pool by oxidation or non-oxidative disposal. 
 GPR = Ra – (GI – U)    [3] 
where GPR is glucose production rate µmol/(kg·h), and GI is the total 
glucose intake (enteral and intravenous) in µmol/(kg·h).  
To measure the splanchnic and whole-body glucose oxidation rate 
with the use of a continuous infusion of [U-13C]glucose, usually a 
correction factor is used to compensate for the losses of labeled carbon 
within the bicarbonate pool. This correction factor can be determined 
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beforehand in a separate study or calculated from the energy intake. 32 
The equation used for the oxidation is:  
 GO = [(VCO2(G) x IEg) / (IG x c)] x Ra   [4] 
where GO is the glucose oxidation in µmol/(kg·h), VCO2(G) is the rate of 
CO2 excretion in µmol/(kg·h) during the [U-13C]glucose infusion, IEg is 
the isotopic enrichment of expired CO2 at plateau during the [U-
13C]glucose infusion, IG is the glucose infusion rate in 
13C/(kg·h), and c 
is the correction factor. 
A more accurate method is to measure the bicarbonate retention 
for each infant individually. The correction factor is determined using 
the following equation: 
 c = [(VCO2(B) x IEn)] / IN   [5] 
where VCO2(B) is the rate of CO2 excretion in µmol/(kg·h) during the 
NaH13CO3 infusion, IEn is the isotopic enrichment of expired air at 
plateau during the NaH13CO3 infusion, and IN is the NaH
13CO3 infusion 
rate in µmol/(kg·h). 
Combining eq.4 and 5 leads to: 
GO = 
[(VCO2(G) x IEg)/((IG) x ((VCO2(B) x IEn))/IN] x Ra [6] 
Since the NaH13CO3 infusion is immediately followed by the [U-
13C]infusion and no changes are made in the intake of the infants, we 
can assume that VCO2(G) = VCO2(B). Removing the term VCO2 from both 
the numerator and the denominator, the following equation can be 
derived: 
 GO = [(IEg x IN) / (IG x IEn)] x Ra  [7] 
Eq.7 shows that, in case of a constant CO2 production over a 
few hours, it is not necessary to measure VCO2.  
The calculation of the metabolism of enterally administered [U-
13C]glucose to CO2 is complicated by the fact that some of the glucose 
tracer is absorbed and thereby labels the arterial pool. Thus, the non-
first pass oxidation of [13C]labeled glucose that was administered 
enterally, but was absorbed and entered the body at study days 2 or 3 
can be calculated as follows: 
Non-first pass oxidation of the enteral administered 
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[U-13C]glucose = (IE13C ig  / IE13C iv) x GO  [8] 
where IE13C ig is the 
13C enrichment in plasma during the intragastric 
[13C]glucose infusion at study days 2 or 3, and IE13C iv is the 
13C 
enrichment in plasma during the intravenous [13C]glucose infusion at 
study days 1 or 4. 
The glucose oxidation at study days 2 or 3 is calculated as 
described before: 
 Total glucose oxidation = 
[(IEG x IN) / (IEB x IG x 6)] x Q iv   [9] 
where Q iv  is the flux of the intravenous [D2]glucose tracer in 
µmol/(kg·h). 
The first-pass glucose oxidation can thus be calculated with the 
following equation: 
  First-pass glucose oxidation = Eq.9 - Eq.8 [10] 
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eonatologists dealing with the preterm infant are privileged to watch 
ontogeny occurring, while simultaneously they have to struggle with 
the problems of immaturity.  
In the context of improvements in survival for the VLBW infant, the 
importance of nutrition has become notable. Preterm infants as 
compared with term infants are more at risk for nutrient deficiencies 
and/or toxicity for several reasons. These factors include: 1) an early 
birth limits the infant’s nutrition sources, 2) rapid growth quickly 
depletes the infant’s nutrition sources and creates the urge for nutrition 
to meet the demands of growth, 3) physiologic immaturity, in specific 
the gastrointestinal tract interferes with the advancement and 
tolerance of enteral nutrition and 4) illness is frequently present and 
changes nutrient demands and feeding tolerance. Because of these 
factors, the preterm infant’s nutrient needs are greater than those 
found in the healthy term neonate. To be adequate, nutrient intakes 
must meet needs for accretion and replace obligatory losses. Accretion 
includes the amounts actually laid down in new tissues plus the cost of 
accretion. Therefore, the VLBW infant presents a nutritional 
emergency: even with the administration of parenteral nutrition from 
day 1, weight loss exceeds 10% in this group and is partly related to 
their high body water composition and caloric deficit, and birth weight 
is regained at a mean of 11 days. 1 The short term consequences of 
inadequate nutrition in this group of infants are easily recognized; e.g. 
increased susceptibility for infection, and delayed recovery. 
Accumulating evidence points strongly to the fact that the clinical 
management of nutrition has long term consequences and 
susceptibility to chronic diseases in adulthood. 2-4 And, perinatal 
nutrition is recognized to have a profound and persistent influence on 
neurologic development and cognitive function. 5,6  
The current variation in clinical practice between neonatal 
intensive care centers highlights the absence of an adequate evidence 
rationale based on which today’s practice can be found. 7 A growing 
body of data is available in gastrointestinal ontogeny, highlighting the 
fetal and postnatal events that influence gut development and allowing 
N
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an increasing rational approach to the use of enteral nutrition in VLBW 
infants.   
 
Gut development and digestion 
The gastrointestinal tract is one of the first structures discernable in 
the developing embryo. During fetal life, increase in gut length is 
particularly fast during the second trimester and, intestinal length 
continues to increase more rapid than body length for 3 to 4 years of 
life. 8 The ontogenetic timetable is complex (Figure 1). In the intestinal 
mucosa, cellular differentiation and villus development occur early in 
the second trimester. At the beginning of the third trimester, lactase 
activity is around 5% of adult levels. This intestinal growth and 
maturation before birth prepare neonates for the abrupt transition from 
receiving nutrients via the placenta and umbilical vein and effectively 
bypassing the intestine, to complete dependence on the intestine for 
processing and absorbing nutrients.  
 
Figure 1. The ontogenic timetable showing structural and functional 
gastrointestinal development. 52 
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As the ontogenetic timetable suggests (Figure 1), problems with 
motility are likely to be critical in determining an VLBW infant’s ability 
to tolerate enteral nutrition. Thereby, prematurity is the principal risk 
factor for problems with enteral feeding relating to gastrointestinal 
disorder or necrotizing enterocolitis (NEC). Susceptibility to NEC may 
thus be closely related to poor gut motility. A multifactorial 
pathogenesis has been proposed, but the pathogenesis remains 
obscure. Because NEC seldom occurs in infants without enteral feeding, 
enteral nutrition have come to be seen as risk factor of NEC. The 
association between enteral nutrition and NEC is likely to be explained 
by the fact that feeding introduces bacterial or viral pathogens or 
toxins, which are more likely to survive the gastric barrier because of 
low acidity and against which the immature intestine is poorly able to 
defend itself. On the other hand, preterm infants fed human milk 
showed a lower incidence of NEC. 9 Efforts aimed at minimizing the risk 
of NEC have focused on the time of introduction of feedings, on 
volumes, and on the rate of feeding volume increments.   
In case of intrauterine growth retardation (IUGR) due to 
inadequate placenta function, poor fetal oxygenation and nutrition 
occur. The changes in the fetus are similar to the diving mammal, in 
which a diversion of blood flow from the splanchnic circulation and 
redistribution toward cerebral blood flow occurs. 10,11 The consequence 
is a negative effect upon intestinal and pancreatic growth and an 
increased susceptibility towards dysmotility and NEC. Awareness of this 
problem and the common observation of difficulties with the 
introduction of enteral nutrition in the IUGR infant leads, in many 
centers, to the deliberately withholding of enteral nutrition for the first 
24 to 48h in VLBW infants who have evidence of IUGR. However, no 
substantive data are available to support the view that this prevents 
NEC. And, although parenteral nutrition has been used widely in the 
management of ill VLBW infants, a smooth transition to the enteral 
route is most desirable.  
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Animal studies have shown that total parenteral nutrition is 
associated with mucosal atrophy and reduction of enzymatic activity. 
12-14 Therefore, an important advance in nutrition field is minimal 
enteral feeding (MEF) which follows the recognition that small volumes 
of milk promote maturation of gut function while avoiding the possible 
disadvantages or difficulties of full enteral feeding. MEF is the 
administration of nutritionally inconsequential quantities of feed while 
the main route for nutrition is parenteral. Typical volumes used in MEF 
are 12 to 24 ml/(kg·d). Infants who have received MEF show more 
normal patterns of gastroduodenal motility, showing maturation of the 
fed response, an effect that is not observed in case of enteral water 
administration. 15-17 Other clinical benefits of MEF include a reduction in 
hospital stay without a concomitant increase in the risk of NEC, and 
indeed MEF may protect against this condition. 18 Summarizing, MEF 
allows the preterm infant to avoid the effects of enteral starvation and 
to benefit from the trophic properties of milk feeding.  
To put the limited existing data in context, and to provide a basis 
for the appropriate design of future studies, a detailed discussion of the 
factors affecting intestinal protein metabolism is required. It follows 
that the understanding of fetal nutrition may be helpful in designing 
nutritional strategies in children with a compromised gut function. 
 
Intestinal metabolism 
Besides being primarily an agent of digestion, the intestine also has an 
endocrine function, and participates in inter-organ nitrogen 
homeostasis. These functions emphasize that metabolism within the 
intestinal tissues is important due to the fact that a substantial part of 
the dietary nutrients being absorbed are used locally to meet the needs 
of the gut. The present thesis has focused primarily on the first-pass 
uptake of dietary nutrients, and the metabolism of nutrients in tissues 
of the visceral region. Several studies in animals concluded that the 
PDV (portal-drained viscera; intestine, pancreas, spleen, and stomach) 
accounted for about one-quarter of whole-body energy metabolism, 19-
21 which is a disproportionate amount of energy for the size of the 
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tissue (about 6% of the whole-body weight). Indeed, the intestine, as 
an organ with a dynamic activity, has one of the highest rates of 
protein synthesis of any tissue in the body. 22 This is to be expected 
given the large number of rapidly dividing cells, especially those of the 
mucosa and the gut-associated lymphoid tissue and its high secretory 
activity. To favor this high rate of intestinal protein synthesis, the 
villous enterocytes are unique among body cells and are presented 
with substantial quantities of substrates from both the diet and the 
mesenteric circulation. Research on nutrient metabolism in the small 
intestine is limited in specific regarding the site and importance of 
absorption of substrates. Already in the early seventies, Alpers 
reported that intestinal crypt cells use arterial amino acids for intestinal 
metabolism, and villus cells use luminal amino acids for protein 
synthesis. 23 Do these results suggest that arterial and luminal 
nutrients are metabolized differently?  
As described in part one of this thesis, we were able to distinguish 
between luminal and arterial substrate absorption by the mucosal cells 
under various feeding circumstances with our arterial-portal 
catheterized piglet model in combination with the use of stable 
isotopically labeled substrates and measurements of portal tracee and 
tracer uptake. We showed a substantial first-pass uptake of dietary 
amino acids (more than 50%) by the intestine in both species. We 
wondered whether these rates of amino acid utilization represented the 
minimum level of nutrients that must be provided enterally to maintain 
normal intestinal metabolism.  
The assignment of the small intestine is to efficiently absorb as 
much as of the dietary nutrient input as possible, in particular during a 
limited nutrient supply. Our study design included a normal dietary 
protein intake and a restricted dietary protein intake (100% vs. 40% 
dietary protein). At a level of 40% dietary protein intake, the net 
intestinal protein utilization was substantial, resulting in a diminished 
systemic availability of amino acids initially. These results are 
consistent with previous findings in neonatal piglets under conditions of 
various levels of enteral nutrition. 14 Furthermore, Stoll et al. found 
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regional differences in the intestinal response to the input of luminal 
nutrients, and speculated that the distal small intestine is less 
dependent on enteral intake for maintenance of protein balance. It is 
conceivable that the distal part of the intestine is more reliable on the 
arterial supply of amino acids. However, from a nutritional perspective, 
the current results from our studies in both preterm neonates and 
piglets support the idea that enteral nutrition is required for the 
maintenance of intestinal protein balance, and the gut fulfills its own 
amino acid needs first.  
In specific, a notable observation was the disproportionate high 
utilization of threonine by the intestinal tissues in both preterm 
neonates and piglets (Chapter 2 and 7). During protein restriction, the 
equivalent of virtually the total dietary threonine intake was extracted 
by the mucosal cells. Obviously, the intestine has a very high 
obligatory need of dietary threonine, presumably to support the 
substantial (glyco-)protein synthesis. Mucin is a (glyco-)protein with a 
high molecular mass and regions rich in threonine, and it is the main 
constituent of the gastrointestinal mucus which protects against 
bacteria, self-digestion and toxins. Considering the relatively large 
mass of the small intestine and its high secretory and proliferatory 
activity, the mucus layer is in a permanent state of renewal. It 
probably represents one of the most significant contributions to the 
flow of endogenous protein out of the small intestine. 24 Intestinal 
reabsorption of endogenous protein was estimated to be equivalent to 
at least 86% of the jejunum flow, 25 demonstrating the importance of 
mucins as a source of endogenous nitrogen. In line with our observed 
high intestinal threonine utilization irrespective of the dietary protein 
intake (Chapter 2 and 7), Fan et al. showed a strong relationship in 
pigs between protein intake and the apparent ileal digestibility of 
amino acids. 26,27 The strength of this relationship suggests that 
variations in the level of protein intake have little impact on the amino 
acid compositions of the endogenously secreted (glyco-)proteins. 28 
Therefore, the intestinal utilization of amino acids for protein synthesis 
does not necessarily involve a net loss from the body, as the amino 
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acids subsequently released from protein breakdown are available for 
reutilization. Moreover, we showed that intestinal recycling of amino 
acids made a significant contribution to the systemic availability of 
amino acids. Over a 24-h period including a fed and a fasted state, 
26% of the dietary protein intake reappeared in the portal vein by way 
of recycling of previously secreted (glyco-)proteins (Chapter 3). 
On the other hand, the utilization of amino acids by the gut tissue 
for purposes other than protein synthesis (i.e. oxidation) has important 
effects on whole-body amino acid economy (Chapter 4). In the 
neonatal pigs, we found that substrate metabolism, including 
catabolism, is compartmentalized in the intestinal tissues, in 
accordance with previous reports of intestinal channeling of dietary and 
arterial amino acids. 29,30 Using simultaneous intragastric and 
intravenous threonine tracers, we measured an equal utilization by the 
PDV of both dietary and systemic threonine (Chapter 2). Although both 
tracers were utilized by the intestinal tissues, the amount of dietary 
threonine being used for oxidative purposes was higher than threonine 
from the arterial site during protein restriction. In other words during a 
limited enteral protein supply, there is substantial greater chance of a 
threonine molecule that enters the enterocytes via the apical 
membrane being oxidized than one that enters the cell from the 
arterial site. Nevertheless, only 10% of the total threonine utilization 
by the PDV was used for oxidative processes under both feeding 
conditions, implying not a major metabolic fate. Furthermore, it is 
important to note that when account is taken of the relative molar 
uptake of amino acids from the diet and the mesenteric artery, dietary 
threonine becomes even more important for the intestinal tissues for 
synthetic purposes.  
Other potential fuels for the PDV are glucose and amino acids in 
general, but the relative importance of these substrates and the 
changes that occur with lowering the level of protein are poorly 
established in vivo until recently. Furthermore, the relative importance 
of these fuels may differ among species. Chapter 3 deals with the 
substrates for intestinal energy generation in neonatal pigs. We found 
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in normally-fed pigs that arterial glucose and enteral glutamate were 
the most important sources of energy for the intestinal tissues, with 
leucine and threonine being less important energy substrates. In fully-
fed human neonates, we could not demonstrate any lysine or threonine 
oxidation by the intestine (Chapter 6 and 7). Glucose, similar as in 
pigs, was a major important intestinal fuel source (Chapter 8). The 
results in preterm infants show that essential amino acids, i.e. lysine 
and threonine, are utilized by the intestine for other metabolic fates, 
implying nutritional efficacy early in postnatal life.   
In both species, we investigated the effect of lowering the level of 
dietary protein on intestinal substrate oxidation. In neonatal pigs fed a 
low protein diet, the intestinal tissues maintain a high rate of energy 
expenditure by increasing the oxidation rate of dietary glucose, and 
reducing the amino acid oxidation (Chapter 4). Presumably, fatty acids 
and ketone bodies become more important for intestinal energy 
generation in order to favor the availability of dietary amino acids for 
whole-body growth. Results from our studies in human preterm infants 
showed that dietary essential amino acids are not used for oxidative 
purposes when dietary protein is limiting, like in normal feeding 
circumstances, whereas dietary glucose is a major important fuel 
source during both a high and a low protein intake. These results are 
consistent with the idea that dietary glucose acts as a fuel that is used 
up first by the intestine, whereas dietary amino acids are used for 
other metabolic pathways in preterm infants. 
As shown by these results, there is a substantial variation in 
intestinal metabolism among amino acids and glucose, reflecting the 
fact that whereas some are catabolized within the intestinal tissues, 
others are synthesized. From other studies we know that the dietary 
leucine oxidation does not reflect the oxidation of all the amino acids, 
as amino acids exhibit different regulatory levels with regard to 
oxidative pathways. In healthy adults receiving increasing levels of 
dietary protein, leucine oxidation was significantly decreased, whereas 
lysine catabolism remained constant. 31 In other words, essential 
amino acids respond differently to identical metabolic situations. And 
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therefore, estimates using single amino acid kinetics may not 
adequately represent the dynamic aspects of whole-body protein 
metabolism. 
 
Methodological critical points  
Amino acid kinetics studies during feeding raise several methodological 
issues. The amino acid composition, protein quantity and protein 
digestion rate of dietary proteins are major factors affecting whole-
body protein accretion. The speed of absorption of dietary amino acids 
depends on gastric and intestinal motility, luminal digestion and on 
mucosal absorption. Moreover, nitrogen can be ingested as either 
whole-body proteins, free amino acids, or peptides of various chain 
lengths, the two latter forms being used in enteral nutrition when 
digestive capacities are compromised. Given the different transporters 
for free amino acids and peptides in the intestinal mucosa, different 
absorption times are reported for these three substrates. 32 Dipeptides 
can be absorbed directly by the enterocyte faster than a free amino 
acid mixture. However, the absorption of a peptide based diet closely 
depends on the peptide profile (e.g. chain length). Whether or not a 
faster absorption renders into a better nitrogen utilization is 
controversial. 33,34 Boirie et al. proposed the concept of “slow and fast 
proteins”. 35 They found that the plasma appearance of dietary amino 
acids is high, fast and transient after whey protein (WP) ingestion. In 
contrast, they found that the plasma appearance of dietary amino acids 
after casein protein (CAS) ingestion is lower and slower. However, the 
significance of these findings for the interpretation of the intestinal and 
whole-body requirements of dietary proteins in neonates, is unclear, as 
a single meal of protein alone was given. Nenatal®, the standard milk 
feeding of preterm neonates besides human milk, consists of both WP 
and CAS protein, carbohydrates and fat. Therefore, we speculate that 
the concept of slow and fast absorption is blunted during more complex 
meals as Nenatal®. Moreover, in the studies presented in this thesis, 
measurements regarding amino acids kinetics are done 4-5h after 
initiation of continuous feeding, once isotopic and substrate steady 
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state is achieved. Under these conditions, any difference related to the 
speed of dietary amino acid absorption is faded away.  
Another confounding factor in studying amino acid kinetics, might 
be the different postprandial metabolic fate of labeled tracers when 
they are ingested as a component of mixed meals (intrinsically labeled) 
or together with a mixed meal (extrinsically labeled). In our studies we 
used extrinsically labeled tracers. However, a potential error at this 
level was not found by Metges et al. In steady state conditions, free 
[13C]leucine added to protein induced identical enrichments and leucine 
fluxes to those observed with an intrinsically [13C]leucine-labeled  
protein. 36 Therefore, it is likely that free tracers added to 
Nenatal®/Litterlife® solutions does represent the digestion rate of the 
meal, at least during the steady state period.  
Finally, recycling of an amino acid tracer can influence amino acid 
kinetics. A labeled amino acid can be incorporated into and 
subsequently be released from protein over the course of an isotope 
infusion, called recycling, and can result in significant errors in kinetic 
parameters. The occurrence of recycling of an amino acid label has 
been suggested on the basis of studies employing isotope infusions for 
up to 18 h in humans. 37 Studies carried out in a limited number of 
subjects demonstrated delayed decline of the isotope from the plasma 
after 8h of isotope infusion compared with 4h of isotope infusion. 38 We 
performed 5h tracer infusions, and our experimental design did not 
permit us to determine when significant recycling occurred. Therefore, 
we presume that the re-entry of the label was very small.  
 
Future perspectives  
There has been limited research regarding the nutritional requirements 
of ill and physiologically unstable preterm infants. The rate of 
administration of protein to septic neonates is currently based on 
nutrition studies performed in healthy term and preterm infants. 39,40 
The available literature suggests that septic neonates have increased 
muscle proteolysis, decreased protein synthesis, and a negative 
nitrogen balance during illness. Therefore, the impact of a catabolic 
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illness in the preterm neonate might be devastating, because growth 
will be discontinued, leaving the infant with a second “disease”: lost 
growth.  
Alterations in whole-body protein turnover in septic infants may be 
accompanied by more subtle changes in the metabolism of individual 
groups of amino acids. Healthy neonates have immature pathways of 
synthesis of some amino acids. Sepsis, with increased protein 
demands, and increased demands of specific amino acids, might 
increase these physiological immaturities. For example, there are 
alterations in phenylalanine metabolism in septic infants,  and cysteine, 
tyrosine and other amino acids may become conditionally essential. 41-
43 Furthermore, Becker et al. showed that infants with NEC have 
certain plasma amino acids deficiencies, i.e. arginine and glutamine. 44 
It is likely that these deficiencies are a result of consumption of these 
amino acids at critical locations during intestinal inflammation.  
Another nutritional important amino acid is arginine, which has 
been shown to be essential in piglets. 45 The importance of arginine to 
the neonatal intestine is related to its role as nitrogen donor for nitric 
oxide synthesis, and might be critical for maintenance of the immune 
function. 46-48 Nitric oxide plays an important role in regulating 
intestinal blood flow, integrity, secretion and epithelial cell migration. 49 
Given the extensive gut atrophy observed in parenterally fed piglets, 
arginine synthesis may therefore be inadequate to meet whole-body 
requirements. 50 In human neonates, limited information is known 
regarding the inter-organ arginine metabolism and the arginine 
requirements. In addition, because arginine deficiency, which cause 
life-threatening hyperammonemia, occurs in preterm infants, 51 it is 
important to elucidate the mechanisms responsible for arginine 
synthesis during fetal and postnatal development. A better 
understanding of the arginine requirement by the gut tissues in 
preterm infants may allow neonatologists to provide adequate arginine 
for growth of all body tissues. Therefore, this interesting area of amino 
acid metabolism merits further investigation.  
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No studies have investigated substrate metabolism in critically ill 
neonates, and no studies in infants have addressed the possibly 
beneficial impact of enteral nutrition on whole-body protein turnover 
during sepsis. We found high intestinal amino acid utilization rates in 
healthy VLBW infants, even during partial enteral feeding. It is 
conceivable that preterm infants with a compromised gut function, or 
septic preterm infants, have a substantial higher intestinal need for 
certain amino acids. In specific, threonine could play an important role 
in the maintenance of the gut integrity. By using the dual stable 
isotope approach in ill preterm infants, the intestinal needs of 
particularly important amino acids, e.g. threonine, arginine, and 
glutamate, can be determined. Knowing the requirements, can help in 
novel nutritional interventions in the ill preterm neonate. Supplying the 
intestine with enough energy substrates and amino acids for intestinal 
protein synthesis, will benefit the ill preterm infant by reducing a major 
complication; lost growth. Thus, future studies are merited to evaluate 
the need for specific amino acids in septic neonates and neonates with 
a compromised gut function.  
 
Concluding remarks 
Today, we have the opportunity to use stable isotopically labeled amino 
acid tracers to accurately determine amino acid kinetics at the level of 
individual and whole-body tissues. Moreover, the studies in this 
presented thesis show, once again, the applicability of the neonatal 
piglet model to the human neonate. These data are useful in increasing 
the precision of the diet formulation and growth modeling in neonates. 
The tracer method enables measurements of substrate requirements in 
preterm infants during periods of rapid change, such as postnatal 
growth. Our current knowledge of intestinal amino acid metabolism 
helps to explain why parenteral nutrition decreases protein synthesis in 
the intestinal mucosa, and further supports the concept that dietary 
amino acids are obligatory for maintaining intestinal mucosal mass and 
integrity. One theme that has emerged from this thesis is that 
intestinal amino acid metabolism plays an major role in modulating the 
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entry of absorbed dietary amino acids into the systemic circulation. 
Thus, the pattern of amino acids in the diet differs considerably from 
that in the portal circulation and does not reflect their availability to the 
peripheral tissues. This concept has important implications for protein 
and amino acid nutrition. First, the intestinal tissues can be seen as a 
amino acid pool, in which recycling plays an important role to favor the 
whole-body amino acid requirements. Second, catabolism of dietary 
essential amino acids in first-pass by the splanchnic tissues results in a 
decreased nutritional efficiency. Third, because of developmental 
changes and disease associated alterations in intestinal amino acid 
metabolism, these factors should be taken into consideration in 
recommending dietary amino acid requirements.  
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etween 26 and 36 weeks of gestation the weight gain of the fetus is 
higher than at any other period thereafter in life. This in utero 
phenomenon is potentially lost to the infant born preterm.  
Adequate nutrition should be provided to obtain similar growth rates as 
in utero, with protein being an important factor for whole-body growth in 
neonates. Given the key role of the gut in digesting and absorbing 
nutrients and its effect on whole-body growth, there has been 
considerable interest in the first-pass utilization and metabolism of amino 
acids by the intestine. This thesis describes the splanchnic amino acid 
metabolism in neonates in their first weeks of life. In the first part of this 
thesis, the intestinal amino acid metabolism is studied in neonatal piglets 
under different feeding regimens, including a fasting state. In the second 
part of this thesis, we investigated the first-pass and whole-body amino 
acid kinetics in preterm infants during partial enteral and full enteral 
feeding. 
In Chapter 1 we describe the background and aims of the studies 
presented in this thesis. We provide an introduction on the use of stable 
isotopes to assess splanchnic and whole-body protein kinetics in clinical 
studies. The available literature on protein metabolism in neonates is 
reviewed. 
In Chapter 2 we show the first-pass uptake and metabolism of 
threonine during a high and a low protein intake in neonatal piglets. 
Firstly, it appears that protein restriction in the diet has a substantial 
negative effect on total body weight. First-pass threonine utilization by 
the intestine is not significantly affected by a lower protein intake, but 
the dietary utilization is much lower. Notably, the net utilization of 
threonine by the PDV during low protein feeding is not different from the 
intake. Almost 98% of the total threonine utilization are derived from the 
diet, which is in contrast to the almost equimolar amounts of utilized 
systemic and dietary threonine during high protein feeding. Regarding 
the metabolic fate of the utilized threonine, the PDV oxidized both 
dietary and systemic threonine in almost equimolar amounts during both 
feeding intakes. However, threonine catabolism was not a major 
B 
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metabolic fate, the threonine oxidation by the PDV represented 
approximately 10% of the total threonine utilization by the PDV. 
In Chapter 3 we present a study in neonatal piglets during a 12-h 
fed and a 12-h fasted state. The recycling of (glyco-)proteins by the 
intestine is measured using different stable isotopically labeled lysine and 
threonine tracers and by quantifying the portal mass balances of all 
amino acids and glucose during a 24-h period. During a prolonged 
continuous feeding period (>6h), the gut utilizes a disproportionately 
large amount of the dietary protein intake, more than 50%. Moreover, 
during a 24-h period including a fed and a fasted state, 26% of the 
dietary protein intake reappears in the portal vein by way of recycling of 
previously secreted (glyco-)proteins released luminally by the intestine. 
In case of the essential amino acid lysine, after 6 h of feeding even 46% 
of lysine appearance in the portal vein was derived from secreted protein 
recycling. With the recycling we mean the following process: the majority 
of the utilized amino acids are incorporated into (glyco-)proteins that are 
secreted into the intestinal lumen. After secretion into the lumen, the 
synthesized proteins are either digested and reabsorbed, or they are 
passed to the colon, where they are degraded, fermented and lost from 
the body. When the previously secreted amino acids are digested and 
absorbed, they will finally appear in the portal circulation to become 
available for whole-body growth. 
Previous animal studies indicate that amino acids and glucose are 
the major oxidative substrates for intestinal energy generation. In 
Chapter 4, the intestinal substrate oxidation is quantified in neonatal 
piglets under high protein (0.9 g/(kg·h)) and low protein (0.4 g/(kg·h)) 
feeding conditions. During a high protein diet arterial glucose and enteral 
glutamate were the most important sources of energy (glucose iv 39% 
and glutamate id 32%) for the intestine. Visceral amino acid oxidation 
was substantially suppressed during a low protein intake, whereas 
glucose oxidation increased to 50% of the total visceral CO2 production. 
However, the oxidation of glucose and amino acids does not provide 
enough substrate for the energy requirements of the portal-drained 
viscera (PDV) during protein restriction. Suggesting that, the gut has to 
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use other substrates like fatty acids or ketone bodies to maintain the 
high mucosal metabolism.   
After the results obtained in neonatal piglets, we performed similar 
stable isotope studies in preterm infants to quantify the first-pass and 
whole-body kinetics of amino acids and to confirm the applicability of the 
neonatal piglet model, as presented in the second part of this thesis.  
In clinical studies, the oxidation of [13C]labeled substrates to 13CO2 
and the measurement of the appearance 13CO2 in expired air has 
progressed to an increasingly common method to study substrate 
oxidation. The collection of respiratory CO2 currently used, occurs via 
trapping of CO2 in sodium hydroxide (trapping method) sometimes in 
conjunction with indirect calorimetry. To collect breath samples from 
preterm infants in a suitable manner, we applied the direct naso-
pharyngeal sampling method. This technique collects expiratory CO2 
directly from the patient with a gastric tube placed for 1 to 1.5 cm in the 
nasopharynx. In Chapter 5, we validate our direct sampling method for 
the collection of breath samples in preterm infants with the trapping 
method. Isotopic breath enrichments obtained by the direct sampling 
technique are precisely related to isotopic breath enrichments garnered 
by the dynamic trapping method. Our results therefore imply that direct 
sampling method for the collection of expired air is a suitable method for 
the use in substrate oxidation studies in preterm infants. 
In Chapter 6 we describe the relationship between the level of 
enteral intake and the splanchnic and whole-body lysine kinetics in 
preterm infants. The infants were studied on average postnatal day 7 
and 8 with 40% enteral and 60% parenteral feeding and on average 
postnatal day 21 and 22 with full enteral feeding. The effects on first-
pass intestinal lysine uptake and metabolism are measured using dual 
stable isotope lysine tracer techniques. Approximately one-third of the 
dietary lysine is utilized in first-pass by the intestine during partial 
enteral feeding, compared to a lower fraction (18%) during full enteral 
feeding. None of this utilized lysine is oxidized in first-pass, neither 
during partial enteral feeding nor during full enteral feeding. 
Furthermore, the administration of full enteral feeding in preterm infants 
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results in a lower whole-body lysine oxidation and higher lysine retention 
than a low enteral nutrient supply. 
In Chapter 7, the first-pass threonine uptake by the intestine in 
preterm infants at different postnatal ages is investigated. We quantified 
threonine kinetics during a low enteral and a high enteral intake. The 
most striking observation to appear from this study is that the fractional 
first-pass threonine uptake by the intestine is very high in the first week 
of life in preterm infants during a restricted enteral intake. More then 
three-quarter of the enteral intake is utilized, which indicates a high 
obligatory visceral need for threonine in neonates, even in early life. As 
we did not find any first-pass threonine oxidation, we suggest that the 
major metabolic fate of intestinal utilized threonine is mucosal (glyco-
)protein synthesis. In addition, full enteral feeding does not affect the 
whole-body oxidation of threonine. 
Finally, in line with our results obtained in neonatal piglets on 
intestinal substrate oxidation, Chapter 8 describes the role of dietary 
glucose as an oxidative substrate for the intestine and the whole-body in 
preterm infants in their first weeks of life. Furthermore, the first-pass 
glucose uptake during both a low and high enteral intake is also 
quantified. Approximately one-third of the dietary glucose intake was 
utilized in first-pass by the intestine, irrespective of the dietary intake. In 
absolute amounts, the first-pass glucose uptake was significantly higher 
during full enteral feeding, due to a significant higher enteral intake. 
More than three-quarters of this utilized glucose was oxidized in both 
periods. In other words, dietary glucose is major important fuel source 
for the generation of intestinal energy in the first weeks of life in preterm 
neonates. 
    
In this thesis, it is shown that approximately 50% of the dietary 
amino acid intake are utilized by the portal-drained viscera (PDV) during 
a 24-h period including 12-h of feeding and 12-h of fasting. To sustain 
the high rate of protein turnover and energy expenditure, amino acids 
more than glucose, are major substrates for intestinal energy generation 
in neonatal piglets. However, during protein restriction glucose becomes 
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a more important fuel source, probably together with fatty acids and 
ketone bodies. To favor whole-body growth, intestinal recycling of amino 
acids contributes significantly to their systemic availability and may be a 
critical factor in the amino acid nutrition.  
Comparable with neonatal pigs, the first-pass utilization of amino 
acids by the intestine is substantial in preterm infants, even in their first 
week of life during a low enteral intake. For threonine, the first-pass 
uptake by the gut is as much as three-quarter of the enteral intake 
during partial enteral feeding, implying its particularly importance for the 
neonatal gut growth and function. In contrast to piglets, lysine and 
threonine are not used as a fuel source by the mucosal cells for their 
high intestinal metabolism. Glucose, on the other hand, is a major 
important oxidative substrate for the neonatal gut during both a low and 
a high enteral intake.  
Furthermore, it is shown that full enteral feeding lowers whole-body 
lysine oxidation and thereby improves whole-body lysine balance in 
comparison with partial enteral and parenteral feeding. Regarding 
threonine, the route of feeding does not effect whole-body threonine 
retention.   
The collection of expired air currently used for the measurement of 
excess 13C after an infusion of [13C]labeled substrates, is not well suited 
for use in a clinical situation. We have developed an alternative method 
for the collection of expired air enabling the calculation of substrate 
oxidation in preterm infants. This direct naso-pharyngeal sampling 
technique for the collection of breath samples, is a fast, non-invasive, 
suitable method in preterm infants for determination of substrate 
oxidation in combination with a [13C]bicarbonate infusion without the use 
of a correction factor.   
 
Overall, the results demonstrate the applicability of the results 
obtained in our animal model/neonatal piglets to human neonates. 
Furthermore, this thesis shows that specific amino acid requirement of 
the intestine is very high and that this requirement has a major impact 
on whole-body growth in the very vulnerable patient group of neonates. 
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The intestine acts selfishly during dietary protein restriction, resulting in 
a diminished systemic availability of dietary proteins. Presumably, to 
preserve a healthy and normal gastrointestinal function, the intestine has 
a high metabolic cost.  
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ergeleken met de intra-uteriene gewichtstoename van de foetus 
tussen de 26ste en 36ste zwangerschapsweek is de groei bij 
prematuren vaak lager.  
Dit “in utero” effect vindt namelijk niet plaats bij neonaten na een 
premature geboorte. Juiste en gebalanceerde voeding is nodig om een 
vergelijkbare groeisnelheid als in utero te verkrijgen. Een belangrijke 
factor voor groei bij neonaten is de opslag van eiwit. Gezien de 
essentiële rol van de darm bij de vertering en opname van 
voedingsstoffen en mede daardoor zijn invloed op de lichaamsgroei, is 
het niet verwonderlijk dat er veel interesse bestaat in het 
darmmetabolisme van aminozuren. Het eerste deel van dit proefschrift 
bestaat uit een serie studies op het gebied van intestinaal aminozuur 
metabolisme in neonatale biggen ten tijde van verschillende 
voedingsschema's. Het tweede deel beschrijft een aantal studies in 
prematuren met betrekking tot het aminozuurmetabolisme in first-pass 
door de darm en in het totale lichaam gedurende een lage en een hoge 
enterale inname. 
In Hoofdstuk 1 worden de achtergronden en doelstellingen 
beschreven van de studies, die in dit proefschrift gepresenteerd worden. 
Tevens wordt een inleiding gegeven over het gebruik van stabiele 
isotopen voor de bestudering van het eiwitmetabolisme.  
In Hoofdstuk 2 wordt een studie beschreven betreffende het 
threonine metabolisme in de darm bij neonatale biggen onder 
omstandigheden van een normale en beperkte eiwitinname. Allereerst 
blijkt dat het verlagen van de eiwitinname een duidelijk negatief effect 
heeft op de gewichtstoename. Een lage enterale eiwit inname heeft geen 
effect op het first-pass threonine verbruik, al het enteraal aangeleverde 
threonine wordt verbruikt door de PDV. Dit betekent dat er geen 
threonine systemisch beschikbaar komt, zodat, gezien de essentialiteit 
van threonine, er ook geen netto synthese van lichaamseiwitten kan 
plaatsvinden en dus ook geen groei. Ondanks het hoge first-pass 
verbruik van threonine door de darm, is threonine niet de belangrijkste 
brandstof voor de darm, slechts 10% van de opgenomen threonine wordt 
verbrand zowel tijdens een hoge als een lage eiwitinname. 
V 
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In Hoofdstuk 3 wordt een studie beschreven in neonatale biggen 
onder specifieke omstandigheden van voeden en vasten. Om de recycling 
van (glyco-)proteïnen door de darm te kwantificeren gedurende een 24-
uurs periode, hebben we gebruik gemaakt van verscheidene stabiel 
isotoop gelabelde lysine en threonine tracers. Tevens werden ieder uur 
arteriële en portale bloedmonsters afgenomen om de netto balans van 
glucose en aminozuren door de portaal gedraineerde viscera (PDV) te 
berekenen. Met behulp van masspectrometrie werd vervolgens de 
verrijking van lysine en threonine in het arteriële en portale bloed 
gemeten. Gedurende de eerste 6 uur van de continue voedingsperiode 
wordt netto 66% van de voedingseiwitten door de darm verbruikt. In de 
tweede helft van de voedingsperiode wordt minder verbruikt, hoewel nog 
steeds een substantieel deel van de inname (48%). Over de gehele 
voedingsperiode komt uiteindelijk 26% van de enterale eiwitinname 
systemisch beschikbaar als gevolg van recycling van intestinaal 
geproduceerde (glyco-)proteïnen. Voor lysine geldt zelfs dat 46% van de 
inname beschikbaar komt voor het lichaam als gevolg van recycling. Met 
recycling wordt het volgende proces bedoeld: een deel van de door de 
darm verbruikte aminozuren wordt gebruikt voor synthese van (glyco-) 
proteïnen. Deze (glyco-)proteïnen worden in het darmlumen 
uitgescheiden. Vervolgens worden deze intestinale eiwitten weer 
verteerd en geabsorbeerd door de darm, zodat dit deel van de verbruikte 
aminozuren uiteindelijk systemisch beschikbaar komt voor het lichaam.
  
In Hoofdstuk 4 worden de resultaten van een studie in neonatale 
biggen gepresenteerd waarin we onderzochten of aminozuren ook onder 
omstandigheden van beperkte eiwitinname als de belangrijkste 
energiebron voor de darm zouden fungeren. De oxidatie van aminozuren 
(glutamaat en leucine) door de PDV draagt, onder normale 
voedingscondities, voor tenminste 44% bij aan de energiebehoefte, 
terwijl de oxidatie van glucose een bijdrage levert van 39%. Door het 
toedienen van eiwitbeperkte voeding wordt de verdeling in brandstoffen 
substantieel anders. De bijdrage van aminozuren als verbrandings-
substraat daalt tot slechts 10%. Daarentegen wordt glucose een 
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belangrijkere bron en de glucose oxidatie bedraagt voor 52% bij aan het 
totale energieverbruik. Deze relatieve toename in oxidatie van glucose 
kan echter niet het verlies van aminozuren als energiebron 
compenseren. Waarschijnlijk nemen korte-keten vetzuren of 
ketonlichamen een deel voor hun rekening. 
Na de resultaten verkregen bij neonatale biggen, hebben we 
vergelijkbare studies gedaan in prematuren om meer inzicht te 
verkrijgen in het metabolisme van aminozuren en glucose door de darm, 
en om te kijken of de resultaten verkregen met het biggenmodel 
toepasbaar zijn op prematuren kinderen. Het tweede deel van dit 
proefschrift beschrijft  zodoende verschillende studies in prematuren met 
stabiel isotoop gelabelde tracers. 
In Hoofdstuk 5 worden twee methoden vergeleken, die gebruikt 
worden bij prematuren om de CO2 productie van het lichaam te schatten. 
Onze directe methode voor het afnemen van uitademinglucht bij 
prematuren is niet-tijdrovend en makkelijk uitvoerbaar in vergelijking 
met de natronloog techniek. De 13C-verrijking in de uitademinglucht, 
gemeten met beide methoden, komt goed overeen. Het direct opvangen 
van uitademinglucht in combinatie met de infusie van [13C]bicarbonaat is 
dan ook een geschikte methode om bij prematuren de verbranding van 
substraten te meten.    
In Hoofdstuk 6 wordt de relatie beschreven tussen de enterale 
eiwit inname en het splanchnisch dan wel het totale 
lichaamsmetabolisme van lysine. De neonaten werden bestudeerd tijdens 
twee verschillende perioden; periode A: 40% enterale en 60% 
parenterale voeding en periode B: volledig enterale voeding. Met behulp 
van verschillende stabiel isotoop gelabelde lysine tracers intraveneus of 
intragastrisch toegediend,  was het mogelijk om de netto absorptie en 
oxidatie van lysine uit de zuigelingenvoeding te meten. Circa eenderde 
van de enterale lysine inname wordt verbruikt in first-pass door de 
neonatale darm, in vergelijking met een lagere fractie (18%) tijdens 
volledig enterale voeding. Er wordt geen enteraal lysine geoxideerd door 
de premature darm, in tegenstelling tot de resultaten gevonden bij 
neonatale biggen. Daarnaast leidt het toedienen van volledig enterale 
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voeding tot een hogere lysine retentie in het lichaam als gevolg van een 
lagere oxidatie van lysine in vergelijking met de toediening van een 
combinatie van parenterale en enterale voeding. 
In vervolg op Hoofdstuk 4 wordt in Hoofdstuk 7 een studie 
beschreven bij premature kinderen betreffende het intestinale threonine 
metabolisme onder omstandigheden van een beperkte en normale 
enterale eiwitinname. Het relatieve first-pass verbruik van threonine is 
zeer hoog met de enterale inname, driekwart van de threonine inname 
wordt verbruikt door de neonatale darm tijdens de eerste levensweek. 
Met andere woorden, de threonine behoefte van de darm is zeer hoog en 
onafhankelijk van de threonine inname. Er vindt geen oxidatie van 
threonine plaats in de darm, suggererend op een andere metabole 
"pathway" voor threonine, namelijk de synthese van (glyco-)proteïnen. 
Verder heeft het toedienen van volledig enterale voeding geen significant 
effect op de lichaamsoxidatie en balans van threonine in vergelijking tot 
gedeeltelijk parenterale en enterale voeding.  
Tot slot, in navolging van het onderzoek bij neonatale biggen 
beschreven in hoofdstuk 3, werd de rol van glucose als brandstof voor de 
darm in detail bestudeerd bij prematuren tijdens twee verschillende 
enterale innamen. Hoofdstuk 8 beschrijft dit onderzoek, waarin tevens 
het first-pass verbruik van glucose tijdens gedeeltelijke 
enteraal/parenteraal en volledig enterale voeding wordt onderzocht. Uit 
deze studie blijkt dat de darm ongeveer eenderde van de glucose uit de 
voeding verbruikt, ongeacht de hoeveelheid aangeboden voeding. Het 
voornaamste doel van dit hoge percentage opgenomen glucose door de 
darm is oxidatie. Zo’n 80% van de opgenomen glucose wordt gebruikt 
voor oxidatieve processen in de darm. Met andere woorden, glucose uit 
de voeding is een belangrijke brandstof voor de premature darm in de 
eerste levensweken. 
 
Uit dit proefschrift blijkt dat ongeveer de helft van de eiwitinname 
wordt verbruikt door de portaal gedraineerde viscera (PDV) en in eerste 
instantie dus niet systemisch beschikbaar komt. Het hergebruik van door 
de darm geproduceerde (glyco-)proteïnen vormt uiteindelijk een 
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belangrijke bijdrage aan de totale systemische beschikbaarheid van 
aminozuren, met name tijdens vasten. Om het hoge eiwitmetabolisme en 
energieverbruik te handhaven, verbruikt de PDV verschillende 
voedingsstoffen. Uit onze studies met neonatale biggen onder normale 
voedingscondities blijkt dat aminozuren, en niet glucose, als de 
belangrijkste brandstof voor de darm dienen. Daarentegen dienen 
aminozuren tijdens eiwitbeperking nauwelijks meer als brandstof voor de 
portaal gedraineerde viscera.   
In vergelijking met neonatale biggen vindt er ook een hoog verbruik 
van aminozuren door de darm plaats bij premature kinderen, zelfs 
tijdens een lage enterale inname. In het geval van threonine geldt zelfs 
een first-pass verbruik van meer dan driekwart van de enterale inname, 
duidend op een enorme behoefte aan threonine voor groei en andere 
mucosale functies. In tegenstelling tot de oxidatie van aminozuren bij 
biggen, worden lysine en threonine niet gebruikt als brandstof door de 
premature darm. Glucose daarentegen, speelt wel een cruciale rol in de 
energievoorziening van de darm, zowel tijdens een lage als een hoge 
enterale eiwitinname. Vervolgens blijkt uit dit proefschrift dat parenteraal 
toegediend lysine niet zo effectief als is enteraal toegediend lysine in het 
bevorderen van eiwitdepositie.  
Verschillende technieken kunnen worden gebruikt bij prematuren 
om uitademinglucht op te vangen om zodoende de CO2 productie van het 
lichaam te schatten. Wij hebben een alternatieve methode gevalideerd, 
waarbij direct verrijkte uitademinglucht wordt opgevangen en kan 
worden gemeten met behulp van massa-spectrometrie. Deze techniek is 
snel en makkelijk uitvoerbaar en kan goed worden gebruikt in oxidatie 
studies bij kinderen in de toekomst.  
 
Zowel de resultaten in het proefdiermodel als in de prematuren 
geven aan dat het darmmetabolisme een enorme weerslag heeft op de 
systemische beschikbaarheid van voeding. Het blijkt dat een gezonde 
darm in de eerste levensfase meer dan de helft van de aminozuren uit de 
voeding consumeert. Voor threonine geldt zelfs een zeer hoog verbruik 
door darm, tot 82% van de enterale inname. Tevens is het duidelijk dat 
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de darm zich egoïstisch gedraagt wanneer de enterale voedselinname 
vermindert, zodat er systemisch nog minder beschikbaar komt van de 
voeding. Blijkbaar kost het instandhouden van een gezonde darmfunctie 
in de eerste levensfase veel eiwit en glucose. 
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